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Abstract
Corticosterone is the main glucocorticoid in rodents. Its secretion follows a circadian
rhythm and is increased in response to stress. Corticosterone is thought to possess
rewarding effects. For example, enhanced corticosterone secretion is associated with
the exposure to natural rewards such as food, sex and running, and it has been
reported that corticosterone is implicated in drug-seeking behaviour. In addition, rats
orally self-administer the steroid hormone and are motivated to nose-poke for stress-
like levels of corticosterone, suggesting that the stress hormone has rewarding effects
on its own, although this proposal is not supported by conditioned place preference
studies. Corticosterone is also found to be critical for learning and memory
performance, but it is unclear whether cognitive effects of the hormone are modulated
by its rewarding properties. Elevated glucocorticoid levels have been reported to
accompany certain psychiatric and cognitive disorders, but it is not clear whether this
is an underlying cause or a consequence of these diseases.
The two broad aims of the present thesis were to investigate potential rewarding
properties of corticosterone in C57BL/6J male mice and to examine their long-term
impacts on cognition. In the first experiment, mice were subjected to a prolonged two-
bottle choice test to measure their preference for the stress hormone. Results indicated
that mice were motivated to self-administer corticosterone at high doses and this was
accompanied by enhanced dopamine turnover in the striatum, suggesting that the
rewarding effects of corticosterone involve the mesolimbic dopamine pathway; the
activity of which is enhanced by the majority of addictive drugs. Corticosterone self-
administration did not impair recognition memory in most groups, but it did improve
spatial memory.
Importantly, corticosterone self-administration induced neuroplasticity changes in the
hippocampus and frontal cortex, indicating the involvement of these memory
processing areas in the development of corticosterone-seeking behaviour. These
results suggest that corticosterone self-administration is associated with spatial
memory improvement in mice. Therefore, the remainder of the studies aimed to use a
stressful natural reward (voluntary wheel running) to extend our understanding of the
role of corticosterone in stress-seeking behaviour and its memory-related effects. The
preliminary results revealed that single or repeated 1-hour running sessions increased
plasma corticosterone levels. Moreover, metyrapone (a corticosterone synthesis
inhibitor) attenuated the running performance of trained mice. In another pilot study,
repeated running sessions prevented the improvement of the spatial memory of mice
but did not impair their recognition memory compared to non-exercising mice. The
final study was undertaken to determine the influences of pharmacological blockade
of glucocorticoid or dopamine D2 receptors on the running performance and the
exercise-related effects on memory in mice. In contrast to metyrapone, mifepristone
(a glucocorticoid receptor antagonist) did not decrease running distances of mice, but
it did induce recognition memory impairment in non-exercising mice. These memory
deficits were reversed by running, suggesting that exercise-evoked corticosterone
increase is involved in the cognitive effects of wheel running. On the other hand, a
dopamine D2 receptor antagonist (sulpiride) attenuated the running performance of
mice and induced exercise-dependent opposite effects on memory. Overall, the results
of this thesis support the hypothesis that corticosterone is rewarding in mice, and that
these effects probably enhance certain aspects of cognition.
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Chapter 1
General Introduction
1.1 Brain and reward
Over the last decades, the science of reward has progressed markedly. Olds and
Milner (1954) were the pioneers in this research field, when they discovered
that electrical stimulation in the septal region or lateral hypothalamus reinforced
rats to lever-press.
1.1.1 Brain areas mediating reward
The mesolimbic dopamine pathway (Fig. 1.1), which has been found to be
activated by natural rewards and abused drugs, is anatomically described as a
part of the mesotelencephalic dopamine system, which also includes the
mesocortical and mesostriatal dopamine pathways (Gardner and Ashby, 2000).
Dopaminergic neurons (A10 group of midbrain dopaminergic neurons) in the
mesolimbic system originate mainly from the ventral tegmental area with some
other neurons projecting from different sites of the substantia nigra and the
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retrorubal dopamine cell field (Gardner and Ashby, 2000), indicating the
involvement of the nigrostriatal dopamine pathway in the response to rewards
(Wise, 2009). These neurons innervate the nucleus accumbens shell, amygdala,
bed nucleus of the stria terminalis, ventral striatum (olfactory tubercles and
nucleus accumbens core), lateral septum, lateral hypothalamus, thalamic loci
and the diagonal band of Broca (Gardner and Ashby, 2000; Wise, 2009), Fig.
1.1. The mesocortical dopaminergic neurons (A10, mainly, and A9) originate
from the ventral tegmental area and project to the cortex including medial,
prefrontal, cingulate and entorhinal cortex (Marsden, 2006), Fig. 1.1. On the
other hand, mesostriatal dopaminergic neurons (A9), which have been thought
to modulate motor function, leave the substantia nigra pars compacta to the
dorsal striatum (caudate-putamen) (Marsden, 2006), Fig. 1.1. The major
neurotransmitters which regulate the activity of these dopamine pathways are
glutamate, GABA, noradrenaline, opioids and endocannabinoids (Marsden,
2006; Koob and Le Moal, 2008; Belujon and Grace, 2011).
1.1.2 Role of dopamine in the rewarding process (dopamine/reward theory)
Exposure to rewards such as food (Hernandez and Hoebel, 1988), sex (Damsma
et al., 1992) and drugs of abuse; e.g. amphetamine, cocaine, morphine, nicotine,
alcohol (Di Chiara and Imperato, 1988; Volkow et al., 2011) and phencyclidine
(McCullough and Salamone, 1992) has been associated with a rise in
extracellular dopamine concentration in the nucleus accumbens and striatum.
Imaging studies using either single-photon emission computed tomography
(Laruelle et al., 1995) or positron emission tomography (PET) / magnetic
resonance imaging (MRI) (Drevets et al., 2001) have shown in healthy
individuals a positive correlation between euphoria and D-amphetamine-
induced dopamine release in the striatum, suggesting that dopamine mediates
drugs of abuse-related reward. Drugs of abuse increase synaptic dopamine
levels directly by blocking dopamine reuptake (cocaine) or by enhancing
dopamine release via reversing dopamine reuptake (amphetamine) and
indirectly by controlling the activity of other neurotransmitters; such as GABA,
opioids, serotonin, glutamate or endocannabinoids, which modulate the activity
of the mesocorticolimbic dopamine system (Tomkins and Sellers, 2001; Koob
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and Le Moal, 2008). In contrast, chronic administration of addictive drugs has
been found to be associated with a decrease in dopamine release. For instance,
PET studies indicated that cocaine addicts exhibited attenuated euphoria and
dopamine release in the striatum but increased responses to methylphenidate (a
dopamine reuptake inhibitor) in the thalamus, indicating cocaine craving
(Volkow et al., 1997). Overall, activation of mesocorticolimbic dopaminergic
neurons is involved in the response to primary rewards and abused drugs, but
chronic exposure to addictive drugs could be accompanied with reduced activity
of the mesolimbic dopamine pathway and enhanced dopamine
neurotransmission in other brain areas such as the thalamus, indicating
compulsive drug-taking behaviour.
The dopamine theory of reward was introduced by Wise et al. (1978). Three
hypotheses have been extensively studied to explain the role of dopamine in the
rewarding process.
1. The anhedonia hypothesis developed by (Wise, 1982; Wise, 2008) states
that dopamine is responsible for liking a reward; i.e. dopamine gives a
rewarding substance such as food their goodness or hedonic properties.
In support of this hypothesis, dopamine receptor antagonists such as
pimozide were found to attenuate animals lever-pressing response to
access food (Wise et al., 1978). The assumption was, however,
contradicted by the fact that schizophrenics present with anhedonia
while being treated with dopamine receptor antagonists (neuroleptics).
However, neuroleptics were found to treat positive symptoms of
schizophrenia rather than the negative symptoms which include
anhedonia (Wise, 2008). An important point is that the effects of
neuroleptics were interpreted as attenuation of positive reinforcement
rather than induction of anhedonia.
2. The incentive (appetitive) salience hypothesis states that dopamine is
important for wanting; so dopamine motivates an individual to work for
a reward. Indeed, depletion of brain dopamine was associated with
decreased motivation for approaching sucrose in rats, despite their
ability to discriminate the sweet (hedonic) taste of sucrose versus the
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bitter (aversive) taste of quinine (Berridge, 1996; Berridge and
Robinson, 1998).
3. Finally, the reward prediction hypothesis proposes that dopamine
increases in the brain when an individual predicts that he/she will obtain
something rewarding (Gluck, 2008). For example, in monkeys first
trained to press a lever to receive juice signalled by a cue such as a light
or a screen picture, brain dopamine levels were found to rise in response
to the presentation of the cue in anticipation of the juice and then to drop
after it was drunk (Hollerman and Schultz, 1998; Schultz, 1998).
Altogether, these hypotheses led to the view that dopamine plays a role in the
anticipation of rewards, reward conditioning and energizing approach behaviour
rather than in mediating hedonic effects of rewards (Ikemoto, 2010).
1.1.3 Dopaminergic neurons and receptors
Dopaminergic neurons are either spontaneously active (population neurons) or
inactive (Grace and Bunney, 1983). The active neurons have two different
patterns of activity, slow irregular tonic and phasic bursting firing (Grace and
Bunney, 1984b; Grace and Bunney, 1984a). The phasic activity has been found
to be induced in response to rewards such as abused drugs (Schultz, 1998). A
diagrammatic representation of neuronal dopamine synthesis is given in Fig.
1.2.
Dopamine mediates its effects through 2 major classes of G protein-coupled
receptors: D1-like receptors (D1, D5) and D2-like receptors (D2, D3, D4), the
first class activates and the second class inhibits the adenylyl cyclase/cAMP/
protein kinase A pathway (Kebabian and Calne, 1979; Lu et al., 2006; Marsden,
2006; Lee and Messing, 2008) which activates cAMP response element binding
protein (CREB) and dopamine- and cAMP-regulated phosphoprotein (32 kDa)
which regulates dopamine signaling (Lee and Messing, 2008), Fig. 1.3.
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Figure 1.1 Three dopaminergic pathways in the brain: mesolimbic (ML),
mesocortical (MC) and nigrostriatal (NS). For ML and MC, dopaminergic
neurons (solid lines) project from the ventral tegmental area (VTA) to the
nucleus accumbens (NAc) and to the prefrontal cortex (PFC). VTA receives
inhibitory GABAergic neurons (dotted lines) from NAc via the ventral
pallidum (VP) and excitatory glutamatergic neurons (divided lines) from
PFC. In NS dopamine pathway, the substantia nigra pars compacta sends
dopaminergic neurons to the caudate-putamen (CU-PU), and receives
glutamatergic neurons from PFC. DA = dopamine, GLU = glutamate. This
diagram was adapted from (Marsden, 2006).
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D1 and D2 receptors are highly expressed in the nucleus accumbens, caudate-
putamen and olfactory tubercle (Marsden, 2006). D2 receptors are expressed at
pre- and postsynaptic sites and activation of presynaptic D2 autoreceptors
decreases dopamine release (Marsden, 2006). D2 receptors are expressed as two
isoforms, D2S (D2 short) and D2L (D2 long), which are encoded by seven
exons of D2 receptor genes (Vallone et al., 2000). Moreover, D3 receptors are
highly abundant in the limbic system and to a lesser extent in the dorsal striatum
(Marsden, 2006). Molecular mechanisms of dopamine D1 and D2 receptors are
illustrated in Fig. 1.3. D1 receptors have a lower affinity for dopamine than D2
receptors, and thus their activation increases by dopamine release evoked by
phasic dopaminergic neuronal firing (Volkow et al., 2012). In contrast, D2
receptors are activated by the tonic activity pattern of dopaminergic neurons
(Volkow et al., 2012). It has been reported that D1 receptors are involved in
abused drugs-induced sensitization (Bertran-Gonzalez et al., 2008), but the
majority of abused drugs reduce levels of D2 receptors in the striatum (Volkow
et al., 2007; Volkow et al., 2009) and this is associated with increased
compulsive drug-taking behaviour (Perez et al., 2011).
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Figure 1.2 Neuronal synthesis and metabolism of dopamine (Marsden, 2006).
After its release in the synaptic gap, dopamine acts on its main receptors:
postsynaptic D1 receptors and pre- (autoreceptors) and postsynaptic D2
receptors. Reuptake of extracellular dopamine is mediated by dopamine
transporters (DAT) into the nerve terminal. Neuronal dopamine is subjected to
reuptake by vesicular monoamine transporters (VMAT2) or breakdown by
monoamine oxidase (MAO). DA = dopamine.
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Figure 1.3 Molecular mechanisms of dopamine D1 and D2 (Lee and Messing,
2008) and glucocorticoid receptors (Fink, 2010). G proteins: stimulatory Gs and
Gq and inhibitory Gi/o, AC = adenylyl cyclase, PKA = protein kinase A,
DARPP-32 = dopamine- and cAMP-regulated phosphoprotein of 32 kDa, CREB
= cyclic AMP response element binding protein, GCs = glucocorticoids, GR =
glucocorticoid receptor, mGR = membrane glucocorticoid receptor, GRE =
glucocorticoid response element, nGRE = negative glucocorticoid response
element.
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1.1.4 How to verify that a drug or behaviour is rewarding?
Three essential criteria are needed to establish whether a drug or behaviour is
rewarding, or not.
1. Individuals should show a clear preference for the drugs or behaviours
and self-access them if they have rewarding properties. In pre-clinical
studies, several methods can be performed, such as self-administration
studies, conditioned place preference (CPP); association between the
exposure to a reward and environmental cues, and behavioural
sensitization (Ikemoto, 2010). Addicts should also be able to describe
the euphoric potential of administered drugs (Laruelle et al., 1995).
2. There should be a clear association between specific brain
neurotransmitters and specific reward-related behaviours (Robbins and
Everitt, 1996). This can be assessed by using microdialysis (Devine et
al., 1993) and voltammetry (Doherty and Gratton, 2007) techniques,
which measure the change in the levels of certain neurotransmitters in
specific brain areas previously reported to be activated in response to
abused drugs. Conversely, the abused drug could be injected in specific
brain areas such as the nucleus accumbens (Delfs et al., 1990) to test
their involvement in the rewarding effects of the drug. In humans,
imaging studies have been used to investigate which areas and
neurotransmitters in the brain are associated with drug-induced euphoria
(Volkow et al., 2012).
3. The blockade of these secreted neurotransmitters by pharmacological
approaches such as antagonism of dopamine receptors (David et al.,
2002) or by destroying the dopaminergic neurons using 6-hydroxy
dopamine (Berridge and Robinson, 1998) should abolish the expression
of their reward-related behaviour.
1.1.5 Drug addiction
Drug addiction is a chronic relapsing disorder induced by rewarding effects of
abused drugs in susceptible individuals (10-20 % of drug abusers who have no
control on drug intake). According to the Diagnostic and Statistical Manual of
Mental disorders fourth edition (DSM-IV), substance-dependents are described
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as those demonstrating uncontrolled compulsive drug intake despite negative
consequences (Volkow et al., 2012). There are three main characteristics of
drug addiction or substance dependence: compulsive seeking for the drug, loss
of control when intake is reduced and appearance of negative emotional
symptoms such as dysphoria and anxiety upon stopping the drug access (Koob
and Le Moal, 2008). Risk factors such as stress, drug access, adolescence,
genetic background and addictive properties of the abused drugs have been
reported to increase the vulnerability to drug-seeking behaviour (Volkow and
Li, 2005; Koob and Le Moal, 2008).
In rodents, increased locomotor activity (behavioural sensitization) following
repeated exposure to abused drugs, such as psychostimulants, is an important
sign of addiction (Robinson and Berridge, 1993), while continuous drug
administration may result in the development of tolerance which is the
reduction of drug-induced euphoria with repeated administration of a fixed dose
of a drug (Nestler, 1992). Previous research has implicated dopamine in the
control of locomotor activity and in abused drugs-related locomotor
hyperactivity. For example, intracerebral injections of morphine into the ventral
tegmental area of rats selectively increased their locomotor activity, an effect
blocked by prior administration of the opioid receptor antagonist, naloxone, or
with the antipsychotic D2 receptor antagonist, haloperidol (Joyce and Iversen,
1979). In addition, direct microinjections of cocaine in the nucleus accumbens
produced a dose-dependent increase in locomotor activity of rats (Delfs et al.,
1990).
Drug addiction develops in consecutive stages: drug taking (feeling euphoric or
high), impulsive drug use (feeling aroused and tense just before the
administration of the drug), compulsive or repetitive drug use (feeling stressed
and anxious, which subsides upon drug intake), dependence, withdrawal
(abstinence) stage, and finally relapse or recovery (Koob and Le Moal, 2008)
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Imaging studies using PET/MRI have shown that there are four major circuits in
the human brain which underlie the development of drug addiction (Volkow et
al., 2011; Volkow et al., 2012), Fig 1.4:
1. The reward pathway (the ventral tegmental area, nucleus accumbens and
ventral pallidum).
2. Salience attribution and motivation/drive (the medial orbitofrontal
cortex, dorsal striatum and motor cortex).
3. Memory, conditioning and habit formation (hippocampus, amygdala, the
medial orbitofrontal cortex and dorsal striatum)
4. Executive function and inhibitory control (the prefrontal cortex).
The major neurotransmitters involved in these areas and in drug-seeking
behaviour include dopamine, noradrenaline, corticotropin releasing factor
(CRF), GABA and glutamate (Volkow et al., 2003; Volkow et al., 2012). In
addicts, the activation of reward pathways enhances motivation (impulsivity) to
seek abused drugs leading to reduced inhibitory control from the prefrontal
cortex on the reward mediating areas ending with impulsivity/compulsivity
cycle (Koob and Le Moal, 2008; Volkow et al., 2012).
Taken together, dopamine and dopaminergic receptors are targeted by the
majority of abused drugs and primary rewards, in particular the
mesocorticolimbic dopamine pathway is involved in the response to rewards.
Other areas associated with the limbic system are also required for the
conditioning, associative learning, memory processing of rewards and
development of addiction.
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Figure 1.4 Theoretical network of human brain
circuits involved in the development of drug
addiction. The consequences of addiction on the
brain as shown by arrows were proposed by
(Volkow et al., 2011) based on imaging studies.
Circuits: 1- Reward (NAc = nucleus accumbens,
VTA = ventral tegmental area). 2- Memory and
conditioning (hippocampus, amygdala, medial
orbitofrontal cortex (OFC) and dorsal striatum). 3-
Motivation/drive (medial OFC, VTA, dorsal
striatum and motor cortex). 4- Executive function
and inhibitory control (PFC = prefrontal cortex
which includes ACC = anterior cingulate cortex,
IPFC = inferior PFC and lateral OFC).
Neurotransmitters involved are CRF =
corticotropin releasing factor, DA = dopamine,
GABA, GLU = glutamate, NA = noradrenaline.
This figure is adapted from (Volkow et al., 2011).
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1.2 Corticosterone
Corticosterone is the main glucocorticoid in rodents. Its secretion by the adrenal
glands peaks naturally during the dark (active) phase and reaches a nadir in the
light (inactive) phase (Halberg et al., 1958). Corticosterone levels also increase
in response to stress (Sapolsky et al., 2000) and abused drugs (Moldow and
Fischman, 1987). Endogenous glucocorticoid (GC) secretion is vital for the
regulation of metabolism, immune and central nervous system functions
(Buckingham, 2006) and plays a role in learning and memory processes (Akirav
et al., 2004). GC elevation have been reported in certain hormonal (Fink,
2010), metabolic (Buckingham, 2006), psychiatric (Souetre et al., 1988) and
cognitive (Swanwick et al., 1998) disorders. As discussed below, corticosterone
is also thought to modulate rewarding effects of abused drugs and may have
rewarding properties of its own. The biosynthesis of corticosterone (Fink, 2010)
is illustrated in Fig. 1.5.
1.2.1 Stress and hypothalamic-pituitary-adrenocortical (HPA) axis
Stress has a profound impact on living organisms, usually triggered by a
stimulus (stressor), to which an organism responds (stress perception). Then,
other physiological systems take part in the response to stress, including the
immune, endocrine, and central nervous systems (Cacioppo et al., 1998;
Sapolsky et al., 2000). The response to stress, acute or chronic, is an
evolutionarily adaptive psychophysiological survival mechanism that gives an
individual the opportunity to react fight or flight, and/or to save energy
(Cannon, 1914). Hans Selye, who introduced the concept of stress in biology,
gave many definitions of stress according to experimental progress. The
simplest definition of stress is a non specific response of the body to any
demand (Fink, 2010). Other stress definitions have been extended to involve
not just the biological response to stress, but also its impact on cognition and
mood status (Fink, 2010).
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Figure 1.5 Biosynthesis of corticosterone in the adrenal cortex (Fink, 2010).
Metyrapone inhibits 11E-hydroxylase which induces the conversion of
deoxycorticosterone to corticosterone.
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The hypothalamic-pituitary-adrenocortical (HPA) axis is well known as a major
component of the stress response (Selye, 1950; Mcewen, 1991; Sapolsky et al.,
2000). In addition, it has been documented that stress activates extra-
hypothalamic limbic-associated regions including the hippocampus, locus
coeruleus (the noradrenaline nucleus), basolateral and central nucleus of the
amygdala, bed nucleus of stria terminalis and adrenal medulla which secretes
adrenaline (Sapolsky et al., 2000; Belujon and Grace, 2011), and the
hippocampus and amygdala are also involved in the regulation of HPA axis
activity (Sapolsky et al., 1984; Lowry, 2002). Activation of the HPA axis
involves the secretion of CRF, a 41 amino acid hypothalamic peptide (Vale et
al., 1981) and arginine vasopressin from parvocellular neurons in the
paraventricular nucleus of the hypothalamus, which trigger the production and
release of anterior pituitary proopiomelanocortin-derived peptides,
adrenocorticotropic hormone (ACTH) and E-endorphin (Vale et al., 1981), Fig.
1.6. ACTH stimulates the adrenal cortex to synthesize and secrete GCs (cortisol
in human and corticosterone in rodents) (Goddyer et al., 1976; Buckingham,
2006), Fig. 1.6
Reul and de Kloet (1985) have shown that GC actions in the rat brain are
mediated via two nuclear receptors: mineralocorticoid receptors (MRs, Type I)
and glucocorticoid receptors (GRs, Type II). Whereas MRs are mainly
expressed in the septohippocampal complex, GRs are widely distributed in the
brain (Reul and de Kloet, 1985). MRs have a 10-fold higher affinity for GCs
than GRs (Reul and de Kloet, 1985). Both MRs and GRs work in a harmonized
pattern. For example, levels of GCs determine their role in the response to
stress starting from a permissive action at basal levels (mediated by MRs), a
stimulatory action which enhances physiological effects, a suppressive action
(mediated by GRs) which inhibits stress-induced effects, and a preparative
action for a subsequent stress exposure (Sapolsky et al., 2000). MRs are
activated during inactivity (basal circadian levels of GCs) and become saturated
during stress and at circadian peaks when levels of GCs rise sharply, which
induce negative feedback effects on the HPA axis activity via stimulation of
Chapter 1: General Introduction
16
GRs (Reul and de Kloet, 1985; Dallman et al., 1989; Ratka et al., 1989;
Bradbury et al., 1991; Funder, 1994), Fig. 1.6.
It should be noted that the intensity of stress determines the magnitude of
corticosterone increase. While stressors such as exposure to cold, ether or cage
transfer is associated with an increase in plasma corticosterone levels between
15 and 20 Pg/dl (Sapolsky et al., 1985), restraint stress produced higher levels
of corticosterone at 40 Pg/dl (Sapolsky et al., 1984) in rats. On the other hand,
corticosterone (40 mg/kg, sc) produced a high plasma level of corticosterone
(68 Pg/dl) which decreased to 32 Pg/dl 24 hours after the end of 21 days of
chronic corticosterone injections (Pavlides et al., 1993).
1.2.2 Pharmacodynamic properties of GRs
GRs are mainly located in the cytosol in an inactive state in combination with
chaperone proteins; heat shock protein 90 and 70 (HSP70 and HSP 90) and 56-
kDa immunophilin. Also, several studies have shown that membrane GRs exist
(Tasker et al., 2006; Roozendaal et al., 2010). When GCs bind to the ligand-
binding domain of the cytosolic GRs, the latter dissociate from the chaperone
proteins, become active and their DNA binding domain becomes available for
interaction with specific DNA regions. The interaction between the GC-GR
complex and DNA takes place in the nucleus after translocation of the active
complex, Fig. 1.3. Within the nucleus, two molecules of GC-GR complex bind
together to form homodimers which bind to positive glucocorticoid response
elements (GRE) or negative GRE in DNA, thereby mediating gene transcription
or repression, respectively (Fink, 2010), Fig. 1.3. The main difference between
nuclear and membrane GRs is that the latter mediate rapid non-genomic effects,
while the shortest gene transcription induced by nuclear GRs has been found to
be 15 minutes (Hallahan et al., 1973).
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Figure 1.6 Schematic representation of the stress response and negative
feedback of glucocorticoids (corticosterone or cortisol) on HPA axis activity
and certain extra-hypothalamic tissues; the hippocampus, amygdala, locus
coeruleus (LC) and adrenal medulla. ACTH = adrenocorticotropic hormone,
$93   DUJLQLQH YDVRSUHVVLQ ȕ(1'   ȕ-endorphin, CRF = corticotropin
releasing factor, CRF1 = CRF receptor1, NA = noradrenaline.
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1.2.3 Impacts of corticosterone on memory
Corticosterone is involved in learning and memory processing (Akirav et al.,
2004; Okuda et al., 2004; Barsegyan et al., 2010; Roozendaal et al., 2010): a
number of studies regarding stress- or corticosterone-related effects on synaptic
plasticity and memory performance are listed in table 1.1. As mentioned earlier,
MRs are abundant in the hippocampus (Reul and de Kloet, 1985), which is
critical for memory performance (Gould et al., 2002; Broadbent et al., 2004;
Heldt et al., 2007). In contrast, GRs are widely expressed in the brain and
mainly activated by high corticosterone levels (Reul and de Kloet, 1985), and,
therefore, stress-related effects on memory are mediated by the activation of
GRs. The intensity of activation of both MRs and GRs controls emotional level
and cognitive learning. It was reported that chronic activation of MRs by
aldosterone was anxiogenic in rats (Hlavacova and Jezova, 2008). In contrast,
activation of MRs was associated with low anxiety levels in mice (Brinks et al.,
2007; Rozeboom et al., 2007). Whereas MRs have been found to be essential
for explorative behaviour (Brinks et al., 2007), GRs have been reported to be
implicated in memory processing such as spatial, recognition and fear memory
(Oitzl et al., 1997; Barsegyan et al., 2010; Roozendaal et al., 2010). Thus,
activation of MRs and moderate activation of GRs improved memory
performance in C57BL/6 mice (Brinks et al., 2007). In addition, moderate
corticosterone elevation enhanced spatial (Akirav et al., 2004) and recognition
memory (Okuda et al., 2004) in rats.
Increased corticosterone levels have been reported to mediate harmful effects of
stress on cognition (McEwen and Sapolsky, 1995; Sandi, 2004). In conjunction
with this, repeated corticosterone injections for 3 months decreased neuronal
number in the hippocampus (Sapolsky et al., 1985). Long-term potentiation
(LTP), long lasting synaptic plasticity which is thought to mediate some forms
of learning and memory, in the hippocampal/prefrontal cortex neuronal circuits
was depressed in rats after exposure to acute (Rocher et al., 2004) or chronic
(Cerqueira et al., 2007) stress. In agreement with the effects of chronic stress on
LTP, repeated restraint stress for 3 weeks induced reversible spatial memory
impairments in Sprague-Dawley rats (Luine et al., 1994). Moreover, 4 weeks of
unpredictable stress impaired spatial working and reference memory in rats
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(Cerqueira et al., 2007). Several factors, such as corticosterone levels and
duration of exposure have been found to induce different effects on synaptic
plasticity and memory. It has been reported that effects of corticosterone on
memory follow an inverted U-shaped pattern (Diamond et al., 1992), meaning
that moderate corticosterone elevation improves memory even for long time
(Pravosudov, 2003). Stress levels of corticosterone (> 20 µg/dl) induced by
implanted corticosterone pellets in adrenalectomized Sprague-Dawley rats
inversely correlated with the magnitude of primed burst potentiation (PBP), a
long-lasting (>30 minutes) physiological model of memory, in the CA1 region
of the hippocampus (Diamond et al., 1992). In contrast, low and moderate
corticosterone levels showed a direct relationship with the magnitude of primed
burst potentiation (Diamond et al., 1992). Whereas hippocampal LTP in
Sprague-Dawley rats was reduced 2 hours after a single corticosterone injection,
there were no effects after 48 hours (Pavlides et al., 1993). In contrast, chronic
corticosterone injections at high doses (40 mg/kg) for 3 weeks impaired
hippocampal LTP in Sprague-Dawley rats 48 hours after the last injection
(Pavlides et al., 1993). Furthermore, a MR agonist (aldosterone) improved LTP,
while a GR agonist (RU28362) impaired LTP in the dentate gyrus, a
hippocampal region in which new granule neurons are generated throughout
adulthood (Gould and Gross, 2002), of Sprague-Dawley rats (Pavlides et al.,
1995). These responses were abolished by treating adrenalectomized rats with
MR and GR antagonists, respectively (Pavlides et al., 1995). It was reported
that mifepristone (a GR antagonist) abolished acute restraint stress-induced
hippocampal LTP impairment in Sprague-Dawley rats via attenuating the
increased activity of extracellular signal regulated kinase 1 and 2, ERK 1/2
(Yang et al., 2004). In contrast, chronic corticosterone treatment decreased
phosphorylated Erk2 levels in the hippocampus and frontal cortex of mice
(Gourley et al., 2008). In effect, ERK 1/2 has been found to modulate synaptic
plasticity and learning processes (Rodrigues et al., 2004).
In agreement with the chronic effects of corticosterone on LTP, memory
performance of animals has been reported to be affected in similar way. Chronic
corticosterone treatment (26.8 mg/kg/day, s.c.) for 8 weeks impaired spatial
memory of Sprague-Dawley rats in a Y-maze (Coburn-Litvak et al., 2003).
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Moreover, corticosterone-implanted rats exhibited poor spatial learning
performance in the radial 8-arm maze after 3 months (Endo et al., 1996).
However, rats treated with a lower corticosterone dose (10 mg/kg/day) for 8
weeks exhibited no impairment in the platform maze spatial task (Bardgett et
al., 1996), indicating no hippocampal LTP impairment (Barnes, 1979).
However, this dose was found to induce atrophy in apical dendrites in the
hippocampal CA3 region of Sprague-Dawley rats (Woolley et al., 1990;
Watanabe et al., 1992). An acute corticosterone injection in the prefrontal
cortex impaired delayed alternation in Sprague-Dawley rats (Barsegyan et al.,
2010). Also, corticosterone treatment shortly before the Morris water maze test
impaired memory retrieval in Sprague-Dawley rats (Roozendaal et al., 2001). In
contrast, acute blockade of GRs prior to the probe test of the Morris water maze
task improved spatial memory in rats (Oitzl et al., 1998), indicating that
elevation of corticosterone shortly before memory testing could impair working
memory (Barsegyan et al., 2010). Also, mifepristone (a glucocorticoid receptor
antagonist) and metyrapone (a corticosterone synthesis inhibitor) ameliorated
recognition memory deficits caused by corticosterone elevation induced by a
short period of morphine withdrawal in mice (Mesripour et al., 2008).
It is important to emphasize that corticosterone plays an important role in
cognitive performance. Adrenalectomized rats showed spatial memory deficits
(Vaher et al., 1994), which could be due to impairment in exploratory activity
(Veldhuis et al., 1982). Also, spatial memory was suggested to be improved in
running rats via corticosterone increase (Hajisoltani et al., 2011). Corticosterone
has been found to be involved in recognition memory (Okuda et al., 2004).
Moreover, post-training corticosterone injections enhanced consolidation of
novel object recognition and location in Sprague-Dawley rats and these effects
were mediated via GRs (Roozendaal et al., 2010). Also, fear memory was
improved by pre-test corticosterone injection in the prefrontal cortex of
Sprague-Dawley rats (Barsegyan et al., 2010).
Overall, short-term exposure to moderate levels of corticosterone is required to
facilitate learning and improve memory. In contrast, chronic corticosterone
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elevation could cause memory deterioration through effects on neural plasticity
and survival.
Table 1.1 A number of studies carried out to examine the effects of acute
and chronic exposure of stress or corticosterone treatment on synaptic
plasticity and memory performance. Underlined references indicate that
Sprague-Dawley rats were used. PBP = primed burst potentiation.
Synaptic plasticity
neuronal survival
Memory
A
cu
te
Impaired LTP (Rocher et al.,
2004; Yang et al., 2004)
Impaired recognition memory with
morphine induced withdrawal
(Mesripour et al., 2008)
S
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s
C
h
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n
ic
Impaired LTP (Cerqueira et al.,
2007)
Spatial impairment after 3 or 4 weeks
of restraint (Luine et al., 1994) or
unpredictable (Cerqueira et al., 2007)
stress.
A
cu
te
Inverted U-shaped relationship
between corticosterone levels
and PBP (Diamond et al., 1992)
A single high corticosterone
dose decreased hippocampal
LTP (Pavlides et al., 1993)
MR activation increased LTP
and GR activation decreased
LTP in the rat hippocampus
(Pavlides et al., 1995)
Inverted U-shaped relationship
between corticosterone levels and
recognition (Okuda et al., 2004) or
spatial (Akirav et al., 2004) memory.
GR blockade improved spatial
memory (Oitzl et al., 1998)
Impairment of delayed alternation
(Barsegyan et al., 2010)
Improvement of inhibitory avoidance
(Barsegyan et al., 2010)
Enhanced consolidation of spatial
(Sandi et al., 1997), recognition and
location (Roozendaal et al., 2010)
memory.
Memory retrieval impairment
(Roozendaal et al., 2001)
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A high dose for 3 weeks
impaired hippocampal LTP
(Pavlides et al., 1993)
Three weeks induced reversible
hippocampal atrophy (Woolley et
al., 1990; Watanabe et al., 1992)
Hippocampal neuronal loss after
three months (Sapolsky et al.,
1985)
A high dose (26.8 mg/kg) did not
impair spatial working memory after
21days, but impaired it after 8 weeks
in a Y-maze (Coburn-Litvak et al.,
2003).
A small dose (10 mg/kg) for 8 weeks
produced no spatial memory
impairment (Bardgett et al., 1996)
Three months of moderate
corticosterone elevation improved
spatial memory (Pravosudov, 2003)
Three months impaired spatial
memory in radial 8-arm maze (Endo
et al., 1996)
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1.3 Rewarding effects of stress and corticosterone
1.3.1 Overview
It has been found that exposure to natural rewards such as food (Merali et al.,
1998), copulation (Szechtman et al., 1974) and wheel running (Droste et al.,
2003) are accompanied by corticosterone elevation. Moreover, several studies
have indicated that corticosterone modulates reinforcing and rewarding effects
of abused drugs (Dong et al., 2006; Mantsch and Katz, 2007). The clinical use
of GCs has been limited by their numerous adverse effects including psychotic
symptoms with persistent euphoria, suggesting that GCs might have rewarding
effects (Hall et al., 1979). In addition, euphoria was reported in a patient with
Cushings syndrome (Myhill et al., 2008), an endocrine disorder characterised
by elevated cortisol levels (Fink, 2010). Taken together, corticosterone is
suggested to have rewarding effects. Previous work showing evidence for
corticosterone-related reward is reviewed in the next section.
1.3.2 Rewarding effects of stress
Avoidance is the most common reaction of an organism to stress. However,
stress-seeking behaviour has been observed in different occasions. For example,
monkeys were trained to lever-press to receive electrical shocks in their tails
(Barrett and Spealman, 1978). Also, rats were found to develop place
preference to certain forms of mild stress such as frequent handling (Bozarth,
1987). Whereas some Sprague-Dawley rats showed high locomotor activity and
sustained corticosterone secretion when exploring novel environments (e.g.
High responders, HR rats), others (e.g. low responders, LR rats) avoided
exploring new environments and had low basal corticosterone levels (Piazza et
al., 1990; Piazza et al., 1991; Rouge-Pont et al., 1993), indicating that GCs
could underlie stress-seeking behaviour as increased corticosterone or cortisol
secretion is a common feature associated with stress exposure. HR rats have
been found to be more sensitive to psychostimulants and exhibit a higher
tendency to self-administer these drugs than LR rats (Piazza et al., 1989; Piazza
et al., 1990; Piazza et al., 1991), suggesting that elevated basal corticosterone
levels in HR rats facilitate drug-seeking behaviour. Interestingly, HR rats
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response to 10-minute tail-pinch (Rouge-Pont et al., 1993), but this difference
in dopamine levels disappeared in adrenalectomized rats (Rouge-Pont et al.,
1998).
Stress has been reported to trigger dopamine release in brain areas associated
with reward. For instance, painless footshocks increased extracellular dopamine
levels in the nucleus accumbens shell of Sprague-Dawley rats (Kalivas and
Duffy, 1995). Moreover, the same rat strain exhibited increased dopamine
release in the nucleus accumbens when they were subjected to ten-minute tail
pinch stress, but adrenalectomized rats exhibited an increase in dopamine
release only after corticosterone treatment (Rouge-Pont et al., 1998), suggesting
that stress-induced corticosterone secretion enhances dopamine release. Stress
has been repeatedly reported to facilitate self-administration of abused drugs
(Piazza and Le Moal, 1998). Furthermore, food restriction enhanced
behavioural sensitization induced by amphetamine or morphine injections in the
nucleus accumbens and the ventral tegmental area of Sprague-Dawley rats,
respectively (Deroche et al., 1995). In addition, the positive effects of food
restriction on sensitization of mesencephalic dopamine release in response to
cocaine was attenuated in Sprague-Dawley rats after being treated with the
corticosterone synthesis inhibitor metyrapone (Rouge-Pont et al., 1995).
It is noteworthy that stress and abused drugs have been found to induce
common alterations in the brain regions involved in drug-seeking behaviour
(Cleck and Blendy, 2008). For instance, enhanced activation of glutamate
receptors in midbrain dopaminergic neurons appears to be involved in the
synaptic adaptation induced by stress and abused drugs (Saal et al., 2003).
Furthermore, modulation of GABA receptor activity in the ventral tegmental
area has been implicated in stress-induced dopamine release in the nucleus
accumbens (Doherty and Gratton, 2007). Similarly, drugs of abuse modulate
GABA neurotransmission in the mesolimbic dopamine pathway (Koob and Le
Moal, 2008). Stress-induced reinstatement of drug-seeking behaviour has been
suggested to involve activation of the ventral subiculum (the main hippocampus
output) / nucleus accumbens pathway via the activation of the basolateral
amygdala and locus coeruleus (noradrenaline secreting neurons); both of them
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regulate glutamatergic activity in the ventral subiculum (Belujon and Grace,
2011). It was found that CRF was involved in footshock-induced cocaine
reinstatement (Erb et al., 1998). Stress-evoked corticosterone increase was also
reported to promote cocaine self-administration (Mantsch and Katz, 2007).
1.3.3 Corticosterone facilitates acquisition and reinstatement of abused
drugs
Stress is implicated in worsening drug addiction (Cleck and Blendy, 2008) and
therefore, a considerable body of research has been carried out to investigate the
role of corticosterone in drug addiction. Several studies have addressed how
addictive drugs alter endogenous corticosterone secretion and others have
investigated the impact of elevated corticosterone levels on drug self-
administration, conditioned place preference (CPP) and behavioural
sensitization. A single cocaine injection in male Sprague-Dawley rats was
associated with transient corticosterone elevation (Moldow and Fischman,
1987). In contrast, low basal plasma corticosterone levels were observed in
Wistar rats 24 hours after chronic non-contingent or self-administration of
cocaine infusions compared to saline-treated rats (Mantsch and Goeders, 2000).
As mentioned earlier, elevated basal corticosterone levels facilitated
amphetamine self-administration in HR Sprague-Dawley rats (Piazza et al.,
1991). Whereas high doses of cocaine enhanced corticosterone secretion which
sufficiently maintained its self-administration, low cocaine doses could not
efficiently be self-administered at reduced corticosterone levels (Goeders and
Guerin, 1996), indicating the role of corticosterone in drug-seeking behaviour.
The reduction of cocaine intravenous self-administration was dose-dependently
reversed in adrenalectomized male Sprague-Dawley rats by simultaneous
administration of corticosterone in the drinking water at concentrations of 25,
50 or 100 Pg/ml (Deroche et al., 1997). Furthermore, intravenous corticosterone
injections (0.37 mg/kg) facilitated cocaine-induced reinstatement in
adrenalectomized rats (Deroche et al., 1997), indicating that corticosterone
underlies stress-induced reinstatement of abused drugs. Nevertheless,
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corticosterone elevation was not involved in chronic footshocks-induced
escalation of cocaine self-administration in male Sprague-Dawley rats (Mantsch
and Katz, 2007), indicating that stress probably modulates drug-seeking
behaviour via corticosterone dependent and independent mechanisms. Also,
administration of corticosterone synthesis inhibitors such as metyrapone or
aminoglutethimide attenuated stress-enhanced CPP to morphine in Sprague-
Dawley rats (Der-Avakian et al., 2005). Moreover, cocaine- or morphine-
induced locomotor hyperactivity was reduced in adrenalectomized Sprague-
Dawley rats compared to sham-operated and corticosterone-supplemented rats
(Marinelli et al., 1994).
It is noteworthy that the corticosterone administration in drinking water (100
µg/ml) or parenterally (0.37 mg/kg, i.v.) was reported to increase plasma
corticosterone levels to ~ 40-60 Pg/dl (Deroche et al., 1995; Deroche et al.,
1997) similar to those levels induced by electric footshocks (Bassett et al.,
1973). This suggests that GR activation is involved in drug-seeking behaviour,
as GRs are found to be activated by stress levels of corticosterone (Reul and de
Kloet, 1985). For instance, morphine-induced dopamine release in the nucleus
accumbens and locomotor hyperactivity, a dopamine-dependent behaviour (Le
Moal et al., 1977; Delfs et al., 1990), was reduced by prior administration of the
GR antagonists, mifepristone or RU39305, in a dose-dependent manner
(Marinelli et al., 1998). In contrast, these morphine-related effects were retained
after treating rats with the MR antagonist, spironolactone (Marinelli et al.,
1998). Furthermore, mifepristone injected into the hippocampus or the nucleus
accumbens of Sprague-Dawley rats impaired morphine-induced CPP in a dose-
dependent manner (Dong et al., 2006), suggesting that the behavioural
expression of CPP to morphine is modulated by GR activation. In contrast,
basal corticosterone levels were sufficient for cocaine reinstatement in Long
Evans rats compared to the adrenalectomized group, indicating that the GR
involvement in cocaine-seeking behaviour is strain-dependent (Erb et al., 1998).
In agreement with this, spironolactone decreased cocaine-induced locomotor
hyperactivity but mifepristone attenuated cocaine-self-administration in
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C57BL/6J mice (Fiancette et al., 2010), suggesting a role of MRs in cocaine-
related unconditioned effects.
In support of behavioural data, there has been some evidence that corticosterone
interacts with the mesolimbic reward pathway. In Sprague-Dawley rats, GRs
are expressed by mesolimbic dopaminergic neurons (Harfstrand et al., 1986).
So, it is expected that mesolimbic dopamine release in response to drugs of
abuse and other rewarding stimuli is controlled at least partially by
corticosterone. Indeed, in vitro application of a GR antagonist and a MR
antagonist to cultured embryonic mesencephalic dopaminergic neurons showed
that only a GR antagonist decreased potassium-activated dopamine secretion in
a dose-dependent manner (Rouge-Pont et al., 1999). This gives some evidence
that corticosterone increases dopamine release via GRs.
Taken together, the evidence supports the proposal that corticosterone facilitates
drug self-administration and conditioning effects likely via activation of GRs.
1.4 Does corticosterone have reinforcing and rewarding properties?
Three experiments directly addressed if corticosterone is rewarding, with
contradictory results. As discussed below, two studies showed that male
Sprague-Dawley rats self-administered corticosterone, but they did not exhibit
corticosterone-induced conditioned place preference in the third study.
1.4.1 Self-administration studies
In the first experiment, Piazza et al. (1993) addressed whether rats self-
administer corticosterone as they do for abused drugs. Rats were subjected to a
series of operant intravenous self-administration sessions, a 30-min session per
day, in the dark phase. The operant self-administration paradigm tests whether a
substance or behaviour acts as a positive reinforcer which is defined as a
consequence (A) for a behaviour (B) which increases the probability of this
behaviour, i.e. A is the reinforcing properties of a drug and B is the response of
the animal such as lever-pressing (Gluck, 2008). In the classical Pavlovian
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conditioning, an animal learns an association between a conditioned stimulus
(sound or light) and an unconditioned stimulus (rewarding or aversive), but the
response of the animal to the conditioned stimulus does not affect the
availability of the unconditioned stimulus (Gluck, 2008). In contrast, in
instrumental conditioning, such as the operant procedures, the animal has to
lever-press to receive a reinforcer (Gluck, 2008).
In the operant procedures, an animal is placed in a computer-controlled
chamber which has two holes or two levers (active and inactive). When the
animal inserts its nose into the active hole or presses the active lever, a dose of
tested substance is then delivered to be consumed within a specified time. Three
dose levels of corticosterone; 12.5, 25 and 50 Pg, i.v., were tested in these
sessions (Piazza et al., 1993). Rats self-administered the two highest doses used,
which produced plasma corticosterone levels in the range induced by stress, as
the number of injections and nose pokes were significantly high in the
corticosterone self-administered group compared to control. Although
corticosterone was self-administered, more investigation is required. These
sessions took place only in the dark phase for only a 30-minute session over 6
days, which might be insufficient to induce reward at low doses. In the dark
phase, rodents are naturally active and corticosterone peaks at this time which
may contribute to the self-administration behaviour. Also, rats in this
experiment were not tested for reinstatement to corticosterone after a period of
withdrawal. This experiment also demonstrated that HR rats, which are stress
(novelty) seekers, self-administrated corticosterone at higher rate than LR rats.
In another experiment, the same research group used a two-bottle choice model
to confirm that corticosterone could be orally self-administrated in rats
(Deroche et al., 1993). Corticosterone was added to drinking water at three
different concentrations. Rats self-administered corticosterone at the two
highest concentrations (50 and 100 Pg/ml) used, as they preferred
corticosterone to water, but not at a low concentration (25 Pg/ml). The short
duration of the choice test, carried out over the dark phase for only 5 days, may
not have been sufficient for the development of corticosterone self-
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administration at low doses. Another explanation is that corticosterone is self-
administered only at doses which produce high plasma levels of corticosterone
comparable to those induced by stress. In the same experiment, rats relapsed to
the highest dose used after being submitted to a withdrawal period.
Additionally, temporary food restriction produced no attenuation of drinking
behaviour in rats that had access to the corticosterone solution compared to rats
which had access to water only. The latter finding means that even when rats
had no access to food, they drank more from the corticosterone solution than
from water; rats naturally drink very little amount of water when being food
restricted, but they drank a lot in the presence of corticosterone.
Overall, these two experiments have provided clear evidence that corticosterone
can be self-administered by rats using the intravenous operant self-
administration and the two-bottle choice paradigms, suggesting that it may be
rewarding.
1.4.2 Does corticosterone induce conditioned place preference?
One experiment was carried out to investigate the rewarding properties of
corticosterone in rats using the CPP test. CPP is a classical conditioning
procedure widely used to study the conditioned reinforcing effects of drug and
non-drug rewards (Shalev et al., 2002). CPP involves 2 separated compartments
which differ in their floor and walls: one compartment is paired with a test drug
and the other is paired with its vehicle. In CPP, an animal learns to associate a
reward with environmental cues after repeated sessions (conditioning), i.e. the
conditioner is a neutral stimuli that cues the rewarding effects of a drug or
behaviour which is solely able to increase dopamine levels in the nucleus
accumbens of the animal predicting the reward (Volkow et al., 2012), and, thus,
a conditioner in CPP is the shape and colour of the floor and walls of one of the
two CPP compartments. On the post-conditioning day, the animal has a probe
test in a drug-free state and the time spent in each chamber is recorded. If the
animal shows a significant preference for a drug-paired chamber, this indicates
that the drug is rewarding (Bardo and Bevins, 2000). It has been reported that
animals spend more time in the chamber previously paired with an abused drug
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such as morphine (Dong et al., 2006) and cocaine (Chen and Xu, 2010) than the
vehicle-paired chamber. Furthermore, the nucleus accumbens (Miller and
Marshall, 2005) and hippocampus (Ferbinteanu and McDonald, 2001) have
been found to be implicated in the development of CPP.
Rewarding effects of corticosterone were tested in CPP in Sprague-Dawley rats
(Dietz et al., 2007). Rats were subjected to 8 alternating sessions in which
corticosterone at two dose levels (2.5 or 10 mg/kg, i.p.) was paired with the
least preferred compartment and saline was paired with the other compartment.
Cocaine (12 mg/kg, i.p) was used as a positive control. The outcome of this
study showed that corticosterone is neither rewarding nor aversive, since rats
did not spend a significantly different time in the compartment paired with
corticosterone. In contrast, cocaine induced CPP in HR and LR rats (Dietz et
al., 2007). Another study testing the effects of corticosterone at 10 mg/kg on
ethanol-induced CPP showed that the stress hormone at this dose did not induce
CPP on its own in mice (Brooks et al., 2004). However, this corticosterone dose
is very unlikely to be rewarding, since rats self-administered corticosterone at
doses which produced stress levels of corticosterone (Piazza et al., 1993) and,
generally, mouse doses should be twice as much as rats to produce the same
physiological levels (Freireich et al., 1966; Reagan-Shaw et al., 2008).
Thus, these results are in apparent contradiction with a previous report showing
that dexamethsone, a high potency GR agonist, induced CPP in rats (Lebedev et
al., 2003) and self-administration studies reporting that corticosterone at stress
levels, required to activate GRs, increased nose-poking by rats (Piazza et al.,
1993).
The lack of behavioural expression of reward in the above study could be due to
methodological factors. CPP has been useful for assessing the rewarding
properties of drugs of abuse, as it is inexpensive, rapidly undertaken (Katz and
Gormezano, 1979) and animals need no surgery and little training (Bardo and
Bevins, 2000). However, major limitations of CPP involve the lack of providing
animals with a state of free choice to administer the drug or not (Bardo and
Bevins, 2000) as opposed to self-administration. This is critical as it is different
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from the way in which drugs are abused by humans. Another limitation of CPP
is the confounding potential of novelty seeking on the post-conditioning test day
when animals are tested in a drug free state. It was documented that rats prefer
novel to familiar contexts (Bardo et al., 1993). Further, it is important to make
sure that animals do not prefer one context over another before conditioning
(Bardo and Bevins, 2000). Also, CPP is limited with regard to producing
pharmacological dose/response relationships (Bardo and Bevins, 2000).
Many arguments have been raised against the outcome of CPP, whether it is due
to learning association between a context (conditioned stimulus) and a drug
(unconditioned stimulus), or if it is due to rewarding properties of the drug
(Beach, 1957; Rossi and Reid, 1976). Moreover, there are a number of drugs
which are self-administered but for which CPP failed to show rewarding
properties; for example, pentobarbital and phencyclidine (Collins et al., 1984;
Marquis et al., 1989; Acquas et al., 1990; Lew and Parker, 1998), suggesting
that the reinforcing and rewarding effects of abused drugs are not identical. As
stated earlier, reinforcing agents are stimuli whose presentation is contingent
upon the response. Reward is a general term which extends to include positive
reinforcement, emotions (feelings of well-being) and appetitive characteristics
and approach behaviours (Cannon and Bseikri, 2004; Salamone et al., 2007).
These differences between the reward and reinforcement probably underscore
why some reinforcers do not induce CPP. Whereas drugs are injected at a high
rate as bolus injections prior to introducing the animal to the compartment in
CPP, the animals self-administer drugs at a much slower rate, and, therefore, the
reward pathway may respond differently to the same drug according to the
mode of exposure. It was found that self-administration but not yoked
(unpredictable) injections of methamphetamine decreased the levels of D1
and/or presynaptic D2 receptors in the substantia nigra, nucleus accumbens and
ventral tegmental area (Stefanski et al., 1999). As mentioned earlier, abused
drugs have been found to decrease D2 receptor expression in the striatum
(Volkow et al., 2007). This suggests that drug self-administration enhances
dopamine release, which decreases the expression of dopamine D2 receptors,
because the animal could predict the reception of the reward. In contrast, the
animal is unable to anticipate the reward with yoked injections of the drug.
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Furthermore, the lag interval between drug administration and the entrance to
the drug-paired compartment is another important point. For instance, cocaine
injections 5 minutes or immediately before the CPP test produced CPP, but
cocaine injections 15 min prior to the CPP test produced conditioned place
aversion (Ettenberg et al., 1999). In agreement with this, it has been established
that addictive drugs induce euphoria after different post-injection times
(Volkow et al., 2012).
1.4.3 Intracranial self-stimulation paradigm
Intracranial self-stimulation (ICSS) has been considered as a paradigm to test
the abuse potential of a substance (Feltenstein and See, 2008). The extent at
which a substance lowers the ICSS threshold is directly proportional to its
reinforcing and addictive properties (Feltenstein and See, 2008). Rats treated
chronically with corticosterone (40 mg/kg, s.c., for 21 days) became more
sensitive to rewarding brain stimulation (Barr et al., 2000).
In summary, rats self administered corticosterone and reinstated this behaviour
after an extinction period. Although rats failed to show CPP to corticosterone,
further investigation is required to demonstrate rewarding responses to
corticosterone or to find out the reason behind corticosterone self-
administration. Also, rewarding reactions to corticosterone should be studied in
different species and different reward testing paradigms. Until now,
corticosterone has shown some evidence of rewarding properties since it was
self-administered in rats and lowered the threshold for intracranial self-
stimulation.
1.5 Wheel running: a rewarding stimulus which increases corticosterone
secretion?
1.5.1 Overview
Wheel running represents a natural stress model which activates HPA axis and
can be used to study the rewarding effects of corticosterone. In animal studies,
exercise can be forced or voluntary. Treadmills and motorized running wheels
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are used to undertake forced exercise, but voluntary exercise studies use
running wheels. It has been reported that chronic voluntary and forced exercise
increases plasma corticosterone levels in mice (Droste et al., 2003; Chang et al.,
2008). An essential difference between the forced and voluntary exercise is that
the use of voluntary wheel running allows the recording of the motivation of
each mouse to run, but mice exercising on treadmills run the same distances
regardless of whether they are motivated or not. Importantly, forced exercise
has been found to induce adverse physiological adaptations similar to those
induced by chronic stress (Moraska et al., 2000) and, technically, the animal
should repeatedly receive mild footshocks to encourage running (Hattori et al.,
1994). Overall, voluntary wheel running is more appropriate than treadmill
exercise to test the involvement of corticosterone in the motivation of mice to
run. Below, previous work studying the rewarding, cognitive and HPA axis
activating effects of voluntary wheel running is reviewed.
1.5.2 Voluntary wheel running is a motivated behaviour
1.5.2.1 Behavioural evidence for motivational effects of voluntary wheel
running
A considerable amount of work has demonstrated that voluntary wheel running
is rewarding (Brene et al., 2007). Outbred strains such as Long-Evans rats
(Iversen, 1993) and Wistar rats (Belke and Wagner, 2005) lever-pressed to get
access to running wheels. Also, Sprague-Dawley rats (Lett et al., 2000; Lett et
al., 2001) and Wistar rats (Belke and Wagner, 2005) exhibited CPP for the
after-effects of wheel running. Moreover, low-running inbred Fischer rats
displayed CPP induced by the after-effects of 6-week wheel running
(Greenwood et al., 2011). In addition, Sprague-Dawley rats demonstrated a
continuous increase in the running activity over weeks (Fediuc et al., 2006).
Similarly, C57BL/6N mice having unlimited access to running wheels kept
increasing the running distances and did not develop habituation to the running
behaviour (Droste et al., 2003). Other inbred mouse strains varied in their
motivation to run ranging from CBA as a high-running strain to DBA/2 as a
low-running strain (Festing, 1977; Brene et al., 2007). As was the case with
abused drugs, animals from the same strain showed variable motivation to run.
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For instance, C57BL/6J mice (Klaus et al., 2009) and Long-Evans rats (Tarr et
al., 2004) showed great variability in the running distances per fixed time.
It is worthy pointing out that wheel running has been reported to modulate drug-
seeking behaviour. For example, cocaine self-administration in female rats was
reduced by concurrent wheel running compared to a no-wheel access condition,
suggesting that reinforcing properties of cocaine can be substituted for by wheel
running (Cosgrove et al., 2002). Moreover, cocaine-primed relapse in female
rats was attenuated by prior or concomitant access to wheel running (Zlebnik et
al., 2010). In contrast, ethanol-withdrawn rats demonstrated enhanced ethanol-
induced relapse after 2-weeks of wheel running (Werme et al., 2002a). Similar
to cocaine, female C57BL/6J mice which had access to 10% ethanol in the two-
bottle choice while undergoing intermittent periods of wheel running increased
their running performance when alcohol was withdrawn, but their running
activity was reduced when ethanol was reintroduced, suggesting that rewarding
effects of wheel running substituted for ethanol-associated reward (Ozburn et
al., 2008).
1.5.2.2 The involvement of dopamine in the rewarding effects of voluntary
wheel running
Several studies have suggested various mechanisms underlying the motivation
to run. Dopamine and its receptors have been implicated in running behaviour.
First of all, treadmill exercise has been reported to increase dopamine levels in
the nucleus accumbens (Freed and Yamamoto, 1985; Wilson and Marsden,
1995) and/or the striatum (Hattori et al., 1994) of Sprague-Dawley, Wistar and
Long-Evans rats after a 20-minute running session. Moreover, chronic
unlimited wheel running increased mRNA levels for tyrosine hydroxylase, the
rate limiting enzyme for dopamine biosynthesis, in the ventral tegmental area,
but decreased mRNA levels for D2 receptors in the nucleus accumbens core of
Fischer rats (Greenwood et al., 2011).
Interestingly, the running distances of Long-Evans rats, which lever-pressed for
accessing wheel running, correlated negatively with potassium-evoked
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dopamine release in the nucleus accumbens core and dorsal striatum, indicating
depletion of dopamine stores with chronic running (Tarr et al., 2004). For
instance, mice bred as a high-running strain were less sensitive to SCH 23390, a
D1 receptor antagonist, than the control mouse line (Rhodes and Garland,
2003), suggesting that low dopamine levels in high-running animals are
probably associated with modified dopamine receptor sensitivity. Furthermore,
high-running rats exhibited greater dopamine release in the nucleus accumbens
after a 20-minute running session than their low-running littermates (Wilson
and Marsden, 1995), suggesting that reduced dopamine release in the nucleus
accumbens core of high-running rats probably motivated them to run more to
enhance dopamine release (Tarr et al., 2004). MPTP (a dopamine depleting
agent used to induce Parkinsonism-like symptoms) decreased wheel running
activity of C57BL/6 mice compared to saline-treated animals, suggesting that
dopamine is required for wheel running performance (Leng et al., 2004). In
contrast, methylphenidate (a dopamine reuptake inhibitor) enhanced running
activity in mice (Rhodes and Garland, 2003). Overall, these findings suggest
that dopamine regulates the motivation for running behaviour.
1.5.2.3 Other mechanisms involved in the rewarding effects of voluntary wheel
running
A number of studies have shown that the opioidergic system is involved in the
rewarding effects of wheel running. Whereas high-running inbred Lewis rats
exhibited high mRNA levels for the endogenous opioids dynorphin and
enkephalin, low-running inbred Fischer rats did not show increased levels of
endogenous opioids in the medial caudate-putamen after long-term unlimited
wheel running (Werme et al., 2000). In contrast, both rat strains showed the
same effects on dynorphin mRNA levels in the medial caudate-putamen in
response to chronic cocaine treatment (Werme et al., 2000), suggesting that
wheel running could be addictive. Moreover, exercising Fischer rats exhibited
increased mRNA levels for delta opioid receptors in the nucleus accumbens
shell and kappa opioid receptors in the nucleus accumbens core compared to
non-exercising rats (Greenwood et al., 2011). On the other hand, naloxone
attenuated CPP induced by the after-effects of wheel running in Sprague-
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Dawley rats (Lett et al., 2001). In addition, inbred BalB/c mice did not show
CPP for wheel running after naloxone treatment which also postponed the
acquisition of this motivated behaviour, compared to the control group (Vargas-
Perez et al., 2008). Overall, this suggests that endogenous opioid peptides and
receptors play a significant role in the rewarding effects of wheel running.
Other work has shown that endogenous cannabinoids could have a role in wheel
running-related reward. It was found that plasma levels of endocannabinoids
such as anandamide increased following 1-hour of intense cycling in men
(Heyman et al., 2011), and there was a positive correlation between levels of
anandamide and cortisol (Heyman et al., 2011). It was reported that
corticosterone injection rapidly increased anandamide levels in the
hippocampus, amygdala and hypothalamus of Sprague-Dawley rats (Hill et al.,
2010). As endocannabinoids have been shown to enhance dopamine release in
the nucleus accumbens (Maldonado et al., 2006), this suggests a role of GCs in
the rewarding effects of exercise via elevation of endocannabinoids.
Similar alterations in the expression of certain markers of plasticity induced by
abused drugs have been reported to occur with wheel running. It has been
reported that natural rewards (Wallace et al., 2008) and abused drugs (Nestler,
2008) enhance the expression of ' FosB (a transcription factor) in the nucleus
accumbens. Compared to other Fos family members, ' FosB is very stable and,
thus, when it is accumulated in response to chronic exposure to abused drugs
and other rewards, it persists for a long time, indicating long-lasting plasticity
changes (Nestler et al., 1999). As with drugs of abuse, wheel running has been
found to enhance expression of ' FosB in the nucleus accumbens of Lewis
(Werme et al., 2002b) and Fischer (Greenwood et al., 2011) rats. Conversely,
transgenic mice over-expressing ' FosB in the striatum demonstrated enhanced
running activity (Werme et al., 2002b).
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1.5.3 Effects of wheel running on HPA axis activity
Physical exercise is a stressor which increases the secretion of catecholamines
and GCs to meet metabolic needs and to maintain homeostasis. Cortisol levels
in men were elevated after cycling (Heyman et al., 2011) and repeated 1-hour
treadmill exercise sessions increased corticosterone levels in C57BL/6J mice
(Chang et al., 2008). Furthermore, the baseline circadian corticosterone peak in
C57BL/6 mice (Droste et al., 2003; Otawa et al., 2007) and the nadir in
corticosterone levels in C57BL/6 mice (Adlard and Cotman, 2004) were
enhanced after 2-4 weeks of unlimited wheel running. Similarly, Wistar rats
showed increased corticosterone levels after 10 days of continuous running
(Hajisoltani et al., 2011). Also, high-running Lewis rats demonstrated an
increase in corticosterone levels at their nadir after 23 days of continuous wheel
running (Makatsori et al., 2003). In contrast, Sprague-Dawley rats exhibited an
initial rise in circadian corticosterone levels which gradually decreased until no
significant differences were found between running and non-running groups
after the fourth week of unlimited wheel running (Fediuc et al., 2006; Sasse et
al., 2008).
HPA axis adaptation has been reported in response to chronic wheel running in
Sprague-Dawley rats (Fediuc et al., 2006) and C57BL/6N mice (Droste et al.,
2003). This was supported by finding a lack of change in plasma ACTH levels
in running mice or rats in response to different stressors such as novelty, forced
swimming (Droste et al., 2003) and immobilization stress (Fediuc et al., 2006),
although there was an increase in corticosterone levels. The rise in
corticosterone levels without an increase in ACTH in response to stress can be
explained as chronic wheel running upregulated enzymes involved in the
adrenal corticosterone synthesis. It was reported that C57BL/6J mice running
for 2 weeks exhibited enhancement of the mRNA expression for steroidogenic
acute regulatory protein, the rate limiting step in corticosterone synthesis, and
this was suggested to underlie chronic exercise-induced corticosterone elevation
without a concomitant ACTH increase (Otawa et al., 2007). Also, chronic
exercise-induced corticosterone elevation did not affect hippocampal levels of
GRs (Droste et al., 2003; Fediuc et al., 2006; Chang et al., 2008). On the other
hand, long-term wheel (Droste et al., 2003) and treadmill (Chang et al., 2008)
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running decreased hippocampal levels of MRs in C57BL/6 mice and this was
found to be involved in exercise-induced neurogenesis improvement in the
dentate gyrus (Chang et al., 2008).
1.5.4 Effects of wheel running on cognition
Exercise has been found to counteract aging-related cognitive decline
(Colcombe and Kramer, 2003; Erickson and Kramer, 2009) and to protect
against Alzheimers dementia (Laurin et al., 2001; Larson et al., 2006; Yuede et
al., 2009; Nation et al., 2011). Voluntary wheel running has been repeatedly
used to study the influences of exercise on learning and memory in rodents.
After chronic unlimited wheel running, young C57BL/6 mice demonstrated
enhanced memory performance; in the Morris water maze, and improved
hippocampal LTP and neurogenesis (van Praag et al., 1999; van Praag et al.,
2005). Neurogenesis is a complex process in which new neurons are generated
via proliferation of immature precursor cells into newborn cells which are
differentiated into granule neurons (Dayer et al., 2003). Also, aged C57BL/6
mice exhibited enhanced spatial learning after 45 days of wheel running (van
Praag et al., 2005). Moreover, it was reported that mice with Alzheimers-like
deficits running in the wheel for 5 months showed improved learning ability in
the Morris water maze and decreased E amyloid plaques expression in the
hippocampus and frontal cortex compared to the non-exercising group (Adlard
et al., 2005). In contrast, wheel running for 3 weeks improved spatial learning
of aged mice with Alzheimers-like deficits (Nichol et al., 2007) and decreased
inflammation but had no effects on E amyloid plaque load (Parachikova et al.,
2008), indicating that the duration of exercise regulates its effect on
Alzheimers-related pathology.
Importantly, the intensity and duration of exercise could produce distinct effects
on cognition. For instance, high-running rats exhibited long-term (24 and 72
hour retention test) recognition memory deficits (Garcia-Capdevila et al., 2009).
In contrast, low-running rats outperformed high-running and sedentary
littermates in the long-term recognition memory test (Garcia-Capdevila et al.,
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2009). Furthermore, continuous wheel running for 24 days reduced
hippocampal neurogenesis in the dentate gyrus, compared to non-exercising rats
(Naylor et al., 2005). On the contrary, either short-term running for 9 days or
reduced running distances (30-50 % less than high-running performance) for 24
days showed enhanced neurogenesis in the dentate gyrus compared to
uncontrolled running for 24 days (Naylor et al., 2005). Adrenal hypertrophy,
thymus involution and high baseline corticosterone elevation (indicators of
chronic stress) were also observed in rats undergoing long-term unlimited wheel
running compared to restricted running rats (Naylor et al., 2005), and this could
underlie the negative effects of extensive running on hippocampal neurogenesis.
However, others have reported neurogenesis improvement and corticosterone
elevation in C57BL/6J mice running on treadmills (Chang et al., 2008),
contradicting the proposal that increased corticosterone with extensive running
underscores reduced neurogenesis (Naylor et al., 2005). It has been established
that enhanced neurogenesis is associated with memory improvement (Dupret et
al., 2007), suggesting that a reduction in neurogenesis could prevent exercise-
induced cognitive enhancement. In agreement with this, it was reported that 24
hours of wheel running enhanced neurogenesis and this was associated with
improved spatial (van Praag et al., 1999) and short-term recognition memory
performance (Lafenetre et al., 2010).
It is critical to emphasize that limited access to wheel running, less than 3 hours
in the dark phase, was found insufficient to enhance neurogenesis (Holmes et
al., 2004). In contrast, the increase in the running performance of exercising
mice by a reward did not enhance hippocampal neurogenesis of C57BL/6J mice
compared to non-rewarded running mice (Klaus et al., 2009), suggesting that
exercise has a therapeutic window for its cognition-enhancing effects, and that
there is a ceiling (threshold) level of exercise that must be reached to show
cognitive improvement but extensive running could impair memory
performance.
There are multiple exercise-induced effects which collectively contribute to the
impact of exercise on cognition. As stated earlier, wheel running has been found
to enhance neurogenesis in the dentate gyrus (van Praag et al., 2005; Lafenetre
Chapter 1: General Introduction
39
et al., 2010) and hippocampal LTP (van Praag et al., 1999), both are involved in
the cognitive improvement. Also, it has been reported that wheel running
increases levels of brain derived neurotrophic factor (BDNF) in the
hippocampus (Adlard and Cotman, 2004; Liu et al., 2009; Lafenetre et al.,
2010), and this is not only implicated in exercise-related cognitive effects, but it
has also been thought to mediate its antidepressant effects (Sartori et al., 2011).
Moreover, exercise improves brain circulation and metabolism (Vissing et al.,
1996; McCloskey et al., 2001). Interestingly, a recent study demonstrated that
spatial memory improvement induced by 10 days of unlimited wheel running
was attenuated in metyrapone-treated and adrenalectomized rats, suggesting that
corticosterone is involved in exercise-dependent memory enhancement
(Hajisoltani et al., 2011). Overall, all these exercise-related effects are
suggested to act together to modulate its effects on learning and memory
performance.
As mentioned previously, treadmills could be used as an alternative for wheel
running to study effects of exercise on cognition in rodents. However, it has
been reported that each of these exercise modes differentially affects animals
performance in various memory tests. For instance, whereas running in the
wheel or on treadmills enhanced spatial memory of BalB/c mice in the Morris
water maze, only mice running on treadmills demonstrated improved
performance in the one-trial passive avoidance task (Liu et al., 2009).
Nevertheless, wheel running enhanced rats performance in the contextual fear
conditioning (Baruch et al., 2004), suggesting that the effects of wheel running
on fear memory could be task-dependent. Chronic treadmill running has been
reported to improve neurogenesis in the dentate gyrus of C57BL/6J mice
(Chang et al., 2008). It has also been found that forced exercise using treadmills
increased bromodeoxyuridine, a marker of proliferating progenitor cells,
(BRDU)-labelled cells in the dentate gyrus compared to rats which voluntarily
ran the same distances in the wheel (Leasure and Jones, 2008). Furthermore,
mice running on treadmills for 4 weeks exhibited an increase in levels of BDNF
and TrkB in the hippocampus (Liu et al., 2008) and amygdala (Liu et al., 2009);
the later underscored the enhancement of mices performance in the passive
avoidance task compared to other mice running in the wheels. Overall, exercise-
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induced memory improvement appears to depend on the exercise protocol and
memory tasks. Whereas mice running in the wheel exhibited enhancements in
spatial learning and hippocampal BDNF levels, and this effect lasted for 1-2
weeks after the end of exercise (Berchtold et al., 2010), mice exercising on
treadmills demonstrated spatial memory improvement and a transient rise in
their hippocampal BDNF levels (Chang et al., 2008), suggesting that wheel
running has longer-lasting effects on cognition.
To sum up, wheel running is rewarding and elevates corticosterone levels, and,
therefore, this mode of exercise provides an appropriate model (stressful natural
reward) to study the role of corticosterone and GRs in the motivation to run and
the influence of chronic running on memory performance.
1.6 Strain differences in vulnerability to addictive drugs
Compared to other strains such as DBA/2J and CBA/J, C57BL/6J mice have
shown excellent spatial learning and memory performance (Hyde et al., 1998;
Nguyen et al., 2000a). Also, the C57BL/6J strain has been commonly used as a
background for genetically modified strains, and, thus, this permits a linkage
between certain memory deficits and specific genetic alterations. For example,
C57BL/6 mice have been used to generate transgenic mouse models of
Alzheimers disease (Green et al., 2006; Jeong et al., 2006). Furthermore,
C57BL/6J mice have been used in operant self-administration studies (Fiancette
et al., 2010), the two-bottle free choice test (Phillips et al., 1998) and the CPP
test (Orsini et al., 2005): all of these paradigms include some aspects of learning
(Bozarth, 1987; Bardo and Bevins, 2000; Tordoff, 2007). Overall, the
C57BL/6J mouse strain is appropriate for studying the influence of
corticosterone-related reward on cognition.
It has been reported that C57BL/6J mice are more sensitive than other inbred
strains such as DBA/2J to addictive drugs. For example, C57BL/6J mice were
more prone to develop CPP to morphine and cocaine than DBA/2J mice (Orsini
et al., 2005; Solecki et al., 2009). In fact, low reinforcing doses of morphine in
C57BL/6J mice were not self-administered by DBA/2J mice (Elmer et al.,
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2010). Consistent with this, morphine enhanced brain reward stimulation in
C57BL/6J mice but attenuated it in DBA/2 mice (Elmer et al., 2010). It has
been found that differences in the expression of endogenous opioids in the
nucleus accumbens underlie the sensitivity to morphine-induced CPP between
the two strains (Gieryk et al., 2010). With regard to psychostimulants, whereas
amphetamine induced CPP in C57BL/6J mice, DBA/2J mice exhibited
conditioned place aversion to amphetamine (Cabib et al., 2000). Nevertheless,
stress induced by food restriction facilitated amphetamine-induced CPP in
DBA/2J (Cabib et al., 2000). Similar to morphine and amphetamine, nicotine
induced CPP in C57BL/6J mice (Scott and Hiroi, 2010). Furthermore,
amphetamine induced locomotor hyperactivity at low doses in C57BL/6J mice
compared to DBA/2J mice.
A considerable number of studies have reported that C57BL/6J mice are
motivated to self-administer addictive drugs with different mechanisms of
actions. For example, C57BL/6J mice lever-pressed to self-administer cocaine,
and extinguished (withdrawn) mice reinstated cocaine-seeking behaviour
(Fuchs et al., 2003; Ward et al., 2009). Moreover, C57BL/6J mice self-
administered midazolam, a benzodiazepine, in the two-bottle choice test (Tan et
al., 2010). C57BL/6J mice have also been widely used in alcohol preference
studies employing the two-bottle choice test (Crabbe and Phillips, 2004;
Melendez et al., 2006). In addition, a single injection of cocaine induced
locomotor hyperactivity and accumulation of 'FosB in the dorsal striatum and
nucleus accumbens of C57BL/6J mice (Lhuillier et al., 2007). On the other
hand, repeated cocaine injections induced behavioural sensitization and
upregulation of 'FosB and phosphorylated cyclic response element binding
protein in the nucleus accumbens (Lhuillier et al., 2007). One important point is
that mifepristone was reported to attenuate the reinforcing effects of cocaine in
C57BL/6J mice, suggesting that GRs in this strain could play a role in self-
administration of abused drugs (Fiancette et al., 2010). Overall, the C57BL/6J
mice are an appropriate strain in which to self-administer addictive drugs and to
study their impact on cognition.
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1.7 Study hypothesis
Previous research over the last decades has advanced our knowledge of the role
of corticosterone in modulating self-administration of abused drugs and its
interaction with reward pathways. In addition, corticosterone as a neurogenic
index of stress may contribute, at least partially, to stress-seeking behaviour.
These findings led us to consider the probability that corticosterone is rewarding
and addictive. Few experiments have addressed this question and shown
evidence for corticosterone self-administration in rats. However, it is unknown
whether mice would also self-administer corticosterone, and whether rewarding
effects of the stress hormone could enhance memory performance.
1.7.1 Objectives of the thesis
x The first objective of this work was to investigate whether
corticosterone was rewarding and addictive in male C57BL/6J mice,
through establishing corticosterone self-administration in the two-bottle
free choice test.
x The second objective was to investigate whether corticosterone self-
administration or exercise-evoked corticosterone elevation improved the
cognitive performance of corticosterone or exercise withdrawn mice,
respectively.
x Thirdly, it was of interest to study whether chronic corticosterone self-
administration altered the expression of key proteins of neuroplasticity
in the hippocampus and frontal cortex.
x Lastly, as the striatum is involved in drug-seeking behaviour, levels of
dopamine, serotonin and their metabolites in the striatum were assessed
in order to establish whether corticosterone self-administration by mice
was accompanied with long-lasting neurochemical changes in the
reward pathway.
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Chapter 2
Investigation of rewarding properties of corticosterone
and their effects on cognition in the mouse
2.1 Introduction
The overall aim of the experiments described in this chapter was to investigate
the rewarding and addictive properties of corticosterone and their impact on
cognition. Drug addiction is defined as a chronic relapsing disorder
characterized by compulsive drug-seeking behaviour which leads to
intoxication, dependence and adverse withdrawal symptoms (Koob and Le
Moal, 2005; Koob and Le Moal, 2008). Seeking drug administration after
withdrawal is defined as relapse (reinstatement) and is considered as a valid
marker of addiction (Stewart, 2000). In the present study, the two-bottle choice
test/oral self-administration model was undertaken to test the development and
reinstatement of corticosterone self-administration. There are several standard
models that are widely used to evaluate rewarding properties of drugs; for
example, conditioned place preference (CPP), intracranial self-stimulation and
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self-administration paradigms. Among the latter models, the intravenous drug
self-administration paradigm is effectively used to measure abuse potential
(Collins et al., 1984) and is a standard alternative for CPP (Bardo and Bevins,
2000). Self-administration paradigms are choice models in which an animal is
allowed to choose to access a drug without enforcing the animal to administer
the drug in contrast to CPP. In the operant intravenous self-administration
model, the reinforcing properties of a drug are determined by manipulating
several factors: I- The drug dose. II- The cost of responding; the fixed ratio and
progress ratio schedules which are changed according to the rates of the
animals response, such as lever presses or nose pokes, to receive a dose of the
tested drug (Kelleher and Goldberg, 1975; Krasnegor, 1978). III- Second-order
schedule in which drug-paired stimuli act as conditioned reinforcers to maintain
the animals response (Koob and Le Moal, 2008). The two-bottle choice model
is another self-administration paradigm which is simple and reliable as animals
have unlimited access to a reward-testing substance, thereby simulating the free
access environment of drugs abused by humans. This test is extensively used to
examine rodents preference for different tasting solutions and nutrients
(Tordoff and Bachmanov, 2002), and it has been frequently used in ethanol
preference studies (Phillips et al., 1998; Carroll et al., 2006). The two-bottle
position is alternated every day to control for side preference to ensure that the
animal can discriminate the rewarding solution, thereby increasing the validity
of the method (Bachmanov et al., 2002; Tordoff and Bachmanov, 2002).
In the present study, a major issue was to help mice to discriminate the
corticosterone solution which is tasteless. A preliminary study, involving the
use of the two-bottle choice test (unpublished data), was carried out to examine
corticosterone self-administration and results showed that mice drank
extensively but equally from the corticosterone solution and water bottles,
suggesting that they could not recognise the taste of the hormone easily or that
corticosterone stimulated the drinking behaviour. Inosine monophosphate (IMP)
was, therefore, used as a flavouring agent to allow mice to distinguish between
the solutions in the two bottles. From the literature, IMP was thought to be an
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ideal flavour because it was tested in the same mouse strain (C57BL/6J) as was
used in the present experiment (Tordoff, 2007), it is water soluble and has no
sodium content which may compromise the choice behaviour as glucocorticoids
were found to increase fluid intake when sodium was added to the drinking
fluid (Thunhorst et al., 2007). The preference for IMP was examined in
C57BL/6J mice using the two-bottle choice test and a dose/response curve
showed that the behavioural detection threshold was at a concentration of 1 mM
(Tordoff, 2007). Therefore a 2 mM IMP concentration was chosen for which
C57 mice showed 60% preference without altering the normal daily fluid intake
(Tordoff, 2007). This ensured that the mice could discriminate the flavour
without developing a strong preference to it, which would confound the
acquisition of corticosterone self-administration.
Corticosterone is well known to influence cognition and memory processing. A
number of studies have shown that chronic stress or high plasma corticosterone
levels have deleterious influences on memory and synaptic plasticity, whereas
moderate stress-induced corticosterone secretion is beneficial for spatial
memory and hippocampal plasticity (Diamond et al., 1992; Akirav et al., 2004;
Rocher et al., 2004; Cerqueira et al., 2007). This depends on plasma levels of
corticosterone and duration of exposure to corticosterone (Diamond et al., 1992;
Pavlides et al., 1993; Bardgett et al., 1994; Coburn-Litvak et al., 2003).
However, it is interesting to investigate whether corticosterone has the same
widely accepted influences on learning and memory when it is self-
administered, and therefore whether its rewarding properties modulate the
impact on cognition. Spatial memory and recognition memory of mice were
examined to determine impacts of chronic oral corticosterone self-
administration on cognition. Spatial working memory was evaluated using the
spontaneous alternation test in a T-maze and the object location test, and the
novel object test was used to evaluate recognition memory.
To investigate whether corticosterone self-administration was accompanied by
synaptic plasticity changes, western immunoblotting was used to measure levels
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of key proteins regulating brain plasticity including synaptophysin (SYN),
brain-derived neurotrophic factor (BDNF), tropomysin-related kinase B (TrkB),
and phosphorylated extracellular signal-regulated kinase 1 and 2 (pERK1/2) in
the hippocampus and frontal cortex, two brain regions which are critical for
working memory, learning and addiction (Asaad et al., 1998; Asaad et al.,
2000; Volkow et al., 2003; Bekinschtein et al., 2007).
SYN, a presynaptic vesicle-associated membrane protein, is a 38 kDa
glycoprotein (Jahn et al., 1985; Wiedenmann and Franke, 1985). It is implicated
in the exocytosis of neurotransmitters from synaptic vesicles (Valtorta et al.,
2004) and, therefore, SYN has been used as a classical marker of
synaptogenesis (Mazer et al., 1997; Thome et al., 2001; Vawter et al., 2002).
Furthermore, it is believed to play a role in learning and memory (Thome et al.,
2001; Nithianantharajah and Murphy, 2008; Schmitt et al., 2009). Interestingly,
SYN expression in the hippocampus and nucleus accumbens of Sprague-
Dawley rats was positively correlated with their performance in CPP for
amphetamine (Rademacher et al., 2006), suggesting it may be involved in drug
addiction.
BDNF is a polypeptide neurotrophin which is required for neuronal survival
(Ghosh et al., 1994) and neuroplasticity (Thoenen, 1995; Kafitz et al., 1999).
Moreover, it has been found that BDNF is required for learning and memory
(Hall et al., 2000; Bekinschtein et al., 2007; Heldt et al., 2007). Also, BDNF
has been reported to modulate self-administration of abused drugs such as
cocaine (Graham et al., 2007). Mature BDNF is synthesized when pre-
proBDNF, a BDNF precursor, is cleaved to proBDNF and then cleaved by
plasmin or metalloproteinases to the mature form (Cunha et al., 2010). BDNF
mediates its actions mainly via its high affinity receptor, full length (FL) TrkB,
but it can also bind to truncated (t) TrkB and the p75 neurotrophin receptor
(p75NTR) which is mainly activated by proBDNF, a precursor of mature BDNF
(Teng et al., 2005). Truncated-TrkB is a degradation form of FL-TrkB which
lacks tyrosine kinase domain essential for downstream signalling (Klein et al.,
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1993). Thus, t-TrkB can act as a negative regulator of BDNF mediated effects
when BDNF/t-TrkB complex forms heterodimers with FL-TrkB to function as a
clearance receptor (Haapasalo et al., 2002). Eventually, proBDNF and p75NTR
can also regulate mature BDNF/FL-TrkB signalling (Cunha et al., 2010).
Activation of FL-TrkB receptors switches on three major downstream signalling
pathways: phospholipase Cb, phosphatidylinositol 3-kinase and extracellular
signal regulated kinase / mitogen-activated protein kinase (ERK/MAPK)
(Cunha et al., 2010).
ERK is a member of the mitogen-activated protein kinases (MAPK) which
contribute to learning, memory formation, neuroplasticity and neuroadaptation
(Mazzucchelli and Brambilla, 2000; Rodrigues et al., 2004). Two ERK
isoforms have been identified in mammalian nerve cells: ERK1 and ERK2
(Zhai et al., 2008). Previous research has revealed that multiple upstream
signalling pathways can activate ERK1/2 by phosphorylation: (1) neurotrophins
including BDNF, nerve growth factor, basic fibroblast growth factor and NT-3,
(2) drugs whose actions are mediated via activating G protein-coupled receptors
such as dopamine, glutamate, opioids and cannabinoids and (3) activation of
calcium channels by drugs such as nicotine or the excitatory neurotransmitter
glutamate (Lee and Messing, 2008). ERK1/2 is widely expressed in the brain
and is particularly abundant in mesocorticolimbic dopaminergic neurons (Zhai
et al., 2008). A considerable body of research supports the role of ERK1/2 in
drug-seeking behaviour and reinstatement of most abused drugs such as
cocaine, amphetamine, opioids, endocannabinoid and alcohol (Valjent et al.,
2004; Zhai et al., 2008). ERK2 seems to be more important for behavioural
expression of drug addiction than ERK1 (Mazzucchelli et al., 2002; Li et al.,
2008).
Dopamine is believed to be a major reward neurotransmitter in the brain. It is
implicated in the rewarding effects of most abused drugs including cocaine,
amphetamine, morphine and nicotine (Yokel and Wise, 1975; De Wit and Wise,
1977; Devine et al., 1993; Lacosta and Roberts, 1993; Glick et al., 1998).
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Mesocorticolimbic dopaminergic neurons project from the ventral tegmental
area mainly to the nucleus accumbens and frontal cortex, and they are believed
to mediate rewarding effects of addicted drugs (Wise, 1998). The nigrostriatal
dopamine pathway, which is traditionally considered to be critical for motor
function, has also been shown to play a role in reward-related effects (Wise,
2009). One important objective was, therefore, to measure levels of
monoamines including dopamine, 5HT and their metabolites in the striatum of
mice by means of HPLC.
2.2 Objectives
x To determine if mice would self-administer and reinstate corticosterone
in the two-bottle free choice test using IMP as a flavouring agent to
allow mice to discriminate the hormone-containing bottle.
x To evaluate the impact of chronic corticosterone self-administration on
mices spatial memory performance by employing the spontaneous
alternation and object location tests.
x To investigate the effects of chronic corticosterone self-administration
on mices recognition memory.
x To use western immunoblotting to measure levels of key proteins
mediating neuronal plasticity including SYN, BDNF, TrkB and
pERK1/2 in the hippocampus and frontal cortex of mice to determine
whether behavioural changes are associated with changes in the level of
expression of these proteins.
x To investigate the effects of corticosterone self-administration on the
mesolimbic reward pathway through measuring, by HPLC, the levels of
dopamine, serotonin and their metabolites in the striatum of mice.
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Chapter 2 - Part 1
Acquisition and reinstatement of corticosterone self-
administration in mice
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2.3 Purpose
This part of the experiment was designed to test the development, maintenance
and reinstatement of oral corticosterone self-administration in mice using the
two-bottle choice model.
2.4 Materials and methods
2.4.1 Animals
Forty six 12-week-old male C57BL/6J mice were purchased from Charles River
UK and housed in groups of three per cage. After one week, the animals were
individually caged and left undisturbed for one week. Standard environmental
conditions including temperature (20 - 22 qC), humidity (55 - 60 %), ventilation
and 12:12 light dark cycle (lights on at 7:00 am) were maintained until the end
of the experiment. Food and water were available ad libitum. After
acclimatization, water bottles were replaced by one or two drinking tubes
according to experimental progress. The body weight (BW) of mice was
recorded weekly at the time of cage change. Animal care and welfare in this
experiment were in compliance with the UK Animal Scientific Procedures Act
1986 under project licence 40/2715. Five mice died during the course of the
experiment; veterinary advice was sought, and it was concluded that
corticosterone treatment was not the cause of death, although we could not
establish the cause of death. These mice were excluded from any statistical
analysis of data.
2.4.2 Drinking solutions
2.4.2.1 Corticosterone solution
&RUWLFRVWHURQH SUHJQHQHȕGLROGLRQH  PJ SHU YLDO 6LJPD
Aldrich UK), was dissolved in 20 ml of absolute ethanol using a sonic probe
and then diluted with distilled water to give a final concentration of 250 Pg/ml.
The ethanol concentration in the diluted corticosterone solution was 1 % (Lee et
al., 2010). The dose of corticosterone consumed was calculated every day for
each animal.
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The dose of corticosterone ingested by each mouse was calculated every day
according to this equation:
Daily corticosterone dose (mg/kg BW animal) =
Intake from corticosterone solution (ml) x 0.25* x 1000#
Animal BW (g)
* Concentration of corticosterone solution (0.25 mg/ml)
# denotes 1000 g (1 kg) animal BW.
The corticosterone solution was gradually diluted for any of the mice whose
dose exceeded 60 mg/kg/day until its daily corticosterone intake returned below
this dose.
2.4.2.2 Vehicle for corticosterone solution
20 mls of absolute ethanol stock solution was sonicated under the same
conditions as were used to dissolve corticosterone. Then, the absolute ethanol
was diluted with distilled water to a final 1% concentration before filling the
drinking tubes. Ethanol intake was calculated according to the following
equation:
Ethanol intake (g/kg BW animal) = (1000# X (A/100) X 0.789)/B
x A is the daily number of mls drunk from the corticosterone solution or
ethanol solution (control-vehicle) when ethanol is used at 1%.
x B is the animal BW (g).
x 0.789 is specific gravity of ethanol.
x # denotes 1000 g (1 kg) animal BW.
2.4.2.3 Preparation of inosine monophosphate (IMP) solution
2QHJUDPRI ,03LQRVLQHƍPRQRSKRVSKDWH IURP6DFFKDURP\FHVFHUHYLVLDH
Sigma-Aldrich UK) was dissolved in 40 ml distilled water as a stock solution
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which was used to flavour distilled water or the corticosterone solution at a final
concentration of 2 mM (696 Pg/ml).
2.4.3 Construction of the drinking tubes
Drinking tubes were built for the purpose in-house (School of Biomedical
Sciences, Medical Engineering Unit) according to protocols described by
Bachmanov et al. (1996) and Bachmanov et al. (2002). Graduated 30 ml
pipettes were used whose conical openings were cut to give the same diameter
at both ends. Silicone stoppers were used to close one end. The second opening
was closed by the same stoppers in which an internal hole was made to
introduce a spout. A ball was added inside each spout to help minimizing
leakage from the drinking tube when the animals were not drinking. Spouts of
the two tubes were inserted into the cage through a perforated metal sheet
attached to the front side of the cage lid to prevent the mice from chewing the
silicone stoppers.
2.4.4 The two-bottle free choice test
In the two-bottle choice model, each individually housed mouse was provided
with two drinking tubes, one for the control solution and the other for the test
solution. Fluid intake from each tube was recorded daily. The use of drinking
tubes helped to minimise the wasting of the drinking solutions since mice drank
up to 10 ml a day and the solutions needed to be renewed twice a week. In the
two-bottle choice test, each mouse was provided with two drinking tubes of
water during the habituation phase and with the relevant test and control
solutions (see table 2.1) during the testing phases. Also, spillage was controlled
through the use of three drinking tubes attached to empty cages which were
placed in the same rack as the experimental animals. The average fluid loss
from these tubes was calculated every day and accounted for spillage and was
then deducted from the amount of fluid drunk by each mouse. This resulted in
accurate drug dose calculation. Weighing tubes to know how much the animal
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had drunk over the past 24 hours was seen as a more sensitive measure than
using the graduations on the drinking tubes.
The weight of drinking tubes was recorded every day, to calculate the difference
from the previous day as described below:
The weight of fluid drunk from one tube =
Weight of this tube on the previous day  (weight of this tube today +
spillage)
Then 1 g water (the main vehicle) is equal to 1 ml.
Drinking tubes containing corticosterone and/or IMP were covered with opaque
paper since corticosterone is light-sensitive.
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Table 2.1 The control and test solutions for each of the five experimental groups during the acquisition, relapse and switching phases
of the two-bottle choice test. * =1 and # =3 mice died before the end of the experiment but post-mortem examination excluded
corticosterone as a cause of death. These mice were excluded from any statistical analysis.
Test
Flavoured
corticosterone
Water
Water
Water
IMP
Ethanol 1%
Unflavoured
corticosterone
Water
IMP
Unflavoured
corticosterone
Water
Water
Water
IMP
Ethanol 1%
Flavoured
corticosterone
Unflavoured
corticosterone
IMP
Water
Unflavoured
corticosterone
Flavoured
corticosterone
Water
Water
Water
IMP
Unflavoured
corticosterone
Ethanol 1%
A (n = 8)
Control-Flavour
C* (n = 9)
D
#
(n = 7)
E* (n = 9)
B (n = 8)
Control-Vehicle
Unflavoured
corticosterone
IMP
Water
Control Control Test Control Test
Choice/Group
Acquisition Relapse (reinstatement) Switching
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2.4.5 Experimental design
The timeline of the experiment is presented in Fig. 2.1.
2.4.5.1 Habituation phase
One week after being individually housed, mice were given access to 2 drinking
tubes containing tap water for 10 days. This experimental period was required
to give mice the opportunity to learn that they could drink from the two tubes,
to monitor their normal daily fluid intake, and to monitor side preference. On
the last two days of the habituation phase, mice underwent the spontaneous
alternation test in a T-maze to evaluate their baseline spatial working memory
performance prior to being randomly allocated to the 5 experimental groups as
illustrated in table 2.1.
2.4.5.2 Pre-choice test induction phase
For 3 days, mice were only given access to the acquisition test solution
delivered in one drinking tube to help them experience the taste of their test
solution.
2.4.5.3 Acquisition of corticosterone self-administration
Mice had unlimited access to two drinking tubes for 3 weeks; one containing
the control solution and the other containing the test solution, as described in
table 2.1. Although one group in which mice rapidly self-administered
corticosterone; starting from the first week, when paired with IMP (group D),
the acquisition phase was extended for two weeks, as a relatively long lag was
probably required for mice in other groups (different choices) to exhibit a
significant preference for corticosterone. Also, this permitted to investigate
chronic effects of corticosterone-related reward on memory. To control for the
side preference, the position of the test and control tubes was switched every
day; for half of each group, the test solution was first given on the right side,
and then on the left side for the rest of the group.
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2.4.5.4 Withdrawal phase I
After 3 weeks of acquisition, the two-bottle choice test was stopped. The two
drinking tubes were replaced by one drinking tube filled with tap water
(withdrawal I). As the total fluid intake of corticosterone-treated mice rapidly
dropped to the control levels on the first day of withdrawal, this period lasted
only for a week. To investigate the effects of the three-week treatment on
cognitive performance, mice were retested in the T-maze one day after the
cessation of the corticosterone treatment.
2.4.5.5 Reinstatement of corticosterone self-administration
Mice were again given access to the same test and control solutions as during
acquisition for a 2-day period, see Table 2.1 for details of relapse. This phase of
the choice test was required to investigate the addictive potential of
corticosterone.
2.4.5.6 Switching phase
This phase was carried out to investigate whether mice would sustain significant
corticosterone self-administration after exchanging the flavour paired to their
solutions. This phase was added to the experiment because we unexpectedly
observed an initial aversion for IMP in the control-flavour group (water versus
IMP) which could affect corticosterone self-administration. Switching was
carried out by exchanging flavoured solutions for unflavoured ones between
groups D and E. One day before the switching phase, each mouse had access to
only one drinking tube which contained the test solution of the switching phase.
Then, the two-bottle choice test was carried out for 5 days to examine the effect
of switching. Throughout Chapter 2, each group will be identified by its choice
offered during acquisition and relapse, but switching will be indicated when it is
relevant.
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2.4.5.7 Withdrawal phase II and behavioural assessment
Drinking was monitored for another five days, during which each animal had
access to only one drinking tube with tap water. Mices spontaneous alternation
performance was again evaluated in the T-maze. Then, mice were habituated to
the open field arenas 24 hours before being subjected to the novel object
recognition test. On the following day, the mice underwent the object location
test, to investigate the long-term effect of corticosterone treatment on spatial
memory.
2.4.6 Blood and tissue collection
Mice were left undisturbed for 48 hours before being sacrificed by cervical
dislocation. Trunk blood was collected in heparinised tubes for the
measurement of plasma corticosterone concentrations. Plasma was isolated
from blood samples after centrifugation at 3000 g at 4 qC for 10 minutes. The
brains were removed, and the hippocampus, frontal cortex and striatum were
rapidly dissected on ice. In brief, each brain, in its ventral view, was fixed by
forceps, and the hypothalamus was removed. After adjusting the brain in its
dorsal view, the olfactory bulb was removed before the frontal cortex on both
sides of the brain was excised. Then, the internal side of cortex was carefully
exposed; by using the scalpel to cut through the middle line between the two
hemisperes, to separate a curved band of cortex (the hippocampus) from
surrounding tissue. Finally, the striatum which is a part of the basal ganglia was
dissected. Plasma and brain tissues were kept in the freezer at  80 qC for
further investigation.
2.4.7 Determination of plasma corticosterone levels (ng/ml)
Circulating plasma corticosterone levels were determined using 96 well plate
enzyme-linked immunoassays (ADI-900-097, Enzo Life, USA) according to the
manufacturers instructions. The sensitivity of the assay was 27 pg/ml: the intra-
assay and inter-assay coefficients of variation were 7.7% and 9.7%,
respectively. All samples were run in duplicate and the plate was read at 405
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nm and correction made at 580 nm using SoftMax® Pro V 4.0 (Life Sciences
Edition).
2.4.8 Statistical analysis
Data are presented as mean ± SEM. Three-way ANOVAs with repeated
measures (time X bottle X group) were used to analyse fluid intake (ml) during
the two-bottle choice test, and two-way ANOVAs with repeated measures (time
X group) were used to analyse fluid intake (ml) during the withdrawal phases,
corticosterone doses (mg/kg), ethanol intake (g/kg) and changes in BW (g). The
between subject factor was groups to compare total fluid intake or changes in
BW (5 levels), corticosterone doses (3 levels) or ethanol intake (4 levels).
Within subject factors were time; including weeks of acquisition (three levels),
days of relapse (two levels) or days of switching (five levels), and bottles (two
levels) to analyse the preference for the test solution in each experimental
group, or changes in BW after completing each experimental phase (5 levels).
During the acquisition phase, data were averaged on a weekly basis because
minor changes were seen within each week. Plasma corticosterone levels were
analysed by a one way ANOVA with groups (5 levels) as the between subject
factor. Post-hoc planned comparisons and paired sample t-tests were used when
significant main effects were obtained. An effect was considered significant
ZKHQ D 3 YDOXH ZDV   7KH 6366 DQG ,Q9LYR6WDW VRIWZDUH ZDV XVHG WR
perform statistical analysis in all experiments presented in the thesis. InVivoStat
software was mainly used to run ANOVAs with repeated measures as it
calculates P values for the between subject factors on each time point.
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Schematic representation of the experimental design
Days 7 18 21 42 49 52 58 67
Preparation phaseA
Treatment and testing phasesB
0
Individual
housing
Habituation (10 days)
Two drinking tubes of water
The position of the two
drinking tubes is fixed 
daily monitoring of water
intake from each tube (side
preference assessment).
SAT
Induction (3 days)
One drinking tube
containing the test
solution.
Acquisition
(3 weeks)
Withdrawal phase I
(one week)
Mice were given
access to one drinking
tube containing water.
SAT
Blood and tissue
collection
Withdrawal phase II (10 days)
Memory assessment: SAT, NORT, OLT
Relapse
(2 days)
Induction
(one day)
Switching
(5days)
Figure 2.1 Experimental design comprised: (A) Preparation phase for the habituation to the two-bottle choice testing, (B) Treatment & bottle choice
testing phases for the investigation of oral corticosterone self-administration. During the three phases (acquisition, relapse and switching) of the two-
bottle choice test, each mouse was provided with two drinking tubes (one for the test solution and the other for the control solution). The position of
the two drinking tubes was alternated every day during the testing phases. Fluid intake was recorded daily to calculate the doses of corticosterone
and/or ethanol ingested by each mouse. The concentration of corticosterone solutions was adjusted when a mouses daily intake exceeded 60 mg/kg
for health reasons. SAT: spontaneous alternation test, NORT: novel object recognition test, OLT: object location test.
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2.5 Results
2.5.1 The two-bottle free choice test
2.5.1.1 Fluid intake from the control and test solutions
Summary of the main statistical effects for the factors: bottle, time and time X
bottle interaction in each group during acquisition, relapse and switching is
presented in table 2.2.
2.5.1.1.1 Did mice self-administer vehicle or flavour?
2.5.1.1.1.1 Group A (control-flavour): water versus IMP
Mice from the control-flavour group exhibited significant avoidance towards
the IMP solution during the three weeks of acquisition (F(1,7) = 10.76, P =
0.013). Paired sample t-tests detected significant avoidance to the IMP solution
during the first (P = 0.042) and third (P = 0.004) weeks of acquisition, Fig.
2.2A. However, this initial avoidance of IMP disappeared during the relapse
and switching phases, table 2.2.
2.5.1.1.1.2 Group B (control-vehicle): water versus ethanol 1%
Mice from the control-vehicle group did not show preference for any of the
solutions during the 3 phases: acquisition, relapse and switching, table 2.2.
However, there was a significant time effect during the switching phase (F(4,28)
= 8.90, P = 0.00009), and post-hoc paired sample t-tests indicated a significant
difference between ethanol and water intake (t = 2.97, P = 0.021) on the second
day of switching only, Fig 2.2B.
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Groups Factors
Acquisition (weeks)
W1, W2, W3
Relapse (days) D50,
D51
Switching (days)
D53-D57
Bottle F(1,7) = 10.76, P = 0.013 F(1,7) = 0.35, P = 0.57 F(1,7) = 0.07, P = 0.80
Time F(2,14) = 0.62, P = 0.55 F(1,7) = 1.57, P = 0.25 F(4,28) = 1.50, P = 0.23
Water versus IMP
(control-flavour, n = 8)
Time X bottle interaction F(2,14) = 0.83, P = 0.46 F(1,7) = 4.65, P = 0.07 F(4,28) = 0.78, P = 0.55
Bottle F(1,7) = 1.02, P = 0.35 F(1,7) = 1.05, P = 0.34 F(1,7) = 2.55, P = 0.15
Time F(2,14) = 0.31, P = 0.74 F(1,7) = 4.64, P = 0.07 F(4,28) = 8.90, P = 0.00009Water versus ethanol 1%
(control-vehicle, n = 8) Time X bottle interaction F(2,14) = 0.35, P = 0.71 F(1,7) = 0.51, P = 0.50 F(4,28) = 0.91, P = 0.47
Bottle F(1,8) = 5.50, P = 0.047 F(1,8) = 26.33, P = 0.001 F(1,8) = 7.43, P = 0.026
Time F(2,16) =1.00, P = 0.39 F(1,8) = 2.54, P = 0.15 F(4,32) = 1.98, P = 0.12Water versus unflavoured
corticosterone (n = 9) Time X bottle interaction F(2,16) = 0.62, P = 0.55 F(1,8) = 8.11, P = 0.022 F(4,32) = 1.13, P = 0.36
Bottle F(1,6) = 52.78, P = 0.0003 F(1,6) = 63.22, P = 0.0002 F(1,6) = 3.94, P = 0.09
Time F(2,12) = 6.26, P = 0.014 F(1,6) = 0.71, P = 0.43 F(4,24) = 2.83, P = 0.047
IMP versus unflavoured
corticosterone # (n = 7)
Time X bottle interaction F(2,12) = 9.25, P = 0.004 F(1,6) = 0.14, P = 0.72 F(4,24) = 0.42, P = 0.79
Bottle F(1,8)= 2.39, P = 0.16 F(1,8) = 0.32, P = 0.59 F(1,8) = 23.71, P = 0.001
Time F(2,16) = 1.52, P = 0.25 F(1,8) = 0.21, P = 0.66 F(4,32) = 2.32, P = 0.08
Water versus flavoured
corticosterone # (n = 9)
Time X bottle interaction F(2,16) = 0.70, P = 0.51 F(1.8) = 3.35, P = 0.10 F(4,32) = 1.64, P = 0.19
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Table 2.2 Summary of the main statistical effects for the following factors: bottle, time and time X bottle interaction, for each of the five groups (n =
7-9) of male C57BL/6J mice over the three phases of the two bottle choice test: acquisition, relapse and switching. Data were analysed using three-
way ANOVAs with repeated measures. Statistical significance is highlighted in bold. # indicates groups whose solutions were exchanged during the
switching phase.
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2.5.1.1.2 Group C: Did mice self-administer corticosterone in the absence of
IMP?
In the absence of IMP, although mice showed an overall significant preference
for the unflavoured corticosterone solution over water during acquisition (F(1,8)
= 5.50, P = 0.047), paired sample t-tests did not reveal any significant bottle
effect on individual weeks (P >0.05, in all case), Fig. 2.2C. This suggests that
mice had difficulty in recognising the unflavoured corticosterone solution when
it was paired with water. However, the preference for the corticosterone
solution increased with time and persisted during the relapse (F(1,8) = 26.33, P =
0.001) and switching (F(1,8) = 7.43, P = 0.026) phases, Fig. 2.2C. Also, there
was a significant day X bottle interaction during relapse (F(1, 8) = 8.11, P =
0.022), reflecting increased corticosterone intake and decreased water intake
with repeated days, table 2.2. Paired sample t-tests revealed a significantly
higher intake from the unflavoured corticosterone solution than from water
during relapse (PD50 = 0.008, PD51 = 0.001) and two separate days of switching
(PD53 = 0.015, PD55 = 0.018), indicating the inability of mice in this group to
easily recognise the stress hormone without a flavour, Fig. 2.2C.
2.5.1.1.3 Did the flavour facilitate corticosterone self-administration and did
mice retain the preference for corticosterone after switching
flavoured for unflavoured solutions?
2.5.1.1.3.1 Group D (IMP versus unflavoured corticosterone and water versus
flavoured corticosterone before and after the switching phase,
respectively)
Mice which had a choice between IMP and unflavoured corticosterone during
acquisition drank almost exclusively from the corticosterone solution (F(1,6) =
52.78, P = 0.0003). During acquisition, there were also significant effects of
weeks (F(2,12) = 6.26, P = 0.014) and week X bottle interaction (F(2,12) = 9.25, P
= 0.004), reflecting an increase in the preference for corticosterone and a
decrease in the intake of IMP with time. Paired sample t-tests showed a
significant preference for corticosterone during all 3 weeks of acquisition (PW1
= 0.0003, PW2 = 0.001, PW3 = 0.001), Fig. 2.2D.
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High intake from the unflavoured corticosterone solution was retained during
the relapse phase (F(1,6) = 63.22, P = 0.0002), table 2.2, and paired sample t-tests
showed significant intake from unflavoured corticosterone during the two days
(PD50 = 0.002, PD51 = 0.00002), Fig 2.2D. After switching there was, however,
no significant preference for flavoured corticosterone over water (F(1,6) = 3.94, P
= 0.09) and no significant time X bottle interaction effect (F(4,24) = 0.42, P =
0.79), but there was a significant time effect (F(4,24) = 2.83, P = 0.047), table 2.2,
reflecting the effects of switching to the new choice. Although paired sample t-
tests did not show a significant preference for flavoured corticosterone on
individual days (PD53 = 0.14, PD54 = 0.20, PD55 = 0.12, PD56 = 0.056, PD57 =
0.09), mices total fluid intake remained significantly high compared to both
control groups (P = 0.005), and they consumed high doses of corticosterone, as
they did during the acquisition and relapse periods, Fig 2.3.
2.5.1.1.3.2 Group E (water versus flavoured corticosterone and IMP versus
unflavoured corticosterone before and after switching, respectively)
Mices intake of the flavoured corticosterone solution was not significantly
different from their intake of water during the acquisition and relapsing phases,
table 2.2. In contrast, mice exhibited a remarkable preference for the
unflavoured corticosterone solution over IMP after switching (F(1,8) = 23.71, P =
0.001), table 2.2. Paired sample t-tests revealed a significant preference for
unflavoured corticosterone over IMP during the first three days of switching
(PD53 = 0.03, PD54 = 0.002, PD55 = 0.0002), Fig. 2.2E.
2.5.1.2 Total fluid intake
Total fluid intake remained unchanged, between 2.5 to 3.2 ml/day, throughout
the experiment for both control groups, Fig 2.2A and Fig 2.2B. Three-way
ANOVAs with repeated measured revealed significant differences between
groups for the total fluid intake during acquisition (F(4,36) = 11.16, P <0.001),
relapse (F(4,36) = 11.44, P <0.001) and switching (F(4,36) = 8.40, P <0.001). Also,
there were significant time (weeks or days) effects during acquisition (F(2,72) =
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6.85, P = 0.002) and switching (F(4,144) = 5.85, P <0.001) but not during the
relapse (F(1,36) = 0.77, P = 0.39). Moreover, there was a significant time X group
interaction effect during acquisition (F(8,72) = 3.48, P = 0.002), reflecting a
gradual rise in the total fluid intake of two corticosterone-treated groups which
began to self-administer corticosterone during the acquisition phase.
For group C, mice which had a choice between water and unflavoured
corticosterone, post-hoc planned comparisons showed a significant increase in
their total fluid intake, which peaked at 4.94 ml/day (1.5 times control levels),
compared to the control-vehicle group starting from the second week (PW2 =
0.005, PW3 = 0.006) during acquisition, and it went up to 8.86 ml/day (~3 times
control levels) during relapse (PD50 = 0.003, PD51 <0.001) and switching (PD53,
PD54, PD55 and PD57 <0.001, PD56 = 0.003) compared to the control-vehicle
group, Fig. 2.2C.
Group D in which mices choice was IMP versus unflavoured corticosterone
showed a significant rise in the total fluid intake from the first week and peaked
at 7.55 ml/day (~2.5 times control levels) during acquisition (compared to the
control-flavour group: PW1 = 0.059, PW2 and PW3 <0.001; the control-vehicle
group: PW1 = 0.048, PW2 and PW3 <0.001) and 6.53 ml/day (~2 times control
levels) during relapse (PD50 and PD51 < 0.001) compared to the two control
groups. After switching, mices total fluid intake remained high and peaked at
7.23 ml/day (~2.5 times control levels) compared to both control groups (the
control-flavour group: PD53 = 0.006, PD54 = 0.008, PD55 = 0.002, PD56 = 0.061,
PD57 = 0.008; the control-vehicle group: PD53 = 0.007, PD54 = 0.007, PD55 =
0.002, PD56 = 0.059, PD57 = 0.009), Fig. 2.2D.
On the other hand, group E in which mice had the choice between water and
flavoured corticosterone showed an increase in total fluid intake only during the
second day of relapse compared to the control-flavour (PD51 = 0.032) and the
control-vehicle (PD51 = 0.032) groups, Fig. 2.2E.
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During habituation, none of the groups, except the control-vehicle group,
showed side preference but this factor was in any case controlled for by daily
counterbalancing the position of the control and test solutions in each group.
The average total fluid intake during the habituation in all groups was between
3-4 ml per day. During the withdrawal phases, the total fluid intake of mice in
corticosterone-treated groups dropped markedly from the first day of both
withdrawal phases, compared to their fluid intake on the last day (Day 41) of
acquisition (paired sample t-tests: PgroupC = 0.01, PgroupD = 0.013, PgroupE =
0.0001) and on the last day (Day 57) of switching (paired sample t-tests: PgroupC
= 0.006, PgroupD = 0.013, PgroupE = 0.04). For withdrawal I (after acquisition), a
two-way ANOVA with repeated measures showed that there was no significant
main effect of groups on total fluid intake (F(4,36) = 1.18, P = 0.34), but there
were significant main effects of time (F(4,144) = 3.91, P = 0.005) and time X
group interaction (F(16,144) = 2.63, P = 0.001), reflecting the gradual decrease in
the total fluid intake over withdrawal days. During withdrawal II (after
switching), no significant differences in the total fluid intake were found
between all groups (F(4,36) = 0.63 , P = 0.65), but significant main effects of
time (F(2,72) = 20.93, P <0.001) and time X group interaction (F(8,72) = 2.99, P =
0.006) were found, and this indicated a gradual decline of the total fluid intake
of corticosterone-treated groups.
Chapter 2(i): Oral corticosterone self-administration in male C57BL/6J mice
66
The two bottle choice test
A
B
C
D
E
Acquisition Relapse Switching
Figure 2.2 The two-bottle
choice test. Fluid intake (ml)
from the two bottles in the 5
groups (A, B, C, D and E) of
male C57BL/6J mice (n = 7-
9) during the three phases of
the choice test. Data are
expressed as mean ± SEM.
*P<0.05, **P<0.01 and
***P<0.001 compared to the
control solution, the bar on the
left. After acquisition, mice
underwent one week
withdrawal which involved
access to one bottle of water.
On Day 52, mice had access
to one bottle of the new test
solution according to the
switching phase, see table 2.1.
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2.5.2 Dose of corticosterone ingested (mg/kg)
During acquisition, the two way ANOVA with repeated measures showed a
significant main group effect for corticosterone intake (F(2, 22) = 16.14, P
<0.001) but no significant effects of time (F(2,44) = 2.09, P = 0.14) or time X
group interaction (F(4,44) = 0.39, P = 0.82). Post-hoc planned comparisons
showed that mice whose choice was IMP versus unflavoured corticosterone
(PW1 and PW2 <0.001, PW3 = 0.003) or water versus unflavoured corticosterone
(only during the second week, PW2 = 0.041) ingested higher doses of
corticosterone than mice which had a choice between water and flavoured
corticosterone, Fig. 2.3. Also, mice whose unflavoured corticosterone was
offered versus IMP ingested more corticosterone than mice which had the
choice between water and unflavoured corticosterone (PW1 = 0.016, PW2 =
0.028, PW3 = 0.022). During relapse, the intake of corticosterone differed
significantly between groups (F(2,,22) = 5.42, P = 0.012) and, overall, increased
over the 2 days (F(1,22) = 5.87, P = 0.02), but there was no significant time X
group interaction effect (F(2,22) = 2.79, P = 0.083). Similarly, mice which had a
choice between water and flavoured corticosterone consumed lower doses of
corticosterone than mice which had unflavoured corticosterone solution paired
with water (PD50 = 0.052, PD51 = 0.004) or with IMP (PD50 = 0.009, PD51 =
0.050), Fig. 2.3. Lastly, there were no significant differences in corticosterone
intake between groups after switching (F(2,,22) = 0.79, P = 0.46) and no time X
group interaction effect (F(8,88) = 0.71, P = 0.68), but there was a significant time
effect (F(4,88) = 4.44, P = 0.003), Fig. 2.3. Planned comparisons showed that
mice whose choice was water versus unflavoured corticosterone significantly
ingested more corticosterone only on Day 53 (P = 0.023) than mice which had
IMP versus unflavoured corticosterone after switching, group E.
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Dose of corticosterone ingested
Figure 2.3 Mean corticosterone doses (mg/kg) orally self-administered over
the three phases of the two-bottle choice test: acquisition (3 weeks), relapse (2
days) and switching (5 days). Three groups of male C57BL/6J mice (n = 7-9)
had access to the corticosterone solution which was flavoured or not with IMP
and paired with water and IMP, respectively. Data are expressed as means ±
SEM. Significant differences between groups were determined by post-hoc
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(water versus flavoured corticosterone), aP <0.05 compared to (IMP versus
unflavoured corticosterone). # is for groups whose flavoured and unflavoured
solutions were exchanged during the switching phase.
RelapseAcquisition Switching
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2.5.3 Ethanol consumption (g/kg) during the two-bottle choice test
During acquisition, the two way ANOVA with repeated measures showed
significant main effects of groups (F(3, 29) = 17.70, P <0.001) and time (F(2,58) =
5.11, P = 0.009), but no significant time X group interaction effect (F(6,58) =
1.44, P = 0.22) was found. Post-hoc planned comparisons indicated that mice
which had a choice between IMP and unflavoured corticosterone ingested
significantly higher doses of ethanol, reaching ~ 2 g/kg during the third week of
acquisition compared to the control-vehicle group (PW1 = 0.006, PW2 <0.001,
PW3 <0.001), Fig. 2.4. In contrast, the other two corticosterone-treated groups
did not exhibit significant ethanol intake during the acquisition phases,
compared to the control-vehicle group (P >0.05, in all case). Significant main
effects of group (F(3, 29) = 8.13, P <0.001), time (F(1,29) = 6.39, P = 0.017) and
time X group interaction (F(3,29) = 3.04, P = 0.045) were detected during relapse.
Planned comparisons showed that mice which had a choice between water and
unflavoured corticosterone (PD50 = 0.019, PD51 <0.001) or IMP and unflavoured
corticosterone (PD50 = 0.003, PD51 = 0.003) ingested significantly higher doses
of ethanol during relapse than the control-vehicle group, Fig. 2.4. During
switching, ethanol intake differed significantly between groups (F(3,29) = 3.36, P
= 0.032) and with time (F(4,116) = 4.93, P = 0.001), but the time X group
interaction effect was not significant (F(12,116) = 0.93, P = 0.52). Mice whose
unflavoured corticosterone solution was paired with water ingested higher
ethanol doses, which peaked at 2.28 g/kg, than the control-vehicle group (PD53 <
0.001, PD54 = 0.006, PD55 = 0.004, PD56 = 0.101, PD57 = 0.061), Fig. 2.4. Also,
mice which had a choice between water and flavoured corticosterone after
switching ingested more ethanol than the control-vehicle group on Day 55 (P =
0.034).
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Ethanol intake during the two-bottle choice test
Figure 2.4 Average ethanol intake (g/kg) in male C57BL/6J mice (n = 7-
9/group) during the acquisition (3 weeks), relapse (2 days) and switching
(5 days) phases of the two-bottle choice test. Data are expressed as means
± SEM. Two-way ANOVAs with repeated measures followed by post-hoc
planned comparisons indicated these significant effects: *P <0.05, **P
<0.01 and *** P <0.001 compared to the control-vehicle (water versus
ethanol 1%). # is for groups whose solutions were exchanged during the
switching.
Acquisition Relapse Switching
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2.5.4 Body weight (BW)
Animal body weight (grams) was recorded weekly throughout the experiment.
Weight gain or loss was calculated as the difference in BW at the following
time points: before habituation and after 3 days of induction of acquisition
(Day7 to Day21), after acquisition (Day 21 to Day 42), after withdrawal I (Day
42 to Day 49), after relapse and switching (Day 49 to Day 56), after withdrawal
II (Day 56 to Day 63). The two way ANOVA with repeated measures showed
no overall significant main effects of groups (F(4,36) = 1.12, P = 0.36), but there
were significant time (F(4,144) = 130.93, P <0.001) and time X group interaction
(F(16,144) = 14.44, P <0.001) effects. After habituation to the two-bottle choice
test, post-hoc planned comparisons revealed no difference in BW between
groups (P >0.05, in all case). In contrast, 3 weeks of acquisition of
corticosterone self-administration resulted in a significant increase in BW of
mice compared to the control-flavour (group D and E, P <0.001) and the
control-vehicle (P <0.001, in all case) groups, Fig 2.5. At the end of withdrawal
I and just before testing relapse of corticosterone self-administration, significant
weight loss was observed in all groups treated with corticosterone compared to
the corresponding control groups (P <0.001, in all case), Fig 2.5. The three
corticosterone-treated groups regained weight after relapse and switching
(PgroupC = 0.006 compared to the control-vehicle group, PgroupD and PgroupE
<0.001 compared to both control groups), Fig 2.5. Similar to withdrawal I, the
body weight of corticosterone-treated mice dropped after withdrawal II
compared to the control groups (P <0.001, in all case), Fig. 2.5.
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Changes in body weight (BW)
Figure 2.5 Differences in BW (g) as a result of oral corticosterone self-
administration. Differences in BW (g) of mice (n = 7-9/group) at the
following time points: before acquisition, after acquisition, after
withdrawal I, after relapse and switching and after withdrawal II. Data are
expressed as mean ± SEM. Post-hoc planned comparisons showed these
significant effects: aP <0.001 compared to the control-flavour group (water
versus IMP), bP <0.01 and cP <0.001 compared to the control-vehicle
group (water versus ethanol 1%). # indicates the groups whose solutions
were exchanged during the switching phase.
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2.5.5 Plasma corticosterone levels (ng/ml)
Trunk blood was collected 10 days after the cessation of the two-bottle choice
test for the measurement of plasma corticosterone levels. There were no
differences in circulating levels of corticosterone between corticosterone self-
administered groups and their respective controls (F(4,35) = 0.49, P = 0.74), Fig.
2.6.
Figure 2.6 Mean plasma corticosterone levels (ng/ml) in the 5 groups of male
C57BL/6J mice (n = 7-9) measured 10 days following the cessation of the two-
bottle choice test. Data are expressed as means ± SEM. # indicates groups
whose two solutions of choice were exchanged during the switching.
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2.6 Discussion
The purpose of this phase of the experiment was to test the hypothesis that mice
orally self-administer corticosterone. We found that mice acquired oral
corticosterone self-administration and extinguished mice reinstated oral
corticosterone self-administration. Throughout the two-bottle choice test, mice
consumed different doses of corticosterone according to the two choices offered
and consequently their ethanol (the vehicle) intake was also different.
Nevertheless, plasma corticosterone levels were not significantly different
between corticosterone naïve and treated groups after a 10 day corticosterone-
free period. Interestingly, all corticosterone-treated groups showed weight gain
during corticosterone treatment and weight loss during withdrawals.
Side preference was investigated during habituation and controlled daily by
counterbalancing and exchanging the location of the two bottles for each
mouse. This was important to ensure the validity of the method (Bachmanov et
al., 2002; Tordoff and Bachmanov, 2002), and that the difference in the fluid
intake between the two bottles was independent of the bottle location. Also, the
mices total fluid intake was between 3 to 4 ml/day on most days in all groups
before acquisition. Since corticosterone is tasteless, IMP was used to flavour the
test or the control solutions during the two-bottle choice test, in order to enable
mice to distinguish between the two solutions and to facilitate corticosterone
self-administration. IMP was used at a concentration of 2 mM for which C57
mice demonstrated 60 % preference over water in the two-bottle choice test
(Tordoff, 2007). In contrast, our results showed that there was an initial mild
avoidance to IMP. The reason for this is unclear, since we used the same mouse
strain as previously reported to have no such aversion (Tordoff, 2007). Given
the initial avoidance to IMP, which may facilitate or prevent corticosterone self-
administration, it was necessary to extend the two-bottle choice test for 5 days
(switching) after the 2-day relapse testing phase to verify that the preference or
aversion to corticosterone was flavour-independent.
The results of the study suggest that corticosterone is rewarding as it was self-
administered by all corticosterone-treated groups during some or all
Chapter 2(i): Oral corticosterone self-administration in male C57BL/6J mice
75
experimental phases. In the absence of IMP, mice showed, overall, a small but
significant preference for unflavoured corticosterone solution during
acquisition, but post-hoc paired sample t-tests failed to show a significant
preference for unflavoured corticosterone versus water over the 3 weeks.
Obviously, this suggests that mice had difficulty in acquiring corticosterone
self-administration when the two solutions were provided without an IMP cue.
The use of IMP, which has an umami taste (Rong et al., 2005), as a control
solution facilitated the acquisition of unflavoured corticosterone self-
administration due to the initial aversion to the flavour, but switching data
showed that corticosterone-dependent mice still self-administered
corticosterone when it was flavoured with IMP, reinforcing the hypothesis that
self-administration is driven by rewarding properties of the hormone. In
addition, mice which did not initially self-administer corticosterone when
flavoured with IMP developed a preference for the unflavoured hormone
solution when it was paired with IMP during the switching phase, and this was
in accordance with the disappearance of the avoidance to IMP in the control-
flavour group. Also, it is important to emphasize that the total fluid intake of
corticosterone-treated mice did not differ from control-vehicle or control-
flavour groups during withdrawals and extinguished mice, which previously
showed a significant preference for unflavoured corticosterone over IMP or
water, markedly relapsed to self-administer the unflavoured corticosterone
solution after withdrawal I.
Thus, these results are consistent with previous work showing that rats self-
administered corticosterone using an operant intravenous self-administration
protocol and the two-bottle choice test (Deroche et al., 1993; Piazza et al.,
1993) and that extinguished rats reinstated oral corticosterone self-
administration (Deroche et al., 1993). Similarly, mice reinstated corticosterone
self-administration during relapse, as they showed a marked preference for the
corticosterone solution over the other choice (water or IMP), and their total
fluid intake increased significantly compared to the control groups. It is
believed that relapse is a valid marker of addiction (Stewart, 2000). Moreover,
food-restricted rats drank more from the corticosterone solution than other rats
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which had access to water only (Deroche et al., 1993), since rats naturally drink
only a small amount of water when food is not available; this means that
corticosterone enhanced drinking behaviour independent of food, and this
suggests that corticosterone is rewarding. Importantly, results revealed that mice
exhibited a significant preference for the corticosterone solution when their
daily intake of the stress hormone was above 30 mg/kg, suggesting that GR
activation is crucial for corticosterone self-administration. In agreement with
that, Sprague-Dawley rats self-administered corticosterone at doses which
produced high plasma corticosterone levels comparable to those induced by
stress (Piazza et al., 1993). In the present study, when unflavoured
corticosterone was paired with IMP during acquisition, mice showed marked
oral corticosterone self-administration and ingested doses of corticosterone over
40 mg/kg on average, peaking at ~ 50 mg/kg. Results clearly indicated that
when daily corticosterone intake was as high as 40 mg/kg, corticosterone self-
administration became more evident, suggesting that it is dose-dependent. In the
current study, the selected concentration of corticosterone (250 µg/ml) solution
was thought to be ideal to rapidly elevate plasma corticosterone levels
depending on the dose consumed in the two-bottle choice test. For instance,
C57BL/6 mice which had access to corticosterone (100 µg/ml) in drinking
water demonstrated an increase of corticosterone levels after 4 weeks of
treatment (Karatsoreos et al., 2010; Lee et al., 2010). Also, corticosterone-
treated mice showed thymus and adrenal atrophy (Karatsoreos et al., 2010).
Despite high corticosterone intake, our results showed no statistical alterations
in plasma corticosterone levels of corticosterone naïve and treated groups. The
lack of difference in corticosterone levels could be attributed to the relatively
long withdrawal II (10 days) interval between stopping of the two-bottle choice
test and blood collection. For example, rats which were injected with
corticosterone (40 mg/kg/day, s.c., for 21 days) showed high plasma levels of
corticosterone similar to those induced by immobilization stress, but elevated
corticosterone levels returned to control levels within 48 hours (Sapolsky et al.,
1985; Pavlides et al., 1993). Also, rats which were subjected to restraint stress
showed high corticosterone levels which decreased to the control values within
4 hours (Sapolsky et al., 1984). Similarly, rats implanted with corticosterone
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pellets for 1 week had high corticosterone levels compared to the controls, but
the elevated corticosterone levels returned to the control level 1 week after
removing the pellets (Fernandes et al., 1997). Altogether, our results are
consistent with previous work, and this suggests that consuming high doses of
corticosterone chronically, as in the present study, is not associated with long-
lasting dysregulation of the HPA axis. Indeed, the purpose of measuring plasma
corticosterone levels was to verify whether HPA axis function was disrupted, as
chronic exposure to high levels of corticosterone has been found to impair the
negative feedback regulation of the HPA axis activity, resulting in high basal
levels of the hormone (Makino et al., 2002). Rats chronically exposed to
stressors including immobilization exhibited high plasma corticosterone levels
and GR downregulation in the hippocampus but reduced GR levels were
restored after a week of recovery, and this was accompanied by normalisation
of corticosterone levels (Sapolsky et al., 1984). Taken together, corticosterone
self-administration and relapse were only observed for high doses of
corticosterone, suggesting the proposal that rewarding properties of
corticosterone are mediated by low affinity GRs which are mainly activated by
high plasma levels of corticosterone (Reul and de Kloet, 1985) produced by
stress or circadian peaks (Selye, 1950).
An important observation is that corticosterone intake was accompanied by an
increase in mices BW, but mice lost weight during the withdrawal phases when
they no longer had access to corticosterone. The change in animal BW which
accompanies corticosterone treatment has been used as a marker for effective
oral corticosterone administration. Previous research, albeit on birds, indicated
that oral corticosterone treatment (20 mg/l in the drinking water) decreased
chickens BW after 1 week (Shini et al., 2009), but treatment with chronic
ACTH increased corticosterone levels and BW of laying hens (Mumma et al.,
2006). It was suggested that ACTH increased BW of laying hens through
increasing water content of muscle through some unknown mechanisms
(Mumma et al., 2006). On the other hand, C57BL/6J mice showed no
significant change in their BW after 4 weeks of corticosterone availability in
drinking water (100 Pg/ml) which doubled their plasma corticosterone levels
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compared to the control group (Lee et al., 2010). In contrast, C57BL/6 mice
showed weight gain and increased food consumption after chronic
corticosterone ingestion offered in drinking water (100 µg/ml) in 1% ethanol
(Karatsoreos et al., 2010). The effects on BW could be attributed to
corticosterone altering electrolyte balance. It was found that dexamethasone (a
GR agonist) plus deoxycorticosterone (a MR agonist) increased urine excretion
and intake of water and sodium from saline solution but decreased BW of rats
(Thunhorst et al., 2007). In the present study, corticosterone-treated mice had
no access to saline but their food was a source of sodium. This suggests that
mice consumed more food to increase their sodium intake and consequently
BW increased. The inconsistencies between our results and those previously
reported need further investigation as the amount of food pellets consumed by
mice was not weighed. The increased total fluid intake which was seen in two
corticosterone-treated groups was very unlikely to have resulted in the observed
weight gain after acquisition or switching, as one of groups (water versus
flavoured corticosterone) showed a similar increase in BW to the other
corticosterone-treated groups but no rise in total fluid intake compared to the
control groups even after switching when mice in this group significantly self-
administered the unflavoured corticosterone solution.
In conclusion, these findings emphasize that corticosterone does not only
facilitate the rewarding effects of natural rewards and drugs of abuse, but also
per se it has reinforcing and rewarding properties.
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Chapter 2 - Part 2
How does corticosterone affect cognition when it is
rewarding?
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2.7 Aims
A main aim of this experiment was to investigate how corticosterone self-
administration could affect 2 cognitive processes: spatial and recognition
memory. Spatial memory was evaluated using the spontaneous alternation and
novel object location tests, while the novel object recognition test was used to
evaluate recognition memory.
2.8 Materials and methods
2.8.1 The spontaneous alternation test (SAT) in a T- maze
The T-maze test uses the strong tendency of rodents to explore a new arm of a
maze after the other arm has been visited shortly beforehand (Montgomery,
1952). The apparatus is composed of three main parts; the starting box (6 cm X
7.5 cm), stem and two identical arms (41.6 cm long), which are closed by
vertical sliding doors. The walls of the T-maze are made of transparent Perspex
which allowed an animal to use different cues present in the room such as a lab
Figure 2.7 Diagrammatic representation of the T-maze apparatus
Stem
Two T-maze
arms
Sliding doors
Starting box
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book, a clock, etcto choose to enter the arm unexplored during the previous
trial. The test was carried out in a sound attenuated room illuminated with
fluorescent lighting. The test was undertaken during the light phase and groups
were counterbalanced throughout the test day. In brief, an animal was placed in
the starting box for 5 sec, and then the door to the stem was opened allowing the
animal to move freely through the stem and the two arms for about 1-minute
habituation. Then, the animal was returned back to the starting box and was
subjected to a series of 9 consecutive trials. In each trial, the door to the stem
was opened after 5 sec, and the animal entered one of the two arms (free
choice). Once the animal entered one arm, the door to that arm was closed for
15 sec as well as the door to the other arm. Then, the animal was returned back
to the starting box by gently pushing its back for the following trial. The
equipment was cleaned with 20 % ethanol between animals to remove olfactory
cues. Mice were tested in the T-maze paradigm before acquisition and during
the two withdrawal phases.
The percentage of correct alternation for each mouse was calculated according
to this equation:
Number of alternations
Maximum alternation (8)
Memory unimpaired rodents significantly alternate between the two arms above
50 % (Montgomery, 1952; Dember and Fowler, 1958).
2.8.2 Novel object recognition and location tests
2.8.2.1 Habituation
Before performing the memory test, habituation is required to make mice
familiar with empty open-field arenas in order to direct their exploratory
behaviour mainly toward the test objects during the memory tests. It has been
reported that mice have to be habituated to the open field arena to learn about
the objects during the acquisition trial (Stefanko et al., 2009). Also, the open
The percentage of correct alternations = X 100
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field has been used to assess motor activity and anxiety-like behaviour (Choleris
et al., 2001), as these factors could interfere with memory performance. Mice
were individually habituated to the test arenas 24 hours before the novel object
recognition test. In accordance with Howlett et al. (2004), mice individually
underwent a 30-minute habituation session during the light phase using open
field Perspex arenas (30 x 35 x 25 cm) with transparent sides and grey bottom.
Sessions were tracked using a camcorder attached to the ceiling of the testing
room which was illuminated by fluorescent lights. The number of defecations
was counted for each mouse, and arenas were cleaned using 20 % ethanol
between mice to remove any olfactory cues. The total distance travelled, the
distance travelled in the centre or the time spent in the centre was automatically
tracked using the Ethovision software (Noldus, Netherlands). The percentage of
distance travelled and time spent in the centre was calculated relative to the total
distance travelled and the total time spent in the arena, respectively. The total
distance travelled, percent distance travelled and percent time spent in the
centre were used to investigate the group differences in locomotion and anxiety-
like behaviour, respectively, prior to the memory tests as these processes may
interfere with object exploration.
2.8.2.2 The novel object recognition test (NORT)
This task depends on the high tendency of mice to explore a novel object for a
longer time than a familiar one (Ennaceur and Delacour, 1988). The test was
carried out one week after the end of corticosterone treatment to evaluate the
effects of chronic corticosterone self-administration on recognition memory.
Twenty four hours after the habituation session, mice were subjected to two
trials, 10 minutes each, separated by a four-hour inter-trial interval (Howlett et
al., 2004), Fig 2.8. In the first trial (acquisition), each mouse was left to explore
one object (a varnished wooden triangular or spherical block); to help mice use
the spatial strategy as well as familiarity to recognise the novel object. During
the second trial (retention), the mouse explored two objects, the same object
explored during the first trial (familiar object) and another object of a different
shape (novel object). Sessions were recorded using a camcorder attached to the
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ceiling of the testing room which was illuminated by fluorescent lights. The
mouse movement in the arena was tracked using the Ethovision software
(Noldus, Netherlands). The arenas and objects were cleaned with 20 % ethanol
between sessions to remove any olfactory cues. The exploration times for the
familiar and novel objects were manually and blindly scored twice for each
mouse, and if the second score of a given mouse differed by 10% from the first
score, a third scoring was done for this mouse and the 2 closest values were
averaged for statistical analysis. The mouse was considered as exploring an
object when it approached and directed its nose toward the object within a
distance of 1 cm. The time spent touching or sitting on an object while the
mouses nose was not directed toward it was not included in the exploration
time. The position of objects in the arenas was counterbalanced to control for
location preferences. Recognition index (RI) was calculated according to the
following equation:
Novel object exploration time + Familiar object exploration time
Novel object exploration time X 100
RI =
Figure 2.8 The novel object
recognition test. In the
acquisition trial (A), a mouse
explored only one triangular
or spherical object for 10
minutes. Four hours later, the
retention trial (B) was
undertaken for the same
duration in which the mouse
explored the same familiar
object and the novel object,
red colour.
B
4 hours
A
Familiar
object Novel
object
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2.8.2.3 The novel object location test (OLT)
This task aims to test spatial memory (Ennaceur et al., 1997; Dix and Aggleton,
1999) through using the high tendency of rodents to explore a familiar object in
the second trial for a longer time when its location has been changed rather than
at a fixed location. This test was undertaken 24 hours after the novel object
recognition test. Mice underwent two 10-minute trials, separated by four hours
or 1 hour (for the other experiments described in Chapters 3 and 4), Fig 2.9.
During the two trials, each mouse was left to explore two identical objects
(hexagonal or square varnished wooden blocks), provided that one of the two
objects was displaced to a different location in the arena for the second trial.
Sessions were recorded by a camcorder attached to the ceiling of the testing
A
1 or 4
hours
B
Non-displaced
objects
Displaced objects
Figure 2.9 The object location
test was undertaken using the
open field arena in which a
mouse was left to explore two
identical objects for 10 minutes
for the acquisition trial (A). In
the retention trial (10 minutes),
the mouse explored the same
two objects after one of them
had been displaced (blue
colour) to a novel location in
the arena (B)
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room which was illuminated by fluorescent lights. The mices movement in the
arena was tracked using the Ethovision software (Noldus, Netherlands). The
arenas and objects were cleaned using 20 % ethanol between sessions to remove
any olfactory cues. The criteria of scoring the object exploration time of each
mouse was as described in the novel object recognition test. A location index
(LI) was calculated using this equation:
2.8.3 Statistical analysis
Variables evaluated during the habituation session; including the total distance
travelled, percent distance and percent time spent in the centre relative to total
and number of defecations, were analysed using one way ANOVAs with groups
as the between subject factor. Two-way ANOVAs with repeated measures were
used to analyze the percentage of correct alternation and total exploration times
in the novel object recognition and location tests. The between subject factor
was group and repeated measures were the within subject factors: time of the
alternation test (three levels) or trials (two levels). Post-hoc planned
comparisons were used when appropriate. Paired sample t-tests were used to
compare the exploration times between the familiar and novel objects and
between the non-displaced and displaced objects in each group. One sample t-
tests were used to compare the percentage of correct alternation, LI and RI to 50
% (lack of discrimination). Data are expressed as mean ± SEM. An effect was
FRQVLGHUHGVLJQLILFDQWZKHQ3
(Non-displaced object exploration time + displaced object
exploration time)
Displaced object exploration time X 100
LI =
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2.9 Results
2.9.1 The spontaneous alternation test
The two-way ANOVA with repeated measures showed no significant main
effects of groups (F(4, 36) = 0.55, P = 0.70) and time (F(2,72) = 1.31, P = 0.28) in
the spontaneous alternation performance, but a significant time X group
interaction effect (F(8,72) = 2.58, p = 0.016) was detected. Post-hoc planned
comparisons revealed a significant decrease in the alternation rate (P = 0.02) of
mice which had a choice between water and flavoured corticosterone during
withdrawal I, compared to the control-flavour group (water versus IMP). Also,
planned comparisons showed a significant increase in the spontaneous
alternation performance in all corticosterone self-administered groups during
withdrawal II, compared to the control-vehicle group (water versus ethanol 1%,
P <0.05, in all case). The percentage of correct alternations was also compared
to 50% (chance alternation) using a one sample t-test for each group at each
time point to test whether mice used a spatial memory strategy. All groups
significantly alternated above the chance level before acquisition (baseline) and
during the first withdrawal period, but mice treated with the ethanol vehicle did
not significantly discriminate between the 2 arms during withdrawal II, Fig.
2.10.
2.9.2 Novel object recognition and location tests
2.9.2.1 Habituation
The one way ANOVA revealed a significant difference between groups in the
total distance travelled (F(4,36) = 5.74, P = 0.001), with all corticosterone-treated
groups being less active than the control-vehicle (P = 0.001, in all case) and the
control-flavour (P <0.05, in all case) groups throughout the 30-minute session,
Fig. 2.11A. Also, there was a significant group effect in the distance moved in
the central sector relative to total (F(4, 36) = 6.05, P = 0.001). Planned
comparisons revealed that mice which had had the choice between IMP and
unflavoured corticosterone exhibited a significantly lower distance moved in the
centre than all groups (P <0.01, in all case), Fig. 2.11B. There were, however,
no significant group differences for the time which mice spent in the centre
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relative to total (F(4, 36) = 0.72, P = 0.59, Fig. 2.11B) and for the number of
defecations (F(4, 36) = 0.38, P = 0.82, Fig. 2.11C).
2.9.2.2 The novel object recognition test
The two-way ANOVA with repeated measures showed no significant main
effects of groups (F(4,36) = 1.76, P = 0.16), trials (F(1,36) = 0.95, P = 0.34) or trial
X group interaction (F(4,36) = 2.45, P = 0.064) for the total object exploration
time, Fig. 2.12A. In the retention trial, the time spent exploring the familiar and
novel objects differed significantly (F(1,36) = 39.47, P = 0.0000003), but there
was no object X group interaction effect (F(4,36) = 2.07, P = 0.11). Post-hoc
paired sample t-tests revealed that mice in the control-vehicle group and the
group in which mice had a choice between IMP and unflavoured corticosterone
had recognition memory deficits, as they did not spend more time exploring the
novel object (t = 1.99, P = 0.09, t = 0.9, P = 0.40, respectively) than the familiar
object, Fig. 2.12B. This was confirmed by one sample t-tests comparing RI of
each group to 50%, although there was no significant group effect for RI (F(4, 36)
= 1.85, P = 0.14), Fig. 2.12C.
2.9.2.3 The object location test
There were no significant main effects of groups (F(4,36) = 0.34, P = 0.85), trials
(F(1,36) = 0.63, P = 0.43) and trial X group interaction (F(4,36) = 0.90, P = 0.48)
for the total exploration times, but significant main effects of object
displacement (F(1,36) = 13.79, P = 0.001) and trial X object interaction (F(1,36) =
4.60, P = 0.039) were revealed. Paired sample t-tests showed no difference in
the time spent exploring the two identical objects in each group during the
acquisition trial, Fig. 2.13A. In the retention trial, mice which had had a choice
between water and flavoured corticosterone spent a longer time exploring the
displaced object than the non-displaced object (t = 2.53, P = 0.035), Fig. 2.13B.
One sample t-tests revealed that the groups in which mice had a choice between
water and unflavoured corticosterone or water and flavoured corticosterone
during the two-bottle choice test significantly discriminated the novel location (t
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= 2.53, P = 0.035 and t = 2.54, P = 0.035, respectively compared to chance), but
the other groups did not, Fig. 2.13C. However, a one way ANOVA showed no
differences in LI between groups (F(4, 36) = 0.56, P = 0.70), Fig. 2.13C.
Chapter 2(ii): Cognitive effects of corticosterone-related reward
89
Spontaneous alternation performance
Figure 2.10 Spontaneous alternations in the T-maze. The percentage of correct
alternations (percent correct) of the control and corticosterone-treated groups (n
= 7-9 mice) before acquisition (baseline) and during the two withdrawal phases.
Data are expressed as means ± SEM. One sample tWHVWV33
and ***P <0.001 significantly different from 50% (alternation by chance).
Planned comparisons:
a
P <0.05 significantly different from the control-flavour
group (water versus IMP),
b
P <0.05 and
c
P <0.01 significantly different from the
control-vehicle group (water versus ethanol 1%), # indicates groups whose
solutions were exchanged during the switching phase.
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Locomotion and anxiety-related behaviour in the open field
A
*** $
B
¥
^ ^
C
Figure 2.11 Locomotion and anxiety-like behaviour during the habituation session.
(A) Total distance travelled. (B) Percent time and distance in the centre relative to
total. (C) Defecation number. One week after the cessation of the two-bottle choice
test, mice (n = 7-9/group) were habituated to the object test arena for 30 minutes, 24
hours before the novel object recognition test. Data are expressed as means ± SEM.
Planned comparisons: ***P = 0.001 compared to the control-vehicle (water versus
ethanol 1%) group, $P <0.05 compared to the control-flavour (water versus IMP)
group, ^^P <0.01 and ¥P <0.001 compared to (IMP versus unflavoured
corticosterone). # is for groups whose solutions were exchanged during the
switching phase.
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Novel object recognition performance
A
B
C
Figure 2.12 The novel object recognition test. (A) Total exploration times for each
group (n = 7-9 mice) during the 10-minute acquisition and retention trials. (B)
Time spent exploring the familiar and novel objects during the retention trial. (C)
Recognition index (RI) was calculated as % (novel object exploration time / total
exploration time). Data are expressed as means ± SEM. Paired sample t-tests: **P
<0.01 and ***P = 0.001 compared to time spent exploring the familiar object. One
sample t-tests: $$P <0.01 and $$$P <0.001 compared to 50% (no discrimination). #
indicates groups whose solutions were exchanged during the switching phase.
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Object location memory
A
B
Figure 2.13 The object location test. (A) Exploration times for the two identical
objects in each group (n = 7-9 mice) of corticosterone naïve and treated mice
during the acquisition trial. (B) Mices exploration times of the non-displaced
and displaced objects during the retention trial. (C) Location index (LI) was
calculated as % (displaced object exploration time / total exploration time). Data
are expressed as means ± SEM. Paired sample t-tests: *P <0.05 compared to the
non-displaced object. One sample t-tests: $P <0.05 compared to 50% (chance). #
indicates groups whose solutions were exchanged during the switching phase.
C
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2.10 Discussion
The second objective of this experiment was to test the impact of corticosterone
self-administration and reinstatement on spatial and recognition memory.
Chronic corticosterone self-administration did not impair spontaneous
alternation performance and only a group of corticosterone-treated mice
exhibited recognition memory deficits. Also, the control-vehicle group
exhibited both recognition and spatial memory deterioration by the end of the
experiment. It is important to emphasize that, although all corticosterone-treated
mice self-administered the hormone, there were differences in the onset and
magnitude of corticosterone self-administration in each group. Mice whose
corticosterone solution was paired with IMP self-administered corticosterone
rapidly and markedly from the first week of acquisition and the ingested doses
remained at high levels during relapse and switching phases. On the other hand,
when the unflavoured corticosterone solution was paired with water, mice
developed corticosterone self-administration more slowly and their
corticosterone doses were lower than mice which had unflavoured
corticosterone versus IMP during acquisition. By contrast, mice whose
corticosterone solution was flavoured with IMP during acquisition and relapse
started to self-administer corticosterone significantly during the switching
phase. Thus, the three groups chronically received different corticosterone
doses, and this was accompanied with distinct effects on memory. Secondly,
ethanol 1% (vehicle) possibly contributed to the effects of corticosterone on
cognitive performance, since ethanol intake was dependent on the amount of
corticosterone consumed in each group.
Because motor activity and anxiety-related behaviour can confound mices
performance in cognitive tasks, mice were first habituated to the open field to
investigate these measures. All corticosterone-treated groups were less active in
the open field arena than the control groups. Likewise, rats which were
implanted with corticosterone pellets for a week exhibited a reduced motor
activity but this disappeared a week after the removal of corticosterone pellets
(Fernandes et al., 1997). Moreover, 3 weeks of corticosterone (100 µg/ml)
treatment in drinking water reduced locomotor activity of C57BL/6 mice
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(Karatsoreos et al., 2010). Also, corticosterone-treated groups showed no
significant difference in BW during the withdrawal phases, and this excludes
weight gain observed during corticosterone treatment as a reason for reduced
activity. However, the decrease in motor activity could be a withdrawal
symptom of the rewarding hormone, and this point needs further investigation.
Anxiety-related behaviour was generally unaltered by corticosterone except for
mice which had a choice between IMP and unflavoured corticosterone, as they
showed reduced activity in the central sector of the open field relative to total,
compared to the other groups. However, there were no group differences for the
percentage of time which mice spent in the centre and for the number of
defecations, which has been used as a measure of emotionality (Candland et al.,
1967). A recent study showed that C57 mice exhibited enhancement of anxiety-
like behaviour in the elevated plus maze test after 4 weeks of unlimited access
to corticosterone at 100 µg/ml concentration in 1% ethanol, but these symptoms
disappeared 4 weeks after the cessation of corticosterone treatment (Lee et al.,
2010). The discrepancies between all anxiety-related measures in one of the
corticosterone-treated groups (IMP versus unflavoured corticosterone) provided
insufficient evidence for changes in anxiety-like behaviour.
Spatial memory of mice was evaluated in the spontaneous alternation test at 3
time points: before acquisition and during the two withdrawal phases. The
spontaneous alternation performance was preserved in all corticosterone-treated
groups which alternated above the chance level at all time points, although
overall performance of all three corticosterone-treated groups tended to be
inferior to the two control groups after the acquisition phase but higher than
control mice after switching. Interestingly, mice which had a choice between
water and flavoured corticosterone had lower alternation rate than the control-
flavour group after acquisition, suggesting that high corticosterone intake by the
other groups which exhibited a significant preference for the hormone during
acquisition did not, however, impair the spontaneous alternation behaviour.
These findings are in agreement with a number of published reports, although
the literature does contain contradictory findings. For instance, chronic intake of
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corticosterone (400 Pg/ml) in drinking water for 21 days did not impair spatial
recognition memory of rats in a Y-maze task (Conrad et al., 2007). Similarly,
most rats receiving corticosterone in drinking fluid (400 Pg/ml in 2 % ethanol,
~30 mg/kg) for 8 weeks showed no spatial memory impairment in the radial
arm maze (Luine et al., 1993). Under a different mode of administration, rats
receiving subcutaneous injection of corticosterone at 26.8 mg/kg for 21 days
showed no spatial memory impairment in the Y maze (Coburn-Litvak et al.,
2003). On the other hand, rats had spatial learning difficulties in the radial 8-
arm maze when implanted with corticosterone pellets for 3 months (Endo et al.,
1996). Whereas 2 months of corticosterone injections (10 mg/kg) impaired
spontaneous alternation in rats (Bardgett et al., 1994), rats treated with the same
dose were unimpaired for spatial memory in a platform-maze test (Bardgett et
al., 1996). During withdrawal II, the object location test was used to assess
spatial memory of mice (Ennaceur et al., 1997; Dix and Aggleton, 1999). Our
results showed that control mice were not able to discriminate the displaced
object to a significant degree. This is likely related to the long 4-hour delay
between the two trials. Previous work showed that mice perform optimally in
the object location test when the duration between the acquisition and retention
trials is up to 2 hours (Murai et al., 2007). The long inter-trial interval was used
in the present study to detect a possible improvement in spatial memory given
previous (unpublished) corticosterone self-administration work. This was
confirmed in the present study as 2 of 3 groups of corticosterone-treated mice
significantly discriminated the displaced object.
The novel object recognition test was used to assess non-spatial memory.
Corticosterone-treated mice were generally unimpaired in this task except for
the group which had a choice between IMP and unflavoured corticosterone.
This could be secondary to ingesting extremely high doses of corticosterone (40
mg/kg/day on average) and/or ethanol, which peaked at 2 g/kg/day, during
acquisition, since ethanol-treated control mice also showed recognition memory
deficits. Although two groups showed recognition memory impairment, RIs
were not significantly different between all groups. Previously, it was found that
plasma levels of corticosterone had an inverted U-shaped relationship with
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primed burst potentiation (PBP), a physiological model of memory (Diamond et
al., 1992). Thus, low plasma corticosterone levels positively correlated with
PBP with the maximal correlation being with moderate levels of corticosterone
(Diamond et al., 1992). Also, it was reported that enhanced performance in the
novel object recognition test had an inverted U-shaped relationship with
corticosterone levels (Okuda et al., 2004). The hippocampus is involved in the
processing of spatial and recognition memory (Clark et al., 2000; Gould et al.,
2002). However, there has been some evidence that the rhinal cortex also
contributes to a great extent to recognition memory (Mumby and Pinel, 1994;
Ennaceur et al., 1996). The hippocampus is very vulnerable to changes in
plasma corticosterone levels as GRs and MRs are highly expressed in this area
(Reul and de Kloet, 1985; Diamond et al., 1992; Pavlides et al., 1995). As
stated earlier, MRs have a 10-fold higher affinity for corticosterone than GRs
which are activated by high levels of corticosterone (Reul and de Kloet, 1985).
Rats showed memory improvement in the Morris water maze when they were
exposed to mild stress and low doses (10 mg/kg, i.p.) of corticosterone (Akirav
et al., 2004). However, relatively high corticosterone doses (26.8 mg/kg) for 8
weeks caused spatial memory impairments in rats in the Y-maze task (Coburn-
Litvak et al., 2003). In the hippocampus, MR activation improved hippocampal
LTP, while GR activation was shown to suppress it (Pavlides et al., 1995).
Furthermore, pre- and post-training intrahippocampal injection of a GR
antagonist enhanced performance of rats in the water maze (Oitzl et al., 1998),
indicating that high levels of corticosterone impaired memory performance.
Taken together, recognition and spatial memory deficits of one corticosterone
treated group (IMP versus unflavoured corticosterone) could be due to elevated
corticosterone consumption, compared to the other two corticosterone self-
administered groups during the acquisition phase of the two-bottle choice test.
To make it clear, the group whose choice was water versus flavoured
corticosterone received the lowest corticosterone dose during acquisition and
relapse (on average less than 20 mg/kg/day but 30 mg/kg during switching),
while the group offered a choice between water and unflavoured corticosterone
ingested average corticosterone doses of 26 mg/kg/day during acquisition but
45 mg/kg/day during relapse and switching. Mice in these groups showed a
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significant preference for the object displaced in the novel location. In contrast,
the corticosterone-treated group which was unable to discriminate the displaced
object received much higher corticosterone doses (40 mg/kg/day on average
during all testing phases). This suggests that short-term exposure to high
corticosterone doses may have a positive effect on spatial memory. Also,
ethanol intake is suggested to contribute to the recognition memory impairment
which was seen in one of corticosterone-treated groups. In agreement with this,
an acute dose of ethanol (1 g/kg) was found to impair rats performance in a
food-reinforced alternation T-maze paradigm (Rossetti et al., 2002). Others
found that both 0.5 g/kg and 1.5 g/kg of ethanol, i.p., impaired spatial working
memory of C57BL/6J mice in a T-maze (Melchior et al., 1993). It was also
reported that alcoholics develop memory impairment and learning difficulties
(Bowden and McCarter, 1993; Parsons and Nixon, 1993). In the present
experiment, chronic small ethanol doses (0.5 g/kg) impaired the spontaneous
alternation behaviour and recognition memory of the control-vehicle group.
However, an acute dose of ethanol (0.5 g/kg) was found to improve working
memory of mice in a delayed-alternation task (Rossetti et al., 2002).
Paradoxically, the two corticosterone-treated groups which consumed more than
2 g/kg/day of ethanol did not show this impairment. Overall, this suggests that
corticosterone self-administration might protect, to some extent, against adverse
cognitive effects of chronic alcohol intake.
It is important to point out that the corticosterone-treated group with recognition
memory deficits did not exhibit memory impairment in the spontaneous
alternation task. One possibility is that the two tests are controlled by different
processes or brain areas which are not equally impaired by corticosterone.
Another explanation is that mice had already been trained during the choice test
to choose to drink from the two bottles whose position was switched daily, and
this choice was controlled by the presence of flavour or corticosterone-seeking
behaviour. This may have provided some forms of cognitive training to mice
and might have partially contributed to keeping their spatial alternation
performance unimpaired even with consuming high doses of corticosterone.
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Indeed, cognitive training has been found to improve working memory and
cognition (Ramsey, 2008; McNab et al., 2009).
In summary, chronic oral corticosterone self-administration did not impair
spatial memory of mice even at high doses. In contrast, mices recognition
memory was impaired only when mice consumed excessive amounts of
corticosterone for a long time. This indicates that short-term exposure to high
doses of corticosterone did not impair memory, and this provides some
evidence that rewarding properties of corticosterone outweigh deteriorating
effects of excessive corticosterone exposure.
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Chapter 2 - Part 3
Effects of corticosterone self-administration on the
expression of protein markers of neuroplasticity in the
hippocampus and frontal cortex of the mouse brain
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2.11 Aim
The aim of this phase of the experiment was to investigate whether oral
corticosterone self-administration alters the expression of proteins involved in
synaptic plasticity in the hippocampus and frontal cortex of mice. Western
immunoblotting was used to measure levels of synaptophysin (SYN) and
components of the brain derived neurotrophic factor (BDNF) signalling
pathway including BDNF, its receptor tropomysin-related kinase B (TrkB) and
phosphorylated extracellular signal regulated kinase 1 and 2 (pERK1/2) which
mediates upstream BDNF/TrkB signalling.
2.12 Materials and methods
2.12.1 Tissue preparation & western immunoblotting
The hippocampus and frontal cortex were homogenised in the following lysis
buffer solution (pH 7.6): 5 mM Tris, 2 mM EGTA, 80 mM E-glycerophosphate,
1 mM sodium fluoride and protease inhibitor cocktail (Roche Diagnostics,
Germany). The protein concentration of homogenates was determined by the
Lowry assay (Lowry et al., 1951) to ensure equal loading onto gels. The protein
concentration of samples was equalised by a mixture of lysis/SDS sample buffer
to provide a final concentration of 1 µg/µl or 1 µg/5µl, depending on the
protein. Samples were heated at 95qC for 5 min, vortex-mixed and centrifuged
at 13.000 g for 1 minute or 5 minutes; to remove impurities whose bands were
found to overlap with BDNF bands. Samples were loaded at a concentration of
1 Pg for SYN (38 kDa) and 10 Pg for all other proteins: BDNF (14 kDa), Full
length TrkB (FL-TrkB, 145 kDa), truncated TrkB (t-TrkB, 95 kDa) and
phosphorylated ERK1/2 (pERK1/2, 44/42 kDa) whose levels were calculated
relative to total ERK1/2 (t-ERK1/2, 44/42 kDa). GAPDH (36 kDa) was also
determined to correct loading errors. All proteins were separated on 10 % Tris-
glycine SDS-PAGE gel except BDNF (12%). Spectra Multicolor Broad
Range Protein Ladder (Fermentas UK, Cat SM1841) or ColorBurst
Electrophoresis Marker (Sigma-Aldrich UK, Cat C1992) was used and loaded
at 2Pl. Samples were run at 200 V for 45 min for all proteins except for BDNF
for which samples were run at 150V for 37 min based on prior optimisation of
Chapter 2(iii): Neuroplasticity of corticosterone self-administration
101
the procedures. After blotting samples to a nitrocellulose membrane, a Ponceau
S solution was applied to the membranes in order to ensure successful transfer
and then removed by washing with TBST (Tris-buffered saline Tween-20; 150
mM NaCl, 50 mM Tris and 0.05 % v/v Tween-20, pH 7.4). The Snap ID protein
detection system (Millipore UK, WBAVDBASE) was used to block and
incubate the membranes with primary and secondary antibodies for all proteins
except for BDNF. Using Snap ID, membranes were blocked with 1.5% cold
water fish skin gelatine (Sigma-Aldrich UK, Cat G7041) dissolved in TBST.
Then, for 10 minutes, separate membranes were incubated with a mixture of
mouse anti-SYN (1:10.000; Millipore UK, Cat MAB5258) and rabbit anti-
GAPDH (1:1000; Sigma-Aldrich UK, Cat G9545) antibodies, or with a mixture
of mouse anti-ERK1/2 (1:500; Cat 9107) and rabbit anti-pERK1/2 (1:500; Cat
4377s) antibodies, both from Cell Signalling Technology UK, or with rabbit
anti-TrkB antibody (1:1000; Millipore UK, Cat 07-225), or with rabbit anti-
GAPDH antibody (1:10.000; Sigma-Aldrich UK, Cat G9545). Then, the
membranes were washed three times with TBST followed by a 10-minute
incubation period with a mixture of infrared absorbing goat anti-rabbit and goat
anti-mouse antibodies. Membranes were again washed three times with TBST.
For BDNF, the membranes were blocked in 3 % cold water fish skin gelatine
for 1 hour and then incubated overnight at 4qC (~18 hour) with a mixture of
mouse anti-BDNF (1:750; Sigma-Aldrich UK, Cat B5050) and rabbit anti-
GAPDH (1:15.000; Sigma-Aldrich UK, Cat G9545) antibodies. The following
day, membranes were washed with TBST three times followed by a 30-minute
incubation period with a mixture of infrared absorbing goat anti-mouse and
anti-rabbit antibodies at ~37ºC. Membranes again were washed three times with
TBST. All antibodies were dissolved in the same blocking buffer. The
Odyssey® Infrared Imaging System was used to scan all membranes and
Odyssey software was used to analyse protein bands detected on all membranes
according to the manufacturers instructions.
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2.12.2 Statistical analysis
Data were analysed by one way ANOVAs followed by post-hoc planned
comparisons when appropriate. Pearsons correlation coefficients were
calculated to estimate if the levels of the measured proteins correlate with the
average corticosterone intake or with memory performance (% of correct
alternation, RI and LI). Data are expressed as mean ± SEM. The level of all
proteins of interest was calculated as a percent of the control-flavour group
(water versus IMP) because mice in this group did not show memory
impairment, while mice in the control-vehicle group (water versus ethanol 1%)
showed spatial and recognition memory impairment at the end of the
H[SHULPHQW$QHIIHFWZDVVLJQLILFDQWLI3
2.13 Results
2.13.1 SYN
There were no differences between groups for SYN levels in either the
hippocampus (F(4, 36) = 0.34, P = 0.85), Fig. 2.14A, or the frontal cortex (F(4,36) =
2.27, P = 0.08), Fig. 2.14B.
2.13.2 BDNF
There was a significant group difference in hippocampal BDNF levels (F(4,36) =
4.88, P = 0.003). Post-hoc planned comparisons indicated a significant decrease
in BDNF levels in the control-vehicle group (P = 0.011) compared to the
control-flavour group, Fig. 2.15A. Also mice which had a choice between IMP
and unflavoured corticosterone or water and flavoured corticosterone had
significantly higher levels of hippocampal BDNF compared to the control-
vehicle group (P = 0.00039 and P = 0.006, respectively), Fig. 2.15A. In the
frontal cortex, no significant alterations in the levels of BDNF were observed
amongst all corticosterone-treated groups compared to the control groups (F(4,36)
= 0.71, P = 0.59), Fig. 2.15B.
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2.13.3 TrkB
For methodological reasons, one mouse was identified as a significant outlier
and removed from the control-vehicle group. In the hippocampus, there were no
statistical differences in the levels of FL-TrkB (F(4,35) = 1.36, P = 0.27) and t-
TrkB (F(4,35) = 0.56, P = 0.69) between any of the experimental groups, Fig
2.16A. Similarly in the frontal cortex, there were no significant changes in the
levels of either FL-TrkB (F(4,36) = 0.29, P = 0.88) or t-TrkB (F(4,36) = 0.67, P =
0.62) between all groups, Fig 2.16B.
2.13.4 Phospho-ERK1/2
One significant outlier in the group whose choice was water versus unflavoured
corticosterone was removed from the analysis. There was a significant
difference between groups in hippocampal pERK2 levels (F(4, 35) = 3.95, P =
0.01). Post-hoc planned comparisons detected a significant decrease in
hippocampal pERK2 levels of mice which had a choice between IMP and
unflavoured corticosterone (P = 0.035) compared to the control-flavour group,
Fig. 2.17A. In addition, the two corticosterone-treated groups which had a
choice between IMP and unflavoured corticosterone or water and flavoured
corticosterone had low hippocampal pERK2 levels (P = 0.001 and P = 0.009,
respectively) compared to the control-vehicle group, Fig. 2.17A. On the other
hand, there was no significant group effect for hippocampal pERK1 levels (F(4,
35) = 2.44, P = 0.065), Fig. 2.17A.
In the frontal cortex, one mouse (water versus flavoured corticosterone) was
identified as a significant outlier, and it was removed from the analysis.
Significant alterations in the levels of pERK2 were found between groups
(F(4,35) = 3.61, P = 0.015). Post-hoc planned comparisons indicated a significant
decrease in pERK2 levels in the frontal cortex of mice whose choice was water
versus flavoured corticosterone (P = 0.040) compared to the control-flavour
group, Fig 2.17B. In addition, all corticosterone-treated groups showed
significantly lower levels of pERK2 (P <0.05, in all case) than the control-
vehicle group, Fig 2.17B. On the other hand, there were no differences in the
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levels of pERK1 between groups (F(4,35) = 2.30, P = 0.078), Fig. 2.17B. Using
GAPDH as a reference protein, no group differences in the levels of t-ERK1
and t-ERK2 were found either in the hippocampus or the frontal cortex of mice
(data not shown).
2.13.5 Correlation between levels of measured proteins and memory
performance using Pearsons correlation
There was a significant correlation between t-TrkB levels in the frontal cortex
and location index (LI) of all corticosterone-treated mice (n = 25, r = 0.54, P =
0.005). For mice in the control-flavour group, there was an inverse relationship
between recognition index (RI) and BDNF levels in the frontal cortex (n = 8, r =
-0.73, P = 0.042) and between hippocampal levels of pERK2 and the percentage
of correct alternation (n = 8, r = -0.75, P = 0.033). In contrast, mice in the same
group showed a positive correlation between hippocampal levels of TrkB and
the percentage of correct alternations (n = 8, r = 0.72, P = 0.046), and between
TrkB levels in the frontal cortex and RI (n = 8, r = 0.90, P = 0.002) and between
hippocampal pERK1 levels and LI (n = 8, r = 0.72, P = 0.045)
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Synaptophysin
SYN 38 kDa
(A) Hippocampus
GAPDH 36 kDa
Figure 2.14 Effects of oral corticosterone self-administration on SYN levels in
the hippocampus (A) and frontal cortex (B). SYN and GAPDH levels were
measured using western immunoblotting. Synaptophysin/GAPDH was
calculated as % of the control-flavour group (water versus IMP). Data are
expressed as mean ± SEM (n = 7-9 mice/group). # indicates groups whose
solutions were exchanged during switching.
(B) Frontal cortex
SYN 38 KDa
GAPDH 36 kDa
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BDNF
Figure 2.15 Effects of acquisition and reinstatement of oral corticosterone self-
administration on BDNF levels in the hippocampus (A) and frontal cortex (B)
of 5 groups (n = 7-9) of male C57BL/6J mice. BDNF/GAPDH was calculated
as % of the control-flavour group (water versus IMP). Data are expressed as
mean ± SEM. Planned comparisons: *P <0.05 versus the control-flavour
group, $$P <0.01 and $$$P <0.001 versus the control-vehicle group (water
versus ethanol 1%). # indicates groups whose solutions were exchanged during
the switching period.
(A) Hippocampus
BDNF ~14 kDa
GAPDH ~36 kDa
(B) Frontal cortex
GAPDH ~36 kDa
BDNF ~14 kDa
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145 kDa
GAPDH 36kDa
95 kDa
(A) Hippocampus
TrkB
Figure 2.16 Levels of full length TrkB (145 kDa) and truncated TrkB (95
kDa) in the hippocampus (A) and frontal cortex (B) of corticosterone naïve
and treated mice (n = 7-9/group). FL-TrkB/GAPDH and t-TrkB/GAPDH
were calculated as % of the control-flavour group (water versus IMP). Data
are expressed as mean ± SEM.
(B) Frontal cortex
145 kDa
GAPDH 36 kDa
95 kDa
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Phospho-Erk1/2
Figure 2.17 Effects of oral corticosterone self-administration on the activation of
ERK1/2 in the hippocampus (A) and frontal cortex (B) of corticosterone naïve and
treated mice (n = 7-9/group). pERK2/t-ERK2 and pERK1/t-ERK1 were calculated
relative to the control-flavour group (water versus IMP). Data are expressed as
mean ± SEM. Planned comparisons: *P <0.05 significantly different from control-
flavour group, $P <0.05, $$P <0.01 and $$$3VLJQLILFDQWO\GLIIHUHQWIURPWKH
control-vehicle group (water versus ethanol 1%).
(B) Frontal cortex
44 kDat-ERK 42 kDa
(A) Hippocampus
t-ERK 42 kDa 44 kDa
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2.14 Discussion
The purpose of this part of the experiment was to investigate whether oral
corticosterone self-administration and its effects on mices memory are
accompanied with persistent changes in markers of neuroplasticity. The present
study showed that oral corticosterone self-administration reduced levels of
pERK2 in the hippocampus and frontal cortex of some or all corticosterone-
treated groups compared to the control groups. Also, two of the corticosterone-
treated groups had higher levels of BDNF in the hippocampus than the control-
vehicle group (water versus ethanol 1%). In addition, mice in the control-
vehicle group showed low levels of BDNF in the hippocampus compared to the
control-flavour group (water versus IMP). In contrast, the levels of SYN and
TrkB in both the hippocampus and frontal cortex were not significantly
different between groups.
It has been proposed that the hippocampus is critical for memory and learning
(O'Keefe and Dostrovsky, 1971; Eichenbaum et al., 1999) and the hippocampus
greatly expresses GRs and MRs (Reul and de Kloet, 1985), and thus it was
vulnerable to changes in plasma corticosterone levels according to the degree
and duration of corticosterone self-administration in each group. Also, the
frontal cortex is involved in cognitive performance and the development of drug
addiction (Markowitsch and Pritzel, 1977; van Haaren et al., 1988; Volkow et
al., 2011).
In the hippocampus and frontal cortex, the levels of SYN were not altered by
oral corticosterone self-administration. SYN has been used as a classical marker
of synaptogenesis (Mazer et al., 1997; Vawter et al., 2002). From the literature,
it is not clear whether SYN levels are affected by the development of drug
addiction. However, CPP to amphetamine increased SYN levels in the
hippocampus and nucleus accumbens core of rats (Rademacher et al., 2006).
SYN and other vesicle-associated membrane proteins are well known to
influence synaptic plasticity and memory performance. For instance, SYN-
knockout mice showed a significant reduction in hippocampal LTP (Janz et al.,
1999) and exhibited memory impairment in the Morris water maze and novel
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object recognition tests (Schmitt et al., 2009). Being important for associative
learning performance, SYN levels were elevated in the basolateral nuclei of the
amygdala of mice after they developed auditory fear conditioning
(Nithianantharajah and Murphy, 2008). In contrast, environmental enrichment-
induced improvement of age-related decline in mices spatial memory was
associated with low SYN levels in the hippocampus and frontal cortex,
compared to control aged mice (Bennett et al., 2006). Furthermore, old female
C57BL/6J mice showed an increase in SYN immunoreactivity in the
hippocampus, but they demonstrated spatial and passive avoidance memory
impairment (Benice et al., 2006). The present work indicated that chronic
corticosterone intake even at high doses did not have a long-lasting effect on
SYN levels in either the hippocampus or frontal cortex. However, single and
repeated immobilization stress decreased SYN mRNA expression in the
hippocampus and cerebral cortex of rats (Thome et al., 2001), and
immobilization stress was reported to substantially elevate plasma
corticosterone levels (Sapolsky et al., 1984). Overall, it can be concluded that
chronic corticosterone self-administration did not recruit SYN, at least in the
hippocampus and frontal cortex, to mediate rewarding and cognitive effects of
the stress hormone.
BDNF/TrkB/ERK1/2 signalling pathway is particularly important for proper
neuronal function, memory and learning capability (Minichiello et al., 1999;
Mazzucchelli and Brambilla, 2000; Yacoubian and Lo, 2000; Heldt et al.,
2007). As mentioned earlier, chronic corticosterone self-administration even at
high doses did not alter levels of BDNF or its receptor (FL-TrkB or t-TrkB) in
the hippocampus and frontal cortex, compared to the control-flavour group.
BDNF is highly expressed in the rat hippocampus (Maisonpierre et al., 1990)
and is important for neuronal survival, neuroplasticity (Gooney and Lynch,
2001; West, 2008), spatial memory (Mizuno et al., 2003; McGauran et al.,
2008) and learning (Bao et al., 1998; Berchtold et al., 2010). Previous work
showed that chronic corticosterone treatment slightly reduced hippocampal
levels of BDNF mRNA and protein in rats (Jacobsen and Mork, 2006), but
adrenalectomy increased BDNF mRNA expression in the rat hippocampus
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(Chao et al., 1998). Also, adrenalectomized rats treated with a single dose of
corticosterone which elevated plasma corticosterone levels exhibited a
significant albeit small decrease in hippocampal BDNF levels 4 or 6 hours after
treatment (Schaaf et al., 1998). Interestingly, mice in the control-vehicle group
had low BDNF levels in the hippocampus, compared to the control-flavour
group and corticosterone self-administered groups which had IMP added to
their test or control solutions. As seen in Chapter 2 - Part 2, mice in the control-
vehicle group had spatial and recognition memory impairment. In contrast,
corticosterone treatment abolished ethanol-induced memory impairment in the
spontaneous alternation test, and two of corticosterone self-administered groups
also had no recognition memory deficits. This suggests that memory
impairment induced by 1% ethanol in the control-vehicle group was possibly
secondary to the decreased hippocampal BDNF levels. In agreement with this,
chronic exposure to ethanol vapour decreased the expression of BDNF mRNA
but increased TrkB mRNA expression in the rat hippocampus (Tapia-Arancibia
et al., 2001). In contrast, expression of BDNF mRNA in the dentate gyrus was
increased 12 hours after the cessation of chronic ethanol exposure (Tapia-
Arancibia et al., 2001).
Over the past two decades, drug self-administration studies have been used to
understand the role of BDNF in drug-seeking behaviour. For instance,
BDNF/TrkB signalling in the nucleus accumbens was reported to be involved in
the acquisition and reinstatement of intravenous cocaine self-administration in
both mice and rats (Graham et al., 2007). Moreover, BDNF infusions in the
ventral tegmental area or the nucleus accumbens of rats facilitated cocaine-
induced behavioural sensitization (Horger et al., 1999). On the other hand,
BDNF was found to modulate the rewarding effects of a high fat diet via the
enhancement of dopamine release in the nucleus accumbens shell and the dorsal
striatum (Cordeira et al., 2010).
A considerable body of research suggests that ERK1/2 plays a dominant role in
the development of drug addiction. Effects on ERK1/2 levels vary according to
the abused drug, the duration of exposure and the brain region (Zhai et al.,
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2008). For example, acute cocaine or amphetamine administration increased
ERK1/2 activity in the hippocampus and frontal cortex of mice (Valjent et al.,
2004; Valjent et al., 2005). Further, repeated cocaine injections raised levels of
pERK1/2 in the nucleus accumbens and ventral tegmental area of rats (Berhow
et al., 1996; Mattson et al., 2005; Yoon et al., 2007). Our results suggest that
ERK1/2 in the frontal cortex was involved in the acquisition of corticosterone
self-administration, but maintenance of corticosterone self-administration was
associated with low pERK2 levels in the hippocampus. For instance, mice
which were offered a new choice (IMP versus unflavoured corticosterone,
group E) after switching started to self-administer corticosterone and showed a
significant decrease in pERK2 levels in the frontal cortex, compared to the
control-flavour group. Also, mice which had the same choice during acquisition
and reinstatement (group D) self-administered corticosterone for a long time
and showed low hippocampal pERK2 levels. Consistent with these results,
chronic administration of corticosterone in drinking water reduced pERK2
levels in the hippocampus and frontal cortex of mice and this effect lasted for
more than 10 days until mice were culled (Gourley et al., 2008). Previous
studies showed that repeated exposure to morphine was associated with low
levels of pERK1/2 in the prefrontal cortex of human addicts and rats (Ferrer-
Alcon et al., 2004) and with high pERK1/2 levels in the nucleus accumbens of
mice (Liu et al., 2007).
It is interesting that the two corticosterone-treated groups which had IMP in
their control or test solutions showed higher BDNF and lower pERK2 levels in
the hippocampus, compared to the control-vehicle group. As mice in the
control-vehicle did not show a significant preference for 1% ethanol, and
corticosterone-treated groups markedly developed and reinstated corticosterone
self-administration, this provides some evidence that low activity of ERK2 in
the hippocampus and frontal cortex of corticosterone-dependent mice underlies
the rewarding properties of corticosterone. In contrast, mice which had a choice
between water and unflavoured corticosterone did not show a significant
decrease in pERK2 levels in either brain area, compared to the control-flavour
group. These conflicting results between corticosterone self-administered
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groups suggest that IMP acted as a cue by which mice learned to choose
between the two solutions of the two-bottle choice test. Clearly, mice learned an
association between IMP as a cue and high doses of corticosterone as a reward.
The frontal cortex was found to be implicated in associative learning tasks
(Asaad et al., 1998; Asaad et al., 2000). For instance, C57BL/6J mice
developed conditioned place preference to morphine and showed a decrease in
levels of pERK2 in the frontal cortex (Li et al., 2008). Also, it was found that
pERK2 levels increased in the hippocampus of rats after being trained in
associative learning and conditioning fear tasks (Atkins et al., 1998).
On the other hand, our results showed that mice whose choice was water versus
unflavoured corticosterone had low pERK2 levels in the frontal cortex,
compared to the control-vehicle group. This indicates that the effects on pERK2
levels, in this control group, could be attributed to repeated intermittent
exposure (2 withdrawals) to 1% ethanol in the control-vehicle group. It was
found that continuous or intermittent moderate ethanol consumption decreased
phosphorylation of ERK1/2 in different brain areas including the hippocampus
and frontal cortex of rats, but pERK1/2 levels increased within 24-hour
withdrawal (Sanna et al., 2002). However, corticosterone probably blocked the
effects of ethanol on the activity of ERK2, as the hormone decreased levels of
pERK2 in the hippocampus and frontal cortex.
ERK1/2 has a key role in learning and memory formation such as recognition
memory (Kelly et al., 2003). Also, induction of LTP in the hippocampus slices
isolated from rats was associated with the increase of pERK2 levels (English
and Sweatt, 1996). It was found that stress-induced hippocampal LTP
impairment was corticosterone-dependent (Korz and Frey, 2003). Taken
together, our findings suggest that low ERK2 activity in the hippocampus could
be involved in the recognition memory impairment of mice which ingested high
doses of corticosterone during all phases of the two-bottle choice test.
It is also important to point out that the control-vehicle group showed memory
impairment and low hippocampal BDNF levels in the hippocampus, but no
Chapter 2(iii): Neuroplasticity of corticosterone self-administration
114
reduction in pERK2 levels in the hippocampus and frontal cortex, compared to
the control-flavour group. This suggests that effects on ERK1/2 activity were
not only linked to BDNF/TrkB signalling, but also to other upstream signalling
systems, such as endogenous opioid and glutamatergic pathways which might
be involved in the plasticity induced by corticosterone self-administration.
There was a positive correlation between levels of t-TrkB in the frontal cortex
of all corticosterone-treated mice and LIs. This finding suggests that the
improvement of LIs was dependent on t-TrkB levels in the frontal cortex, and
this was accompanied with a decrease of pERK2 levels in the frontal cortex of
all of corticosterone-treated mice compared to the control-vehicle group. As the
control-flavour group did not develop memory deficits compared to the control-
vehicle group, it was interesting to explore whether levels of the marker
proteins in the hippocampus or frontal cortex might correlate with memory
performance in the control-flavour group. Results revealed that RIs were
negatively correlated with BDNF levels, but they were, however, positively
correlated with TrkB levels in the frontal cortex. Whereas the percentage of
correct alternation increased when hippocampal TrkB levels increased, it
decreased when hippocampal pERK2 levels increased. Also, LIs were
positively correlated with hippocampal pERK1 levels. It is difficult to
understand the mechanisms behind these correlations. However, these proteins
are involved in the same signalling pathway and these observations can be
interpreted, as a decrease in one component of the pathway triggers a
compensatory increase in the others, despite there being no correlation between
the measured proteins in the same brain area. From this work, it can be
concluded that the BDNF/TrKB/ERK1/2 signalling pathway is implicated in the
rewarding and cognitive effects of corticosterone self-administration, but further
investigation is necessary to determine the involvement of other endogenous
reward modulators whose actions involve ERK1/2.
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Chapter 2 - Part 4
Impact of corticosterone self-administration on
levels of amine neurotransmitters in the mouse
striatum
Chapter 2(iv): Impact of corticosterone self-administration on levels of
amine neurotransmitters in the mouse striatum
116
2.15 Aims
Many abused drugs mediate their rewarding effects via enhancing dopamine
neurotransmission in the mesolimbic dopamine pathway (Hoebel et al., 1983;
Devine et al., 1993; Glick et al., 1998), and imaging studies using single-photon
emission computed tomography, MRI and PET showed correlation between
dopamine release in the striatum of addicts and amphetamine-induced euphoria
(Laruelle et al., 1995; Drevets et al., 2001). Moreover, locomotor hyperactivity
induced by acute morphine treatment was accompanied by increased levels of
serotonin (5HT) and its major metabolite 5-hydroxyindoleacetic acid (5HIAA)
in the nucleus accumbens and dorsal striatum of C57BL/6J mice (Fadda et al.,
2005). This suggests that corticosterone self-administration could be
accompanied by alterations in the levels of amines in the striatum of
corticosterone-dependent mice compared to corticosterone naïve mice.
Dopamine and its metabolites 3, 4-dihydroxyphenylacetic acid (DOPAC) and
homovanillic acid (HVA), 5HT and 5HIAA were, therefore, measured in the
striatum of mice by means of HPLC.
2.16 Materials and methods
2.16.1 HPLC determination of amine neurotransmitters in the striatum
Each mouses striatum was homogenised in a measured volume of ice-cold
perchloric acid (PCA) (0.05 M perchloric acid containing 0.02% w/v sodium
metabisulfite and 0.01 % w/v EDTA dissolved in HPLC Grade water). Samples
were homogenised by a sonic probe for 20-30 sec (MSE Soniprep 150 UK,
power 20) and centrifuged at 14.000 g (MSE Harrier 18/80) at 4qC for 20
minutes. Then, the supernatants were removed, filtered through 0.45 Pm PVDF
syringe filters (Kinesis UK) and stored at -80qC until analysis. Dopamine,
DOPAC, HVA, 5HT and 5HIAA were determined by HPLC with
electrochemical detection. Samples (20 Pl) were injected onto an
electrochemical detector (Antec, the Netherlands). The mobile phase (50 mM
KH2PO4, 0.1 mM EDTA and 0.32 mM octane sulfonic acid in HPLC Grade
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water, pH 3.5 adjusted by orthophosphoric acid before addition of 13% v/v
methanol) was pumped at a rate of 1 ml/min. A Phenomenex reverse phase
column; C-18, 5 Pm ODS-2 (150 X 4.6 Pm), was used to separate and measure
the previously mentioned amines and their metabolites using a glassy carbon
working electrode with a potential of + 0.7 V versus an Ag/AgCl reference
electrode. The height of peaks of each amine was measured relative to a
calibration mixed standard of dopamine, DOPAC, HVA, 5HT and 5HIAA with
known concentrations (5 x 10-7M). The mixed standard solution was injected at
the start and end of running samples through the HPLC system. The levels of
amines or metabolites were expressed as pmol/mg tissue. An example
chromatogram illustrates the separation of dopamine, 5HT and their metabolites
in the standard mixture and the striatum of a corticosterone-treated mouse, Fig
2.18.
2.16.2 Statistical analysis
One way ANOVAs with groups (5 levels) as the between subject factor were
used to analyse levels of dopamine, 5HT, their metabolites and their turnover
ratios: DOPAC/dopamine, HVA/dopamine and 5HIAA/5HT. Post-hoc planned
FRPSDULVRQV ZHUH XVHG ZKHQ VLJQLILFDQFH 3   ZDV UHDFKHG $OVR
Pearsons correlation coefficients were calculated to investigate whether levels
of the measured amines or their metabolites correlate with the average
corticosterone doses consumed over the whole experiment. Data are expressed
as mean ± SEM.
Chapter 2(iv): Impact of corticosterone self-administration on levels of
amine neurotransmitters in the mouse striatum
118
BA
Figure 2.18 Example chromatogram produced by HPLC for the separation of
dopamine, DOPAC, HVA, 5HT and 5HIAA of (A) a mixed standard at 5 x
10 7 M concentration and (B) mouse striatum tissue homogenate, water versus
unflavoured corticosterone.
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2.17 Results
2.17.1 Dopamine and its metabolites, DOPAC and HVA
There was no significant main group effect for the levels of dopamine in the
striatum (F(4,34) = 1.41, P = 0.25), table 2.3. Similarly, levels of the dopamine
metabolites, DOPAC and HVA, were not significantly different between groups
(F(4,34) = 1.03, P = 0.41, F(4,34) = 0.65, P = 0.63, respectively), table 2.3.
Nevertheless, there were significant group differences for the ratio
DOPAC/dopamine (F(4,33) = 3.02, P = 0.032). Post-hoc planned comparisons
showed a significant increase in the DOPAC/dopamine ratio in the striatum of
mice which had water versus flavoured corticosterone compared to the control-
vehicle (P = 0.006) and the control-flavour (P = 0.044) groups, table 2.3. Also,
mice whose choice was IMP versus unflavoured corticosterone showed a
significant increase in the DOPAC/dopamine ratio (P = 0.016) compared to the
control-vehicle group, table 2.3. On the other hand, the HVA/dopamine ratio,
another estimate of dopamine turnover, was not significantly different between
groups (F(4,33) = 2.44, P = 0.066), table 2.3. Interestingly, there was a positive
correlation between averaged corticosterone doses that mice consumed over the
whole study and DOPAC levels in the striatum (n = 24, r = 0.44, P = 0.03), Fig.
2.19. In contrast, levels of dopamine and HVA or HVA/dopamine ratios did not
significantly correlate with averaged corticosterone doses.
2.17.2 5HT and its metabolite 5HIAA
There were no significant group differences in the levels of 5HT and its
metabolite 5HIAA in the striatum (5HT: F(4,34) = 1.33 , P = 0.28, 5HIAA: F(4,34)
= 0.36, P = 0.83), table 2.3. Also, there were no alterations in the 5HIAA/5HT
ratio (F(4,34) = 1.12, P = 0.37), table 2.3. Likewise, no correlation was found
between levels of 5HT or 5HIAA and the average of corticosterone doses
consumed.
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Variables
Groups
Dopamine DOPAC HVA 5HT 5HIAA
DOPAC /
dopamine
HVA /
dopamine
5HIAA /
5HT
Water versus IMP
(control-flavour)
47.25 ± 5.81 28.19 ± 2.93 10.26 ± 0.98 1.41 ± 0.16 2.20 ± 0.10 0.62 ± 0.03 0.23 ± 0.01 1.76 ± 0.28
Water versus unflavoured
corticosterone
48.49 ± 6.63 30.2 ± 4.48 10.34 ± 1.21 1.20 ± 0.14 2.39 ± 0.15 0.64 ± 0.06 0.22 ± 0.01 2.19 ± 0.28
IMP versus unflavoured
corticosterone #
34.68 ± 6.03 32.58 ± 6.38 9.72 ± 1.43 1.70 ± 0.21 2.38 ± 0.22 0.78 ±0.09 * 0.25 ± 0.02 1.44 ± 0.08
Water versus flavoured
corticosterone #
31.92 ± 8.03 21.55 ± 4.47 7.91 ± 1.70 1.70 ± 0.24 2.46 ± 0.19 0.80 ± 0.09**$ 0.29 ± 0.03 1.77 ± 0.38
Water versus ethanol 1%
(control-vehicle)
45.77 ± 5.35 24.03 ± 2.76 10.19 ± 0.83 1.30 ± 0.26 2.45 ± 0.20 0.53 ± 0.03 0.23 ± 0.01 2.39 ± 0.57
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Table 2.3 Striatal levels (pmol/mg tissue) of dopamine, 5HT and their metabolites. In addition, the rates of DOPAC/dopamine, HVA/dopamine, and
5HIAA/5HT were calculated in the striatum of corticosterone naïve and treated mice (n = 7-9 / group). Data are presented as mean ± SEM. There was
an increase in the DOPAC/dopamine ratio which reflects dopamine utilisation, planned comparisons: *P <0.05, **P <0.01 compared to the control-
vehicle group and
$
P <0.05 compared to the control-flavour group. # indicates groups whose solutions were exchanged during switching.
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Figure 2.19 The correlation between DOPAC concentrations in the striatum of
all corticosterone self-administered mice and averages of their daily
corticosterone doses consumed over the whole experiment. Pearsons
correlation (n = 24, r = 0.44, P = 0.03).
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2.18 Discussion
The results of the present work suggest that acquisition and reinstatement of
chronic oral corticosterone self-administration were accompanied by some
alterations in the dopamine neurotransmission in the striatal complex. There
were no significant changes in levels of dopamine, 5HT and their metabolites in
the striatum of corticosterone self-administered mice compared to the two
control groups. Also, the HVA/dopamine and the 5HIAA/5HT ratios were not
significantly different between groups. These results are consistent with
previous work which revealed that chronic exposure to high corticosterone
doses (50 mg/kg, s.c.) did not significantly modify levels of these variables in
the rat striatum (Inoue and Koyama, 1996), despite the fact that rats were
sacrificed 24 hours after the last corticosterone injection, but in this study mice
were sacrificed 10 days after the end of the corticosterone treatment. In contrast,
chronic corticosterone administration increased 5HT levels and decreased
5HIAA levels in the hippocampus and frontal cortex of rats which were
sacrificed 24 hours after 21 days of corticosterone (32mg/kg, s.c.) treatment
(Jacobsen and Mork, 2006). Interestingly, the two groups in which mice self-
administered corticosterone when it was flavoured or paired with IMP had
significantly higher DOPAC/dopamine ratios, an indicator of dopamine
turnover, in the striatum compared to both control groups. However, mice
whose unflavoured corticosterone solution was paired with water did not show a
significant change in the DOPAC/dopamine ratio. Most importantly, the
average of corticosterone doses of all corticosterone-treated mice positively
correlated with levels of DOPAC in the striatum.
The role of dopamine in the reward and development of drug addiction has been
studied over the past few decades. There are anatomically three dopamine
pathways in the brain: mesolimbic, mesocortical and nigrostriatal.
Dopaminergic neurons in the mesocorticolimbic dopamine system project
mainly from the ventral tegmental area to the nucleus accumbens and the frontal
cortex (Wise, 1998). Nigrostriatal dopaminergic neurons originate from the
substantia nigra and project to the dorsal striatum, and this pathway has been
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traditionally implicated in motor function (Wise, 2009). However, there has
recently been some evidence that the nigrostriatal dopamine pathway works in
association with the mesocorticolimbic dopamine system in response to the
rewarding substances (Wise, 2009). It is well established that the
mesocorticolimbic dopamine system mediates rewarding effects of abused
drugs. For example, rats self-administered amphetamine (Hoebel et al., 1983)
and nomifensine (Carlezon et al., 1995), a selective dopamine reuptake
inhibitor, into the nucleus accumbens. Additionally, rats learned to lever-press
for dopamine microinjection into the nucleus accumbens (Dworkin et al., 1986).
Furthermore, natural rewards like palatable food (Martel and Fantino, 1996b;
Martel and Fantino, 1996a) and copulation (Fiorino et al., 1997) were
accompanied with an increase in dopamine and their metabolites in the nucleus
accumbens. Dopamine per se was initially given attention as a reward
mediating neurotransmitter when pimozide, a selective dopamine receptor
antagonist, treated rats exhibited low self-stimulation rates of the medial
forebrain bundle (Liebman and Butcher, 1973). Dopamine is also believed to
play a fundamental role in the habit forming actions of abused drugs. For
instance, the rewarding effects of cocaine and amphetamine were diminished in
rats by pimozide but not affected by phentolamine HCl, a selective
noradrenergic blocker (Yokel and Wise, 1975; De Wit and Wise, 1977), or by
methysergide, a 5-HT1/5-HT2 receptor blocker (Lacosta and Roberts, 1993).
Moreover, other abused drugs such as morphine and nicotine increased
dopamine levels, measured by microdialysis, in the nucleus accumbens of rats
(Devine et al., 1993; Glick et al., 1998).
Whereas oral acute corticosterone treatment minimally decreased the
DOPAC/dopamine ratio in the striatum, two weeks of adrenalectomy increased
the DOPAC/dopamine ratio in the medial prefrontal cortex of Sprague-Dawley
rats (Lindley et al., 1999). In the present study, corticosterone-treated mice
which had IMP in their solutions had a significantly higher DOPAC/dopamine
ratio than the control groups. In contrast, the third corticosterone-treated group
in which mice self-administered unflavoured corticosterone paired with water
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showed no significant changes in dopamine turnover. This suggests that when
mice tasted IMP, they could predict they would be rewarded. This cue probably
resulted in an increase in the dopamine release when it was paired with a
reward, corticosterone, as mice in the control-flavour group (water versus IMP)
did not show a significant increase in the DOPAC/dopamine ratio, compared to
the control-vehicle group. It has been thought that dopamine acts as alerting
device for the receipt of a reward rather than mediating its hedonic effects
(Schultz et al., 1997). In agreement with this, it was observed that intracranial
self-stimulation initially enhanced dopamine release, measured using cyclic
voltammetry, in the rat caudate-putamen but dopamine levels began to fall as
rats lever-pressed to receive more brain stimulation (Kilpatrick et al., 2000).
When light was used as a cue, trained monkeys showed a rise in dopamine
levels which dropped when they started to consume the rewarding juice
(Hollerman and Schultz, 1998; Schultz, 2010). IMP in the present experiment
probably acted like the light, as the conditioned stimulus.
Corticosterone treatment increased, decreased or did not change levels of
extracellular dopamine, 5HT and their metabolites in different brain regions
(Rothschild et al., 1985; Wolkowitz et al., 1986; Dunn, 1988; Tanganelli et al.,
1990; Imperato et al., 1991; Inoue and Koyama, 1996). It is necessary to
distinguish between corticosterone self-administration and corticosterone
treatment where animals had no free access to corticosterone, as the dopamine
reward pathway was reported to respond to non-contingent drug injections and
drug self-administration in a different way (Stefanski et al., 1999). It has been
found that corticosterone modulates effects of abused dugs on the dopamine
reward pathway. For example, mifepristone, a glucocorticoid receptor
antagonist, reduced the elevated extracellular dopamine concentrations induced
by morphine in the nucleus accumbens (Marinelli et al., 1998), and this could
be direct effects on dopamine release, as the mesocorticolimbic and nigrostriatal
dopaminergic neurons were found to be GR immunoreactive in Sprague-
Dawley rats (Harfstrand et al., 1986). Also, cocaine-evoked dopamine release
was enhanced by stress-induced sensitization via corticosterone secretion
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(Rouge-Pont et al., 1995). Moreover, corticosterone enhanced the activity of
tyrosine hydroxylase, the rate limiting step in catecholamine synthesis, in the
ventral tegmental area (Nestler et al., 1989). In contrast, application of
mifepristone to cultured mesencephalic neurons produced a dose-dependent
decrease in dopamine release (Rouge-Pont et al., 1999). Our results also
showed a direct relationship between DOPAC levels in the striatum and the
averaged corticosterone dose consumed over the entire experiment. This
suggests that dopamine turnover was altered in a dose-dependent manner during
the acquisition, relapse and switching phases of the two-bottle choice test.
This work suggests possible connections between the rewarding effects of
corticosterone and dopamine neurotransmission in the striatum. Further
investigations using techniques such as microdialysis are required to
demonstrate the immediate effects of corticosterone self-administration on the
levels of dopamine and their metabolites in the nucleus accumbens and other
brain regions which are involved in the reward-seeking behaviour.
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General conclusion
This experiment showed that mice acquired and reinstated oral corticosterone
self-administration in the two-bottle choice test. The use of IMP was extremely
important, as results revealed that mice used IMP to discriminate the stress
hormone, and IMP facilitated and enhanced corticosterone self-administration
as a result of its initial aversive taste. The switching phase improved the
interpretation of results of acquisition and relapse. Firstly, corticosterone-
dependent mice (IMP versus unflavoured corticosterone, group D) received
corticosterone doses similar to what they self-administered prior to switching.
Secondly, mice in group E (water versus flavoured corticosterone) developed
significant corticosterone self-administration after switching, provided that they
did not show avoidance to flavoured corticosterone during acquisition and
relapse. Altogether, switching indicated that the rewarding effects of
corticosterone are flavour-independent. Apart from ethanol self-administration
studies using saccharine fading procedures (the addition of a sweetener to
gradually increasing concentrations of the ethanol solution to facilitate its self-
administration followed by a gradual withdrawal of the sweetener after animals
have self-administered the highest ethanol concentration), this is the first study
in which a flavour has been used in the two-bottle free choice model for testing
the rewarding effects of a substance. Short term self-administration of high
corticosterone doses did not impair the spontaneous alternation performance
and recognition memory but improved the object location memory. In contrast,
mice whose choice was IMP versus unflavoured corticosterone chronically
received high doses of corticosterone and consequently had recognition memory
deficits but no spatial memory impairment in the alternation test. This suggests
that spontaneous alternation and recognition memory are regulated by different
brain circuits. Overall, rewarding effects seem to outweigh deleterious effects of
excessive exposure to the stress hormone. Corticosterone self-administration in
mice probably induced plasticity in the hippocampus and frontal cortex as
shown by changes in pERK1/2 levels which were significantly different
between corticosterone naïve and treated groups. Also, the frontal cortex
appears to mediate the development of corticosterone self-administration, but
the hippocampus is more likely involved in corticosterone dependence. Our
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results suggest that IMP acted as a cue by which mice learned the association
between the taste of flavour and the rewarding hormone, and this was
accompanied by significant effects on BDNF/pERK2 levels in the
hippocampus. However, mice did not show these effects when they had no IMP
in the control or test solutions. Additionally, corticosterone self-administration
resulted in enhancement of dopamine utilisation in the striatum as
DOPAC/dopamine ratio was higher only in the corticosterone-treated groups
which had IMP-flavouring solutions. This reinforces the role of IMP as a cue
which triggered dopamine release in the striatum of mice when they drank from
the corticosterone solution. Finally, DOPAC levels in the striatum were directly
proportional to the average corticosterone doses consumed by all mice over the
whole study. In summary, although this experiment has provided more
evidence, in addition to previous work, that corticosterone is rewarding, its
rewarding properties do not impair but are likely to improve memory. Further
work is required to investigate whether corticosterone recruits certain signalling
pathways in specific brain regions to mediate its rewarding effects and how all
these affect cognitive performance.
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Chapter 3
The rewarding and cognitive effects of voluntary wheel
running: role of the stress hormone corticosterone
3.1 Introduction
It is well established that voluntary wheel running is a natural reward. Indeed,
wheel running reinforces lever pressing (Iversen, 1993; Belke and Wagner,
2005), while rats develop conditioned place preference (CPP) to the after-
effects of voluntary wheel running (Lett et al., 2000; Lett et al., 2001; Belke
and Wagner, 2005). Moreover, long-term wheel running decreases dopamine
D2 receptor mRNA expression in the nucleus accumbens core of rats
(Greenwood et al., 2011), as observed in morphine-dependent rats (Georges et
al., 1999). Furthermore, the mesolimbic and nigrostriatal dopamine pathways
have been found to be implicated in the wheel running activity of mice bred for
high running performance (Mathes et al., 2010).
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Voluntary wheel running has been extensively used to study the effects of
exercise on cognition. Wheel running enhances spatial memory, long-term
potentiation (LTP) and neurogenesis in the hippocampus of young mice (van
Praag et al., 1999; Vasuta et al., 2007) and also improves hippocampal
neurogenesis in aged mice (van Praag et al., 2005). Moreover, wheel running
also ameliorates aging and Alzheimers-related cognitive decline in mice (van
Praag et al., 2005; Nichol et al., 2007; Parachikova et al., 2008).
It is also believed that voluntary wheel running activates the HPA axis and
elevates plasma corticosterone levels (Girard and Garland, 2002; Droste et al.,
2003; Adlard and Cotman, 2004; Fediuc et al., 2006). Although previous work
reports increases in plasma corticosterone levels as a result of unlimited access
(24 hours) to wheel running (Droste et al., 2003; Fediuc et al., 2006), it is not
clear whether limited access (1-hour) to wheel running is sufficient to increase
corticosterone levels. As mentioned in the previous chapters, corticosterone has
been implicated in drug-seeking behaviour (Mantsch et al., 1998; Dong et al.,
2006; Mantsch and Katz, 2007) and is self-administered in rats (Deroche et al.,
1993; Piazza et al., 1993) and mice (Chapter II). Taken together, this suggests
that corticosterone elevation induced by wheel running may also be involved in
its rewarding and cognitive effects.
This chapter comprised two preliminary studies to investigate the involvement
of corticosterone in the rewarding and/or cognitive effects of single and
repeated 1-hour voluntary wheel running sessions in mice.
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Chapter 3  Part 1
Effects of repeated 1-hour voluntary wheel running
sessions on HPA axis and memory in mice
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3.2 Aims
In this pilot study, there were 3 questions to be addressed:
1- What is the minimum number of sessions required for mice to run
effectively?
2- Do repeated 1-hour voluntary wheel running sessions increase plasma
corticosterone levels after 5 weeks of exercise?
3- What is the impact of chronic intermittent wheel running on memory?
3.3 Materials and methods
3.3.1 Animals
Twenty 6-8 week old male C57BL/6J mice were bought from Charles River
UK, individually caged and kept undisturbed for a week of acclimatization.
Mice were kept under standard environmental conditions of temperature (20 -22
qC), humidity (55  60 %), ventilation and 12:12 light dark cycle (lights on at
7:00 am) throughout the experiment. Mice had unlimited access to food and
water. Body weight (BW) of mice was recorded once a week. All procedures
undertaken in this study were in accordance with the UK Animal Scientific
Procedures Act 1986 under project licence 40/3283.
3.3.2 Running wheels
Each wheel (4.5 inches in diameter) was tightly fixed to the internal side of the
cage lid facing the cage bottom. A small circular magnet was then mounted on
the top of the wheel. A cycle computer was attached to the side of the cage lid
with its sensor directed at a distance of < 1 cm to the magnet placed on the
wheel to count the number of the revolutions. Cycle computers were calibrated
according to the wheel size to calculate the running distance over the exercise
sessions. The wheel running equipment is illustrated in Fig. 3.1
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3.3.3 Experimental design
At the end of the acclimatization period, spatial memory was examined using
the spontaneous alternation test (SAT) in a T-maze. Based on performance in
the alternation test, mice were assigned to one of two groups (n = 10): running
and sedentary (non-exercising), to ensure equal baseline alternation
performance. Mice underwent a series of daily 1-hour voluntary wheel running
sessions, 5 days a week for 5 weeks, during which running distances were
automatically calculated using the cycle computers. It was reported that this
exercise protocol but using treadmills improved hippocampal neurogenesis and
memory performance (Chang et al., 2008; Liu et al., 2009). Sedentary mice
were given access to static wheels. After the completion of the exercise
Figure 3.1 Voluntary wheel running apparatus. For each 1-hour running session,
the lid of a mouse cage was replaced with another fitted with a running wheel
and a cycle computer. The number of wheel revolutions was recorded by the
cycle computer attached to the side of the cage lid. The distance run was
calculated automatically by the cycle computer according to the wheels
diameter and number of revolutions. Each sedentary mouse had access to a static
wheel during the exercise sessions. All mice had access to food and water during
the exercise session.
Sensor
Water
Food pellets
Wheel
Cycle computer
Magnet
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regimen, mice were re-tested in the SAT, novel object recognition test (NORT)
and object location test (OLT). Methodological details of memory tests are
given in Chapter 2-Part 2. On the termination day, mice had their final running
session immediately before being culled. Trunk blood was collected and plasma
was kept at -80qC for measuring corticosterone levels. The timeline of the
experiment is illustrated in Fig. 3.2
3.3.4 Plasma corticosterone levels (ng/ml)
Circulating corticosterone levels were determined using a commercial ELISA
kit. Details are given in Chapter 2-Part 1.
3.3.5 Statistical analysis
For the exercise group, paired sample t-tests were used to compare the average
running distances of mice for each of the 5 weeks to the level of running
activity recorded during the prior week. Two-way ANOVAs with repeated
Figure 3.2 The timeline of the experiment. After acclimatization, mice
underwent 5 weeks of repeated 1hour/day voluntary wheel running sessions (5
days a week). Mice were then subjected to the spontaneous alternation test
(SAT), habituation (H) session in the open field arena, novel object recognition
test (NORT) and object location test (OLT). On Day 49, mice were sacrificed
immediately after the final running session.
Repeated 1-hour voluntary
wheel running sessions
Acclimatization Week1 Week2 Week3 Week4 Week5 Week6/Memory
Final running session
Trunk blood collected
HSAT OLTSAT NORT
43 44 45Day 0 4 7 14 21 28 35 42 49
Chapter 3(i): Effects of repeated 1-hour voluntary wheel running sessions on
HPA axis and memory in mice
134
measures were used to analyse BW, percentage of correct alternation in the
SAT (time X group) and total exploration times (trial X group) in the NORT
and OLT. Groups (2 levels, sedentary and running) were the between subject
factor, and timeBW (7 levels, weeks), timeSAT (2 levels, before and after running)
or trialNORT, OLT (2 levels, acquisition and retention) was the within subject
factor. Paired sample t-tests were used to compare the exploration times
between the familiar and novel objects, and between the non-displaced and
displaced objects. Unpaired t-tests were used to analyse plasma corticosterone
levels, total distance travelled and anxiety-related behaviour during the
habituation session prior to the object memory tests, recognition index (RI) and
location index (LI). The percentage of correct alternation, RI and LI were also
compared to 50 % (lack of discrimination) using one sample t-tests. The
Pearsons correlation coefficient was used to analyse correlations between
running distances of mice over 5 weeks and memory performance or running
distances of mice during the final session and their plasma corticosterone levels.
'DWD DUH SUHVHQWHG DV PHDQ  6(0 DQG VLJQLILFDQFH ZDV UHDFKHG ZKHQ 3 
0.05.
3.4 Results
3.4.1 Running distance (km)
Paired sample t-tests revealed a significant increase in the distance run by mice
over the 5 weeks of exercise, which reflected the gradual development and
maintenance of running behaviour. Mice ran only 0.143 km per 1-hour session
on average during the first week, but they reached a maximum average running
distance of ~ 0.88 km per 1-hour session by the end of the fifth week, Fig 3.3.
Also, there was no significant difference in the running performance of mice
before sacrifice (around 0.81 km) compared to their average running distance
during the fifth week. Moreover, body weights of running mice were not
significantly different from those of sedentary mice over the entire study (F(1,18)
= 0.23, P = 0.64). There was also no significant main effect of week X group
interaction (F(6,108) = 1.16, P = 0.34), but there was a significant time effect
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(F(6,108) = 67.07, P <0.001), which reflects the normal increase in BW of mice
over time.
3.4.2 Plasma corticosterone levels (ng/ml)
There was a significant rise in circulating corticosterone levels of running mice
compared to sedentary mice (the unpaired t-test: t(18) = 6.03, P = 0.000011) after
the last running session, Fig 3.4. Also, there was no correlation (n = 10, r =
0.33, P = 0.35) between running distances (km) of mice during the final
exercise session and their plasma corticosterone levels (ng/ml).
3.4.3 Spontaneous alternation
The two-way ANOVA with repeated measures showed no significant main
effects of groups (F(1,18) = 4.11, P = 0.058), time (F(1,18) = 0.05 , P = 0.83) and
time X group interaction (F(1,18) = 1.24, P = 0.28) on spatial alternation
performance. The averaged performance of both sedentary and running groups
did not differ from 50 % (chance) during acclimatization, but sedentary mice
improved their spontaneous alternation performance after the second alternation
test as indicated by one sample t-tests (t = 3.87, P = 0.004), Fig 3.5.
3.4.4 Locomotor activity and anxiety-like behaviour in the open field
Unpaired t-tests revealed no significant alterations in locomotor activity and
measures of anxiety-related behaviour between the sedentary and running
groups. Data are presented in table 3.1
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3.4.5 The novel object recognition test
For the total exploration times, the two-way ANOVA with repeated measures
showed no significant main effects of groups (F(1,18) = 2.23 , P = 0.15), trial
(F(1,18) = 0.05 , P = 0.82) and trial X group interaction (F(1,18) = 0.45 , P = 0.51),
but there was a significant object effect during the retention trial (F(1,18) = 22.56,
P <0.001). Post-hoc paired sample t-tests revealed that mice significantly
preferred the novel over the familiar object in both sedentary (t = 2.45, P =
0.037) and running (t = 4.17, P = 0.002) groups, table 3.2. One sample t-tests
Groups
Measures
Sedentary Running
Unpaired t-tests
Distance travelled (m) 90.97 ± 3.22 96.17 ± 4.85 t(18) = 0.89, P = 0.38
% Distance in the centre
relative to total
11.75 ± 0.53 10.84 ± 0.38 t(18) = 1.40, P = 0.18
% Time spent in the
centre relative to total
9.31 ± 0.84 8.02 ± 0.71 t(18) = 1.17, P = 0.26
Defecation number 6.80 ± 0.61 5.90 ± 0.86 t(18) = 0.85, P = 0.41
Table 3.1 Locomotor activity and anxiety-related behaviour of sedentary and
running groups (n = 10 mice) in the open field 24 hours before the novel object
recognition test. Data are presented as mean ± SEM. Unpaired t-tests indicated
that repeated 1-hour voluntary running sessions did not affect motor activity and
anxiety-like behaviour.
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confirmed that RIs of sedentary (t = 2.51, P = 0.033) and exercising (t = 5.95, P
= 0.0002) mice were significantly different from 50% (lack of discrimination),
Fig. 3.6A. There was no difference in RIs between the two groups (t(18) = 1.44,
P = 0.17). Interestingly, there was a significant negative correlation between RIs
and running distances during the last 4 weeks of exercise in the running group:
week2 (r = - 0.75, P = 0.013), week3 (r = - 0.83, P = 0.003), week4 (r = - 0.72,
P = 0.02) and week5 (r = - 0.79, P = 0.007).
3.4.6 The object location test
The two-way ANOVA with repeated measures revealed no differences between
sedentary and running groups for the total exploration times during the
acquisition and retention trials (F(1,18) = 0.64, P = 0.43). Also, there were no
significant main effects of trials (F(1,18) = 0.38, P = 0.54) and trial X group
interaction (F(1,18) = 1.42, P = 0.25). Moreover, the two-way ANOVA indicated
no significant effects of object displacement (F(1,18) = 1.11, P = 0.31), trial X
object interaction (F(1,18) = 3.54, P = 0.076) or object X group interaction (F(1,18)
= 1.17, P = 0.29), table 3.2. No differences in LIs were found between groups
(t(18) = 0.73, P = 0.47) and the LIs of both groups were not significantly
different from 50 % (no discrimination), although running mice (t = 1.96, P =
0.082) tended to perform better than the sedentary (t = 1.03, P = 0.33), Fig.
3.6B.
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Groups
Memory tests
Trials Objects
Sedentary Running
Acquisition Single 52.20 ± 4.91 64.00 ± 9.32
Familiar 20.25 ± 2.01 24.95 ± 3.76
Novel 28.40* ± 3.44 40.80** ± 6.06
N
o
v
el
o
b
je
ct
re
co
g
n
it
io
n
Retention
Total
a
48.65 ± 4.54 65.75 ± 9.34
Object A1 26.90 ± 3.69 27.25 ± 4.74
Object A2 24.55 ± 2.82 27.40 ± 4.02Acquisition
Total
b
51.45 ± 5.93 54.65 ± 8.24
Non-displaced 21.75 ± 2.43 24.40 ± 3.63
Displaced 24.00 ± 1.62 32.05 ± 5.17
N
o
v
el
o
b
je
ct
lo
ca
ti
o
n
Retention
Total
c
45.75 ± 2.86 56.45 ± 7.66
Table 3.2 Exploration times (sec) during the novel object recognition and
location memory tests. Data are presented as mean ± SEM (n = 10 mice/group).
A1 (non-displaced object), A2 (object to be displaced), a (familiar + novel), b
(object A1 + object A2), c (non-displaced + displaced). Paired sample t-tests: *P
<0.05 and **P <0.01 compared to the familiar object.
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Figure 3.3 Mean running distances (km) of exercising mice (n = 10). Male
C57BL/6J mice increased their running distances over the 5 weeks of repeated 1-
hour/day (5 days/week) voluntary wheel running sessions. Data are expressed as
mean ± SEM. Paired sample t-tests: **P <0.01 and ***P <0.001 compared to the
prior week. The average running distances of mice was not significantly different
between the fifth week and the final session.
Development and maintenance of running behaviour
in the exercising mice
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Figure 3.4 Plasma corticosterone levels (ng/ml). After the final running
session, mice (n = 10 / group) were immediately sacrificed and trunk blood
was collected to investigate effects of repeated 1-hour voluntary wheel running
sessions on HPA axis function. Data are presented as mean ± SEM. The
unpaired t-test revealed a significant corticosterone rise in the running group:
***P <0.001 compared to sedentary.
Plasma corticosterone levels
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Figure 3.5 The spontaneous alternation performance in the T-maze. Sedentary
and running mice (n = 10 / group) underwent the spontaneous alternation test
before and after the 5 weeks of repeated 1-hour voluntary wheel running
sessions. Data are expressed as mean ± SEM. One sample t-tests: **P <0.01
compared to 50 % (chance).
Percentage of correct alternations in the T-maze
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Figure 3.6 The object memory tests. (A) Recognition Index. (B) Location
index. Data of sedentary and running mice (n = 10 / group) are presented as
mean ± SEM. One sample t-tests: *P <0.05 and ***P <0.001 compared to 50 %
(no discrimination).
The novel object recognition and location memory
performance
A
B
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3.5 Discussion
The present study confirmed that repeated 1-hour voluntary wheel running
sessions motivated mice to run more over the course of 5 weeks and this was
not accompanied with a habituation of exercise-induced elevation of
corticosterone levels. Whereas sedentary mice exhibited an improvement in the
spontaneous alternation performance by the end of the experiment, both
sedentary and running groups did not effectively acquire the object location
task. In contrast, recognition memory was intact in both groups.
These results emphasize that wheel running is a motivated behaviour, as mice
kept increasing their running performance over consecutive limited (1-hour)
running sessions, consistent with previous work showing that wheel running is
reinforcing and rewarding (Iversen, 1993; Belke and Wagner, 2005).
Furthermore, it is believed that wheel running is a spontaneous behaviour which
increases with experience and, therefore, animals do not habituate to wheel
running (Lett et al., 2001; Cosgrove et al., 2002).
These results also showed that exercising mice exhibited a significant increase
in plasma corticosterone levels after the final running session, which was
undertaken 10 days after a 5-week exercise regimen. This is in agreement with
previous work which demonstrated that C57 mice had high corticosterone levels
after 4 weeks of continuous wheel running (Droste et al., 2003). Likewise,
chronic running increased the weight of adrenal glands and decreased thymus
weight of exercising mice (Droste et al., 2003), indicating corticosterone
elevation. In contrast, rats exercising for 5 weeks in the wheel exhibited
enhancement of circadian corticosterone levels after the first and second week,
but there was a gradual decline in the elevated corticosterone levels so that
further running no longer increased corticosterone levels compared to the
sedentary group (Fediuc et al., 2006). Both sedentary and exercising rats had
similar GR levels in the hippocampus and anterior pituitary (Fediuc et al.,
2006), reflecting HPA axis adaptation. Nevertheless, in running animals, HPA
axis responses to novel stressors such as restraint stress, new environments and
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forced swimming were maintained (Droste et al., 2003; Fediuc et al., 2006). In
fact, diminished HPA axis responsiveness with chronic exercise was indicated
by the increment of corticosterone levels but low levels of ACTH in exercising
animals in response to the previously mentioned stressors compared to
sedentary animals (Droste et al., 2003; Fediuc et al., 2006). Also, C57BL/6J
mice exercising for 2 weeks exhibited increased plasma corticosterone levels
without a comparable increase in ACTH levels. This was, however,
accompanied by a significant rise in mRNA expression for adrenal
steroidogenic acute regulatory protein and tyrosine hydroxylase, both of which
are directly or indirectly involved in corticosterone synthesis (Otawa et al.,
2007). In the present study, running mice did not develop HPA axis adaptation
in response to long-term intermittent exercise-induced corticosterone elevation,
suggesting that running mice were exposed to high corticosterone levels until
the last session.
Mice did not show differences in their locomotor activity and anxiety-like
behaviour during the 30-minute habituation session which was carried out 24
hours prior to the novel object recognition test. This eliminates the possibility
that effects on memory performance were secondary to motor or emotional
variability between groups. Interestingly, only sedentary mice showed an
improvement in spontaneous alternation performance. As stated earlier,
sedentary mice were left to explore the static wheels during the exercise
sessions, but running mice had the opportunity to run in the wheels and explore
them during the running session. This suggests that exploration behaviour
without running enhanced spontaneous alternation performance, reflecting
spatial memory improvement. In the object location test, however, neither
sedentary nor running groups were able to discriminate the displaced object
during the retention trial, which was carried out 1 hour after the acquisition trial.
Although the LI of the running group was slightly higher than the LI of the
sedentary group, the LIs of both groups did not significantly differ from 50 %
(no discrimination). It was found that mice demonstrated a significant
preference for the displaced object, when the inter-trial interval between the
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acquisition and retention trials was not more than 2 hours (Murai et al., 2007).
The inability of mice in this study to spend more time exploring the displaced
objects could be method-related. For example, the lack of significant extra-field
cues was found to disrupt the ability of mice to discriminate the displaced object
(Murai et al., 2007). In contrast, the arrangement of objects in the arena and the
entry position of a mouse into the arena were not critical for the optimum
performance (Murai et al., 2007). Mice were also examined in the novel object
recognition test, in which both groups spent more time exploring the novel
object than the familiar object. The RIs of both sedentary and running mice
were significantly higher than 50%, and there was no significant difference in
performance between the two groups, although running mice tended to
outperform sedentary mice. In agreement with these results, it was found that
short-term (13 days) unlimited wheel running improved recognition memory
and enhanced neurogenesis and BDNF levels in the hippocampus of mice
(Lafenetre et al., 2010). A recent study indicated that metyrapone-treated or
adrenalectomized rats did not exhibit spatial memory enhancements induced by
wheel running (10 days) in saline-treated and sham-operated rats (Hajisoltani et
al., 2011), suggesting the involvement of exercise-induced corticosterone rise in
the cognition-enhancing effects of short-term exercise.
The lack of statistical differences in the cognitive performance between running
and non-running mice could be explained as follows. First, sedentary mice had
access to a static wheel during the exercise sessions, and this probably provided
mice with some forms of environmental enrichment which was reported to
improve memory and hippocampal neurogenesis (Kempermann et al., 1997;
Bennett et al., 2006). Previously, it was reported that mice housed with static
wheels exhibited enhancement of their cognitive performance (Pietropaolo et
al., 2006; Nichol et al., 2007). This suggests that the cognitive effects generated
by wheel exploration were almost equal to those produced by the limited
duration of wheel running. Therefore in the experiment described in Chapter 4,
a no-wheel group was added to investigate the cognitive effects of wheel
exploration. Second, repeated 1-hour running sessions could be insufficient to
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show enhancements of cognitive performance compared to sedentary mice,
despite the elevated plasma corticosterone levels of the running group. Thus, it
can be suggested that short 1-hour wheel running sessions were sufficient to
increase corticosterone levels, but they were insufficient for other exercise-
related effects on cognition to take place. For instance, exercise was found to
increase BDNF mRNA and protein levels in the hippocampus of rats and mice
after having unlimited access to wheel running or during the dark phase (Neeper
et al., 1995; Oliff et al., 1998; Lafenetre et al., 2010). In agreement with this,
rats having unlimited access (24 hours) to wheel running for only 5 days
showed enhanced spatial memory performance (Ebrahimi et al., 2010), and also
running for 4 days at night ameliorated spatial memory impairment in rats
(Shaw et al., 2003). Thirdly, rats running as short a distance as 0.1 km per night
reversed spatial memory deficits (Shaw et al., 2003), suggesting that little
exercise but in the dark/active phase is more beneficial for cognitive
performance than in the light/inactive phase despite corticosterone elevation.
However in the present study, 1-hour access to wheel running in the light phase
was a priority in this work to avoid confounding effects of circadian
corticosterone peaks in the dark phase and to prevent chronic exercise-induced
HPA axis adaptation. Also, it was necessary to keep corticosterone levels at
high values in the running group to study whether corticosterone is implicated
in the rewarding/cognitive effects of chronic wheel running. As described in
Chapter 4, pharmacological interventions were used to test this hypothesis and
short running sessions were necessary for the optimum effects of the drugs
used, and to avoid injecting animals more than once daily. In addition, it was
suggested that short exercise sessions would allow clear accurate assessment of
drugs effects on running performance of mice. As stated earlier, it has been
reported that 1-2 hours of voluntary wheel running is rewarding and reinforcing
(Belke and Wagner, 2005), and, therefore, 1-hour wheel running per day is
believed to be rewarding.
Finally, running mice showed extensive running performance over the last three
weeks of exercise as a result of limited access to wheel running. Subsequently,
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running mice showed no improvement in their spontaneous alternation
performance, and their RIs were inversely proportional to average running
distances on most weeks of exercise, suggesting that exercise-induced
corticosterone release was indeed linked to cognitive performance. In
agreement with this, high-running rats showed recognition memory deficits but
low-running rats exhibited improvement in memory performance, as compared
to the sedentary group (Garcia-Capdevila et al., 2009).
To summarize, mice showed a great tendency to increase their running
performance over repeated 1-hour exercise sessions. Also, five weeks of
repeated 1-hour voluntary wheel running sessions induced plasma
corticosterone elevation after the final running session. Although chronic
intermittent wheel running did not improve spontaneous alternation
performance, it did not impair recognition memory despite the negative
correlation between running distances and memory performance. Lastly, a no-
wheel group was added to the study described in Chapter 4 to investigate
whether exploration of the wheel without running improves learning and
memory of sedentary mice.
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Chapter 3  Part 2
The corticosterone synthesis inhibitor metyrapone
attenuates rewarding effects of voluntary wheel running
through decreasing the exercise-induced elevation in
corticosterone levels in trained mice
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3.6 Aims
Metyrapone is a corticosterone synthesis inhibitor which suppresses the
conversion of 11-desoxycorticosterone to corticosterone via the inhibition of 11
E-steroid hydroxylase (Jenkins et al., 1958; Akirav et al., 2004), and it has been
used to investigate the role of corticosterone in the development of drug
dependence (Piazza et al., 1994). It is, therefore, suitable for the investigation of
the role of corticosterone in the motivation of mice for wheel running. The aim
of this pilot study was to demonstrate that a single 1-hour voluntary wheel
running session is sufficient to elevate plasma corticosterone levels in trained
mice and to determine whether rewarding effects of wheel running are
dependent on exercise-induced elevation in plasma corticosterone. We
hypothesised that metyrapone would attenuate the running performance of
mice, if corticosterone is involved in the rewarding effects of wheel running.
3.7 Materials and methods
3.7.1 Animals
Thirty two 6-8 week old male C57BL/6J mice were purchased from Charles
River UK. They were individually housed and kept undisturbed for a week to
acclimatize to the animal facility. Mice were kept under standard environmental
conditions of temperature (20  22 qC), humidity (55  60 %), ventilation and
12:12 light dark cycle (lights on at 7:00 am) throughout the experiment. Food
and water were available ad libitum. Body weight (BW) of mice was recorded
weekly. All procedures undertaken in this experiment were in compliance with
the UK Animal Scientific Procedures Act 1986 under project licence 40/3283.
3.7.2 Metyrapone
Metyrapone, 2-Methyl-1,2-di-3-pyridyl-1-propanone, (Sigma-Aldrich UK) was
dissolved in saline immediately before use. Mice were injected with metyrapone
(35 mg/kg, i.p.) 30 minutes before the challenge running session. This dose was
previously found to significantly block corticosterone elevation induced by
electric footshocks in mice (Chauveau et al., 2010).
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3.7.3 Experimental design
Mice underwent a daily 1 hour-running session (5 days a week) until they met
running criteria; showing motivation to run for 3 consecutive sessions with a
total running distance over 0.3 km, to be assigned to running groups. On the
challenge day, mice were divided into 3 groups: saline-treated sedentary (Sed-
Sal, n = 11), and running (Run-Sal, n = 9) and metyrapone-treated running
(Run-Met, n = 12). Metyrapone (35 mg/kg) or saline was intraperitoneally
injected 30 minutes before the challenge session. Sedentary mice were offered a
static wheel during the challenge session. Immediately after the challenge
session, mice were sacrificed by cervical dislocation and trunk blood was
collected and kept at -80 qC for further analysis of plasma corticosterone levels.
The experimental timeline is described in Fig. 3.7
3.7.4 Plasma corticosterone levels (ng/ml)
A commercial ELISA kit was used to measure plasma corticosterone levels;
details are provided in Chapter 2-Part 1.
Figure 3.7 The experimental design. Mice were trained to meet the running
criteria. On the challenge day, mice had a 1-hour voluntary wheel running
session 30 minutes after saline or metyrapone treatment. Simultaneously, each
sedentary mouse had access to a static wheel.
Running distance
over 0.3 km /session
Habituation to
running wheels
Wheel running
Challenge dayTraining
Trunk blood
collected
Metyrapone
(35 mg/kg)
or saline i.p.
Motivation to run
Day 1 Day 2 Day 3
60 min30 min
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3.7.5 Statistical analysis
Running distances were analysed using a two-way ANOVA with repeated
measures with treatment (2 levels, saline or metyrapone) as the between subject
factor, and training time (3 levels, days) as the within subject factor. Post-hoc
paired sample t-tests were used to analyse the motivation of mice to increase
their running distances over the 3 day training period versus the first training
session after reaching the criterion of over 0.3 km per session. Also, paired
sample t-tests were used to analyse differences in the running distances between
the last training day and the treatment day. Running distances during the
challenge session, plasma corticosterone levels and BW were analysed using
unpaired t-tests. The Pearsons correlation coefficient was used to analyse the
relationship between plasma corticosterone levels of exercising mice and their
running distances on the challenge day. An effect was considered significant
ZKHQWKH3YDOXHZDV
3.8 Results
3.8.1 Running activity (km)
Data showed that saline-treated mice ran ~ 0.6 km during the 1-hour challenge
session on average and this level of exercise increased plasma corticosterone
levels (83.98 ng/ml ± 6.46) compared to sedentary mice (58.77 ng/ml ± 5.72).
In contrast, the mean running distance of metyrapone-treated mice was 0.37 km
during the acute session and this was accompanied by a lack of elevation in
corticosterone levels (65.41 ng/ml ± 4.87) compared to saline-treated exercising
mice. The two-way ANOVA with repeated measures showed neither significant
main effects of groups (F(1,19) = 0.85, P = 0.37) nor time X group interaction
(F(2,38) = 0.72, P = 0.49), but there was a significant time effect (F(2,38) = 6.91, P
= 0.003) which indicates the increase in running performance over training
days. Post-hoc paired sample t-tests showed a significant increase in the
distances run by saline-treated mice during the last training session compared to
the first one (t = 3.26, P = 0.012), Fig. 3.8. During the challenge session, there
was a decrease in the distances run by metyrapone-treated mice compared to
saline-treated mice (t(19) = 2.44, P = 0.025), Fig. 3.8. Moreover, paired sample t-
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tests indicated that metyrapone-treated mice ran significantly less during the
challenge session than during the last training session (t = 2.98, P = 0.012), Fig
3.8. Finally, unpaired t-tests revealed no differences in BW between saline-
treated sedentary and running mice (t(18) = 0.12, P = 0.91) and between saline
and metyrapone treated running mice (t(19) = 1.47, P = 0.16).
3.8.2 Plasma corticosterone levels (ng/ml)
Results revealed that a 1-hour voluntary wheel running session significantly
increased plasma corticosterone levels in saline-treated exercising mice
compared to sedentary mice (t(18) = 2.92, P = 0.009), Fig 3.9. By contrast,
metyrapone treatment attenuated the exercise-induced corticosterone rise
compared to saline-treated running mice (t(19) = 2.34, P = 0.030), Fig 3.9.
3.8.3 Correlations
There was a positive correlation between the running distances of all exercising
mice during the challenge session and their plasma levels of corticosterone (n =
21, r = 0.375, P = 0.047), Fig. 3.10
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Figure 3.8 Running distances (km) in the wheel during 1-hour voluntary
exercise sessions: training (Day1 to Day3) and challenge. Development of
running performance in male C57BL/6J mice over the three days of training and
effects of treatment with saline (n = 9) or metyrapone (n = 12) on running
activity during the challenge session. Data are expressed as mean ± SEM. Paired
sample t-tests:
$
P <0.05 compared to Run-Sal (Day1) and
#
P <0.05 compared to
Run-Met (Day3). Unpaired t-tests: *P <0.05 compared to Run-Sal.
Running activity during training and challenge
Challenge3 day training (no treatment)
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Figure 3.9 Plasma corticosterone levels (ng/ml). Data are expressed as mean ±
SEM (n = 9-12 mice /group). Unpaired t-tests: **P <0.01 compared to Sed-Sal,
#
P <0.05 compared to Run-Sal.
Plasma corticosterone levels
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Figure 3.10 The positive correlation (n = 21, Pearsons r = 0.375, P = 0.047)
between running distances (km) of mice during the challenge session and their
plasma corticosterone levels (ng/ml) at the end of the session.
Correlation between plasma corticosterone levels and
running distances during the challenge session
0
20
40
60
80
100
120
140
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
Running distances (km)
P
la
sm
a
co
rt
ic
o
st
er
o
n
e
le
v
el
s
(n
g
/m
l)
Chapter 3(ii): Metyrapone (corticosterone synthesis inhibitor) attenuates
voluntary wheel running performance
156
3.9 Discussion
The present experiment demonstrates that a single 1-hour voluntary wheel
running session is sufficient to increase plasma corticosterone levels of trained
mice compared to sedentary mice. In contrast, metyrapone prevented the
exercise-induced increase in corticosterone levels, and attenuated the motivation
of mice to run during the challenge session. Consistent with our results, one or
two weeks of unlimited voluntary wheel running resulted in an increase in
circadian corticosterone peaks in rats (Fediuc et al., 2006) and C57 mice
(Otawa et al., 2007), respectively. These findings suggest that corticosterone is
involved in the rewarding effects of voluntary wheel running. It is well
established that metyrapone prevents rise in circulating corticosterone levels via
inhibition of 11 E-steroid hydroxylase in the adrenal cortex which converts 11-
desoxycorticosterone to corticosterone (Jenkins et al., 1958).
Mice underwent a series of training sessions until they met the suggested
criteria: running distance over 0.3 km per 1-hour session for 3 consecutive
sessions. These criteria were derived from the chronic pilot study, Chapter 3-
Part I, which showed that once mice ran over 0.3 km per 1-hour session, they
kept increasing their running performance over the following sessions.
Although most mice in the chronic pilot study required 1-2 weeks to achieve the
training criteria, a few mice in this study were absolutely unwilling to exercise
even after weeks of access to wheel running equipment and were allocated to
the sedentary group. In contrast, mice and rats were successfully bred to exhibit
great tendency to exercise spontaneously in the running wheels (Swallow et al.,
1998; Naylor et al., 2005). For example, female Hsd:ICR mice demonstrated an
increased tendency for wheel running and a greater exercise-induced rise in
corticosterone levels than male counterparts (Coleman et al., 1998). However,
male mice were used in the present study to avoid confounding effects of the
oestrous cycle which was previously found to influence running activity (Girard
and Garland, 2002). Nevertheless, C57BL/6J mice, which were used in the
present study, possess a natural tendency to run in the wheel (Brene et al.,
2007). In the present study, training was, however, necessary to ensure that
mice in the exercising groups were sufficiently motivated to run during the
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short challenge session in order to elevate plasma corticosterone levels in the
control group, and to exclude the possibility that metyrapone-treated mice did
not run because of a lack of motivation. Interestingly, rats having unlimited
access to a running wheel for 5 weeks demonstrated the highest running
distances during the fifth week of exercise, but this exercise level no longer
increased corticosterone levels (Fediuc et al., 2006). This suggests that
corticosterone is involved in the acquisition of wheel running but its role in
maintaining running levels is unclear. In contrast, other work including the
present study showed that running mice had high corticosterone levels even
after 4 weeks of wheel running (Droste et al., 2003).
Our results also showed that there was a correlation between the running
distances of all exercising mice and their plasma corticosterone levels after the
challenge session, suggesting that the increase in corticosterone levels of
running mice was dependent on their running distances during the challenge
session, or that mice increased their running distances to enhance the secretion
of the rewarding hormone. In agreement with this, it was previously found that
plasma corticosterone levels were directly proportional to the number of wheel
revolutions during the 20 minute wheel running prior to blood sampling (Girard
and Garland, 2002).
It has been reported that corticosterone elevation increases motor activity. For
example, adrenalectomy was found to attenuate amphetamine-induced
locomotor hyperactivity in rats (Cador et al., 1993), and to decrease the
exploratory activity of rats in the open field (Veldhuis et al., 1982). Similarly,
metyrapone-treated and adrenalectomized rats having unlimited access to wheel
running for 10 days tended to run less and exhibited a significant decrease in
their running distances during the last two days of wheel running compared
with vehicle-treated and sham-operated running rats, respectively (Hajisoltani et
al., 2011). On the other hand, some work suggests that metyrapone has a direct
non glucocorticoid-dependent central effect. In a study using metyrapone at a
high dose (150 mg/kg), rats showed a rapid (1-3 min) decrease of their motor
activity in the actimeter (Canini et al., 2009), and it was found that the fastest
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glucocorticoid- mediated genomic effects required at least 15 minutes (Hallahan
et al., 1973). On the contrary, metyrapone treatment and adrenalectomy had
similar influences on the wheel running performance of rats (Hajisoltani et al.,
2011), and this provides some evidence that metyrapone decreased running
distances of mice as a result of lowering corticosterone synthesis, rather than
acting centrally.
In summary, metyrapone attenuated the rewarding effects of a single 1-hour
voluntary wheel running session in trained mice in conjunction with a decrease
in plasma corticosterone levels. However, more work is required to determine
whether corticosterone mediated these effects through non transcriptional
actions.
Chapter 3: General conclusion
159
General conclusion
Results of this chapter suggest that single and repeated 1-hour voluntary wheel
running sessions activated HPA axis and increased plasma corticosterone levels.
Moreover, metyrapone attenuated running performance of mice compared to
saline-treated group via the inhibition of exercise-induced corticosterone rise,
and there was a positive correlation between running distances of mice and their
plasma corticosterone levels during the challenge session. Overall, this indicates
that corticosterone is involved in the rewarding effects of voluntary wheel
running. Furthermore, the exercise regimen used in this study did not improve
spontaneous alternation performance and spatial memory of running mice in the
novel object location test, compared to sedentary mice.
It is, however, interesting to understand how corticosterone could mediate
rewarding and/or cognitive effects of wheel running. As a result of repeated
voluntary wheel running, corticosterone levels were repeatedly and transiently
elevated, and this probably contributed to rewarding/cognitive effects of
exercise. As mentioned previously, MRs and GRs are highly expressed in the
brain particularly the hippocampus (Reul and de Kloet, 1985), and therefore, the
hippocampus is vulnerable to fluctuation in corticosterone levels (Diamond et
al., 1992). Thus, it is suggested that repeated fluctuations of corticosterone
levels in response to intermittent running probably contribute to its rewarding
effects, and expectedly imposes long-term effects on learning and memory of
running mice, in particular hippocampus-dependent memory such as spatial and
recognition memory (O'Keefe and Dostrovsky, 1971; Clark et al., 2000;
Broadbent et al., 2004). Most importantly, a number of studies showed that GRs
are essential for drug seeking behaviour (Fiancette et al., 2010) and
corticosterone was only self-administered at high doses which produced high
plasma corticosterone levels, required to activate GRs (Reul and de Kloet, 1985;
Piazza et al., 1993), and Chapter II. This suggests that GRs are a potential target
to study mechanisms underlying corticosterone involvement in the rewarding
and cognitive effects of voluntary wheel running. It is also important to
investigate whether dopamine, which is the major reward neurotransmitter in
the brain (Wise and Rompre, 1989; Wise, 2009), is involved in the
rewarding/cognitive effects of voluntary wheel running. Chronic wheel running
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has been reported to produce plasticity changes in the mesolimbic reward
pathway, such as reduced mRNA expression for dopamine D2 receptors in the
nucleus accumbens core of rats (Greenwood et al., 2011). Altogether, this
suggests that dopamine and/or corticosterone via GRs play a role in exercise-
related reward and memory enhancing effects, in particular if cognitive effects
of exercise depend on its rewarding properties.
As described in Chapter 4, a study was therefore carried out to investigate
whether GRs and/or D2 receptors mediate the cognitive effects of voluntary
wheel running via its rewarding effects. In an attempt to make effects of this
exercise protocol on memory stand out, one more control group was added to
the study in which mice had no access to running wheels in order to examine
the influence of wheel exploration on memory.
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Chapter 4
Glucocorticoid and dopamine D2 receptors: Are they
involved in the rewarding and cognitive effects of the
repeated 1-hour voluntary wheel running sessions?
4.1 Introduction
Voluntary wheel running is rewarding to mice (Brene et al., 2007), elevates
plasma corticosterone levels (Droste et al., 2003) and is reported to enhance
learning and memory performance (van Praag et al., 1999; Lafenetre et al.,
2010; Hajisoltani et al., 2011). In agreement with this, the two pilot studies
described in Chapter 3 demonstrated that single and repeated 1-hour voluntary
wheel running sessions evoked corticosterone elevation. Also, mice were
motivated to run and continued to increase their running performance over 5
weeks of the repeated 1-hour wheel running sessions, Chapter 3-Part 1. On the
other hand, repeated exercise sessions did not improve alternation rates or
recognition memory performance of exercising mice compared to sedentary
mice. Instead, there was a negative correlation between running distances of
mice and their recognition indices. Also, results of the pilot study, Chapter 3-
Part 2, showed that metyrapone, a corticosterone synthesis inhibitor, decreased
the running activity of mice. Similarly, metyrapone attenuated the running
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performance of rats which had unlimited access to the wheel running for 10
days (Hajisoltani et al., 2011). Altogether, corticosterone is suggested to
modulate the rewarding and cognitive effects of repeated 1-hour voluntary
wheel running sessions.
Glucocorticoid receptors (GRs) are thought to mediate rewarding effects of
corticosterone. First, GRs have a 10-fold lower affinity for corticosterone than
mineralocorticoid receptors (MRs) (Reul and de Kloet, 1985), thus GRs are
mainly activated by high corticosterone levels of circadian corticosterone peaks
or elevations induced by stress. It has been thought that GRs are involved in the
rewarding effects of corticosterone, since corticosterone is self-administered at
levels comparable to those induced by stress (Piazza et al., 1993).
A considerable body of research suggests that corticosterone is critical for
cognitive performance (Belanoff et al., 2001b; Akirav et al., 2004), since GRs
are widely expressed in the brain particularly the hippocampus, suggesting a
possible role of GRs in the cognitive effects of repeated exercise-induced
corticosterone elevation. Thus, GRs represent a potential target to examine
whether corticosterone elevation mediates the rewarding and/or cognitive
effects of voluntary wheel running. Mifepristone (RU-38486) was the first
synthetic GR antagonist (Bertagna et al., 1984), which also has antiprogestin
activity (Cadepond et al., 1997; Niinimaki et al., 2009). Mifepristone has been
shown to attenuate self-administration of cocaine in rats and mice (Deroche-
Gamonet et al., 2003; Fiancette et al., 2010) and to impair the expression of
CPP to morphine in rats (Dong et al., 2006), reinforcing the hypothesis that
GRs mediate the rewarding effects of corticosterone.
It has been reported that dopamine levels in the nucleus accumbens increase in
response to natural reward (Hernandez and Hoebel, 1988; Damsma et al., 1992)
and abused drugs (Di Chiara and Imperato, 1988; Koob and Le Moal, 2008;
Volkow et al., 2011). Voluntary wheel running is a natural reward (Brene et al.,
2007) and is found to influence the mesolimbic dopamine pathway in a way
similar to addictive drugs (Werme et al., 2000; Werme et al., 2002b). For
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instance, long-term voluntary wheel running is accompanied by plasticity
changes in the mesolimbic reward pathway such as reduction of dopamine D2
receptors in the nucleus accumbens core (Greenwood et al., 2011), possibly via
exercise-enhanced dopamine release. Similarly, morphine-dependent rats
exhibited a low level of D2 receptors in the caudate-putamen and the nucleus
accumbens core (Georges et al., 1999). Dopamine D2 receptors have been
shown to have a significant involvement in the development of drug addiction
(Volkow et al., 2002). Moreover, D2 receptor blockade by sulpiride (a D2/D3
receptor antagonist) attenuates self-administration of muscimol (a GABA A
receptor agonist) and morphine (David et al., 2002; Gavello-Baudy et al.,
2008). In the present study, sulpiride was used to block dopamine D2 receptors
because it showed more selectivity on mesolimbic than nigrostriatal dopamine
pathways (White and Wang, 1983) and, therefore, the decrease in the running
performance would reflect the lack of motivation to run. Also, sulpiride in the
doses used in this study showed no inhibitory effects on spontaneous motor
activity (Simon et al., 2000; Hidaka et al., 2010).
4.2 Hypothesis
The present experiment used pharmacological approaches to test the hypothesis
that the rewarding and cognitive effects of repeated 1-hour/day voluntary wheel
running sessions are mediated via the activation of GRs and/or D2 receptors.
4.3 Materials and methods
4.3.1 Animals
Eighty three 6-8-week-old male C57BL/6J mice were purchased from Charles
River UK. Mice were individually housed and left undisturbed for a week to
acclimatize to the animal holding room. Standard environmental conditions of
temperature (20  22 qC), humidity (55  60 %), ventilation and 12:12
light/dark cycle (lights on at 7:00 am) were maintained throughout the
experiment. Mice had unlimited access to food and water. Body weights (BW)
of mice were recorded weekly at the time of cage cleaning. All experimental
Chapter 4: Mifepristone and sulpiride regulate rewarding and/or cognitive
effects of voluntary wheel running in mice
164
procedures and animal care were performed in accordance with the UK Animal
Scientific Procedures Act 1986 under project licence 40/3283.
4.3.2 Drugs
4.3.2.1 Mifepristone
Mifepristone (MIF, RU-38486) was purchased from Sigma-Aldrich UK and
kept at 2-8 qC. Immediately before use, MIF was freshly suspended in vehicle
A, 1% Tween 80 in saline (Mesripour et al., 2008), and sonicated for ~30 sec on
ice. MIF (30 mg/kg, i.p.) was injected 2 hours before the running sessions. The
chosen dose was reported to attenuate cocaine self-administration in C57BL/6J
mice (Fiancette et al., 2010). For the vehicle-treated group, vehicle A was also
sonicated for ~30 sec on ice.
4.3.2.2 (±)-Sulpiride
(±)-Sulpiride was bought from Sigma-Aldrich UK and freshly dissolved in
vehicle B (1 % acetic acid/saline) and the pH of the solution was then
neutralised to 7 by 1M NaOH. Sulpiride (25 or 50 mg/kg, i.p.) was injected 30
minutes before the running sessions. The sulpiride 50 mg/kg (Sul50) was
reported to reduce reinforcing properties of abused drugs such as morphine and
muscimol (a GABA A receptor agonist) in mice (David et al., 2002; Le Merrer
et al., 2007; Gavello-Baudy et al., 2008). The sulpiride 25 mg/kg (Sul25) was
previously used to examine the involvement of dopamine D2 receptors in the
rewarding food-induced locomotor hyperactivity (Le Merrer and Stephens,
2006).
4.3.3 Experimental design
The experimental timeline is described in Fig 4.1. After acclimatization, all
mice were subjected to a 2-week training phase of 1-hour/day (5 days/week)
voluntary wheel running sessions to ensure that they were motivated to use
wheels, and it was critical to verify that effects of drugs were not due to a lack
Chapter 4: Mifepristone and sulpiride regulate rewarding and/or cognitive
effects of voluntary wheel running in mice
165
of motivation to run. Based on the pilot studies described in Chapter 3, mice
were assigned to running groups if they ran over 0.3 km per 1-hour session for
three consecutive running sessions during the training period. After mice met
these criteria, their baseline memory performance was evaluated on Day 18 in
the spontaneous alternation test (SAT) using a T-maze. Mice were assigned to
two main groups, sedentary and running, and mice which demonstrated no
motivation to run during the training period were excluded from the running
groups. Mice were subdivided into 4 groups (n = 8-9): vehicle (A, n = 4-5 and
B, n = 4, i.p.), MIF (30 mg/kg, i.p), Sul25 (25 mg/kg, i.p.) and Sul50 (50 mg/kg,
i.p.). Each sedentary mouse had access to a static wheel during the running
session. One more running group was added in which mice were not injected to
assess injection-related stress on the running performance. A vehicle-treated no-
wheel group was added in which mice were not offered access to a static wheel
to evaluate the impact of this environmental enrichment on cognition. Mice
underwent 4 weeks of pharmacological treatment and running sessions. On
Days 49-52, mice were examined in the SAT, novel object recognition test
(NORT) and object location test (OLT); all methods are described in detail in
Chapter 2-Part2. On Day 56, mice were treated exactly as before the memory
tests and had their final running session. Immediately after, mice were
sacrificed, trunk blood was collected and plasma was kept at -80 qC for the
determination of plasma corticosterone levels.
4.3.4 Plasma corticosterone levels (ng/ml)
Circulating corticosterone levels were determined using a commercial ELISA
kit. Details are given in Chapter 2-Part 1.
4.3.5 Statistical analysis
Data are presented as mean ± SEM. Averaged running distances of the 4 treated
running groups during the last 3 days of the training phase (during which mice
ran over 0.3 km per 1-hour session) were used to analyse differences between
the pre-treatment running performance of mice and their running activity during
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each of the following 4 weeks of the treatment X exercise phase. Mice were
assigned to running groups according to their running and spontaneous
alternation performances during the training phase, to control for possible
confounding effects of variability in performance between the experimental
groups. Two-way ANOVAs with repeated measures; with group as the between
subject factor (4 levels) or (2 levels, non-injected and vehicle-treated groups)
and time as the within subject factor (5 levels, training and 4 weeks of
treatment), was used to analyse the running distances (km) of mice during the
repeated 1-hour voluntary wheel running sessions. The unpaired t-test was used
to analyse running distances of the non-injected and vehicle-treated running
groups during the final session. In addition, separate one way ANOVAs with
repeated measures were performed to demonstrate time effects of Sul25 or
Sul50 on repeated running sessions. A one way ANOVA was used to analyse
the running distances of mice during the final session prior to sacrifice, with
groups (4 levels) as the between subject factor.
Two-way ANOVAs were used to analyse plasma corticosterone levels, total
distance travelled, measures of anxiety-related behaviour during the habituation
session in the open field, recognition index (RI) and location index (LI), with
exercise (2 levels, sedentary and running) and groups (4 levels) as the between
subject factors. Three-way ANOVAs with repeated measures were used to
analyse the percentage of correct alternation, BW, and the total exploration
times during the novel object recognition and location memory tests, with
exercise (2 levels) and groups (4 levels) as the between subject factors, and
timeSAT (2 levels, before and after), timeBW (8 levels, weeks) or trials (2 levels,
acquisition and retention) as the within subject factor. Two-way ANOVAs with
repeated measures were used to analyse the total exploration times during
NORT and OLT, the percentage of correct alternation and BW, and unpaired t-
tests were used to analyse plasma corticosterone levels, RI and LI between the
vehicle-treated sedentary and no-wheel groups and between the non-injected
and vehicle-treated running groups. Post-hoc planned comparisons and paired
sample t-tests were used as required. Paired sample t-tests were also used to
compare the exploration times between the familiar and the novel objects and
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between the non-displaced and the displaced objects in each group. One sample
t-tests were used to compare the percentage of correct alternation, RI and LI to
50%. Pearsons correlations were calculated when required. An effect was
FRQVLGHUHGVLJQLILFDQWZKHQ3ZDV
Chapter 4: Mifepristone and sulpiride regulate rewarding and/or cognitive effects of voluntary wheel running in mice
168
C
h
a
p
ter
4
:
M
ifep
risto
n
e
a
n
d
su
lp
irid
e
reg
u
la
te
rew
a
rd
in
g
a
n
d
/o
r
co
g
n
itive
effe
cts
o
f
vo
lu
n
ta
ry
w
h
eel
ru
n
n
in
g
in
m
ice
1
6
8
Experimental design
Training
Drug treatment followed by a
1-hour running session
Final running session
prior to mice sacrifice
Week 4 Week 7 Week 8/Memory Week 9Week 5 Week 6Week 2 Week 3
SAT H NORT OLT
5649 50 51 52
Days
Acclimatization
0 187 21
Week 1
SAT
Figure 4.1 The experimental design. After one week of acclimatization, mice were trained over two weeks to meet the running
criteria (over 0.3 km per 1-hour session for 3 consecutive sessions). Then, mice (n = 8-9 / group) underwent 4 weeks (5 days/week)
of treatment with vehicle (A and B, i.p.), MIF (30 mg/kg, i.p.) or sulpiride (25 or 50 mg/kg, i.p.) followed by a 1-hour voluntary
wheel running session. Corresponding sedentary groups were treated exactly as running groups except that they had access to static
wheels during the exercise sessions. In week 8, mice were examined in the spontaneous alternation test (SAT), a 30-minute
habituation (H) session in the open field, the novel object recognition test (NORT) and the object location test (OLT). Prior to
sacrificing mice, on Day 56, mice were treated in the same way as before and had their final running session.
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4.4 Results
4.4.1 Running distances (km)
The two-way ANOVA with repeated measures revealed significant main effects
of groups (F(3,31) = 8.54, P <0.001), time (F(4,124) = 11.56, P <0.001) and time X
group interaction (F(12,124) = 5.61, P <0.001). Planned comparisons showed no
differences in the running performance of MIF or sulpiride-treated groups
compared to vehicle-treated groups (PMIF = 0.70, PSul25 = 0.95, PSul50 = 0.92)
during training, indicating equal distribution of mice performance amongst all
groups. Moreover, paired sample t-tests showed that the running performance of
vehicle-treated mice was unaltered over 4 weeks of treatment (week1: t = 0.45,
P = 0.67; week2: t = 0.64, P = 0.54; week3: t = 0.28, P = 0.79; week4: t = 0.23,
P = 0.82) compared to the training performance, Fig. 4.2. This suggests that
running mice were motivated to maintain their running performance over all
weeks. Although there were no significant differences in the running
performance of MIF-treated mice compared to the vehicle-treated mice
(planned comparisons: P >0.05, over all weeks), they ran less than their training
level during the first week of treatment (week1: t = 2.67, P = 0.028; week2: t =
0.002, P = 0.99; week3: t = 0.54, P = 0.61; week4: t = 0.08, P = 0.94), Fig. 4.2.
Sul25 reduced running distances of mice over most weeks of treatment
compared to their training performance (week1: t = 2.67, P = 0.028; week2: t =
1.70, P = 0.13; week3: t = 2.94, P = 0.019; week4: t = 3.08, P = 0.015), and
planned comparisons showed also a decrease in the mices running distances
during the third (P = 0.037) and fourth (P = 0.024) weeks of treatment
compared to the vehicle-treated mice, Fig. 4.2. In contrast, Sul50 markedly
lowered running distances of mice compared to the vehicle-treated group (P
<0.001, over all weeks) and to the mean distance which they ran during the
training phase (week1: t = 4.85, P = 0.002; week2: t = 4.24, P = 0.004; week3: t
= 6.13, P = 0.00048; week4: t = 6.95, P = 0.00022), Fig. 4.2. Moreover, the one
way ANOVA detected a significant group effect during the final exercise
session (F(3,31) = 3.27, P = 0.034), and planned comparisons revealed that Sul50-
treated mice exhibited decreased running distances (P = 0.005) compared to
vehicle-treated mice, Fig 4.2. To show time effects of sulpiride on the running
performance of mice over repeated sessions, separate ANOVAs with repeated
Chapter 4: Mifepristone and sulpiride regulate rewarding and/or cognitive
effects of voluntary wheel running in mice
170
measures revealed significant day effects by Sul25 (F(21, 168) = 1.86, P = 0.017)
and Sul50 (F(21, 147) = 3.24, P <0.001), and paired sample t-tests were used to
show significant effects on separate days, Fig. 4.3. Averaged running distances
were not significantly different between the non-injected and vehicle-treated
groups (F(1,15) = 0.07, P = 0.79), and the unpaired t-test also showed no
significant difference in the running activity of the two groups during the final
running session (t(15) = 1.06, P = 0.31), table 4.1.
4.4.2 Plasma corticosterone levels (ng/ml)
The two-way ANOVA revealed significant main effects of exercise (F(1,58) =
26.85, P <0.001) and groups (F(3,58) = 2.88, P = 0.043), but there was no
significant exercise X group interaction effect (F(3,58) = 2.24, P = 0.09). Post-hoc
planned comparisons indicated that vehicle- and MIF-treated running mice had
higher corticosterone levels than the corresponding sedentary group (P <0.001,
Groups
Time Non-injected Vehicle
Training 0.603 ± 0.025 0.735 ± 0.052
Week1 0.674 ± 0.082 0.699 ± 0.080
Week2 0.778 ± 0.126 0.784 ± 0.060
Week3 0.771 ± 0.103 0.759 ± 0.081
Week4 0.773 ± 0.102 0.754 ± 0.076
Final session 0.654 ± 0.083 0.759 ± 0.058
Table 4.1 Distances (km) run by mice in the non-injected group (n = 8)
compared to the vehicle-treated group (n = 9) during the 3-day training phase, 4
weeks of treatment and final running session. Data are presented as mean ± SEM
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in all case), Fig. 4.4. In contrast, Sul25 and Sul50 attenuated exercise-induced
corticosterone rise in the running mice (planned comparisons: P = 0.11 and P =
0.33, respectively) compared to their respective sedentary controls. Also, Sul25
(P = 0.027) and Sul50 (P <0.001) reduced corticosterone levels in exercising
mice compared to vehicle-treated exercising mice, Fig. 4.4. However, there
were no alterations in plasma corticosterone levels between any of the sedentary
groups (P >0.05, in all case). Also, there were no differences in plasma
corticosterone levels between the vehicle-treated sedentary and no-wheel
groups (t(14) = 0.48, P = 0.64) and between the non-injected and vehicle-treated
exercising groups (t(15) = 0.55, P = 0.59), see table 4.2.
4.4.3 Spontaneous alternations
The three-way ANOVA with repeated measures showed no significant main
effects of exercise (F(1,59) = 0.05, P = 0.82) and groups (F(3,59) = 0.56, P = 0.64),
but there was a significant time effect (F(1,59) = 16.78, P <0.001). There were
also no significant main effects of exercise X group interaction (F(3,59) = 0.25, P
= 0.86), time X exercise interaction (F(1,59) = 0.18, P = 0.67), time X group
interaction (F(3,59) = 1.36, P = 0.27) and time X exercise X group interaction
(F(3,59) = 0.56, P = 0.65). Paired sample t-tests revealed improvement of the
spontaneous alternation performance only in Sul50-treated sedentary mice (t =
2.97, P = 0.021) and Sul25-treated running mice (t = 3.54, P = 0.008) compared
to prior treatment performance, Fig. 4.5. Similarly, one sample t-tests
comparing the percentage of correct alternation to 50% (chance) showed
enhancements of the spontaneous alternation performance after treatment
(Sul25: t = 3.16, P = 0.013; Sul50: t = 2.76, P = 0.028), Fig. 4.5. There were no
differences between the vehicle-treated sedentary and no-wheel groups (F(1,14) =
0.02, P = 0.88) or between the non-injected and vehicle-treated running mice
(F(1,15) = 0.02, P = 0.90), table 4.2.
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4.4.4 Locomotor activity and anxiety-related behaviour during the
habituation session
For the total distances travelled in the arena, there was a significant main effect
of groups (F(3,59) = 3.53 P = 0.02), but no significant main effects of exercise
(F(1,59) = 3.35, P = 0.07) or exercise X group interaction (F(3,59) = 0.12, P =
0.95). Post-hoc planned comparisons showed that Sul25-treated running mice
moved shorter distances (P = 0.031) during the habituation session than vehicle-
treated running mice, table 4.3. On the other hand, measures of anxiety-like
behaviour were not significantly altered between groups. Firstly, percent
distance moved in the central zone relative to total was not significantly altered
by exercise (F(1,59) = 0.90, P = 0.35), groups (F(3,59) = 0.66, P = 0.58) and
exercise X group interaction (F(3,59) = 0.01, P = 0.999), table 4.3. Also, there
were no significant main effects of exercise (F(1,59) = 0.57, P = 0.45), groups
Group
Variable
Vehicle-
Sedentary
No-wheel
Vehicle-
Running
Non-injected
running
Plasma corticosterone
levels (ng/ml)
63.80 ± 5.66 60.24 ± 4.94 106.05*** ± 7.52 100.01 ± 8.08
Before
45.31 ± 7.45 43.75 ± 9.45 45.83 ± 8.84 45.31 ± 11.56
Percentage of
correct alternation
After 62.50 ± 11.08 60.94 ± 7.26 62.50 ± 6.59 60.94 ± 6.44
Table 4.2 Plasma corticosterone levels (ng/ml), after the final running session, and
% of correct alternation (before and after treatment) of mice (n = 8-9) in the no-
wheel and non-injected groups compared to the vehicle-treated sedentary and
running groups, respectively. Data are presented as mean ± SEM. ***P <0.001
compared to vehicle-sedentary mice.
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(F(3,59) = 0.80, P = 0.50) and exercise X group interaction (F(3,59) = 0.09, P =
0.97) on percent time spent in the central sector relative to total, table 4.3.
Similarly, the number of defecations were not affected by exercise (F(1,59) =
0.11, P = 0.74), groups (F(3,59) = 0.53, P = 0.67) and exercise X group
interaction (F(3,59) = 1.21, P = 0.31), table 4.3. Moreover, locomotor activity and
anxiety-like behaviour did not differ between the vehicle-treated sedentary and
no-wheel groups (total distances: t(14) = 0.001, P = 0.999; % distance: t(14) =
1.13, P = 0.28; % time: t(14) = 0.84, P = 0.42; number of defecations: t(14) = 0.44,
P = 0.66) and between the non-injected and vehicle-treated running mice (total
distances: t(15) = 0.03, P = 0.97; % distance: t(15) = 0.15, P = 0.86; % time: t(15) =
0.41, P = 0.69; number of defecations: t(15) = 0.71, P = 0.49), see table 4.3
Group
Total distance
travelled (km)
Percent
distance
Percent
time
Defecation
number
No-wheel 82.06 ± 5.33 13.39 ± 0.97 10.70 ± 1.21 5.00 ± 0.46
Non-injected 88.73 ± 4.65 15.36 ± 0.72 11.88 ± 0.85 5.63 ± 1.10
Vehicle-Sedentary 82.07 ± 4.20 14.88 ± 0.89 11.96 ± 0.89 4.63 ± 0.71
MIF-Sedentary 83.82 ± 2.55 14.66 ± 0.97 11.38 ± 1.42 4.88 ± 1.11
Sul25-Sedentary 72.69 ± 2.83 14.60 + 1.12 12.24 ± 1.35 4.00 ± 0.89
Sul50-Sedentary 75.59 ± 1.65 15.82 ± 0.77 14.09 ±1.48 5.13 ± 0.72
Vehicle-Running 88.50 ± 4.94 15.55 ± 0.98 12.57 ± 1.40 4.22 ± 0.72
MIF-Running 88.23 ± 4.09 15.17 ± 1.07 12.69 ± 1.18 3.33 ± 0.71
Sul25-Running 75.87* ± 5.74 15.40 ± 0.99 13.37 ± 1.69 5.44 ± 0.87
Sul50-Running 83.41 ± 4.93 16.51 ± 1.04 14.06 ± 1.70 4.88 ± 0.52
Table 4.3 Locomotor activity and variables of anxiety-like behaviour of mice (n
= 8-9 / group) during the 30-minute habituation session in the open field, which
was undertaken 24 hours before the novel object recognition test Data are
expressed as mean ± SEM. Planned comparisons: *P <0.05, compared to
vehicle-treated running mice. MIF = mifepristone (30 mg/kg, i.p.), Sul25 =
sulpiride (25 mg/kg, i.p.), Sul50 = sulpiride (50 mg/kg, i.p.)
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4.4.5 The novel object recognition test
The three-way ANOVA with repeated measures showed no significant main
effects of exercise (F(1,59) = 0.05, P = 0.82) and trials (F(1,59) = 0.60, P = 0.44),
but there was a significant group effect (F(3,59) = 10.73, P <0.001). Also, there
were no significant main effects of exercise X group interaction (F(3,59) = 1.97, P
= 0.13), trial X exercise interaction (F(1,59) = 0.11, P = 0.74), trial X group
interaction (F(3,59) = 2.02, P = 0.12) and trial X exercise X group interaction
(F(3,59) = 1.09, P = 0.36). Post-hoc planned comparisons revealed that running
mice treated with Sul25 (P = 0.002) or with Sul50 (P <0.001) spent a longer
time exploring the single object during the acquisition trial compared to vehicle-
treated exercising mice, table 4.4. Sul50 also increased the total object
exploration times of exercising mice (P = 0.008) during the retention trial
compared to vehicle-treated exercising mice, table 4.4. Moreover, there were
significant object effects during the retention trial (F(1,59) = 104.58, P <0.001).
Post-hoc paired sample t-tests showed that all exercising and sedentary groups
preferred to explore the novel object to the familiar one (P <0.05, in all case),
table 4.4. Furthermore, the two-way ANOVA analysing RIs revealed significant
main effects of exercise (F(1,59) = 4.42, P = 0.04) and groups (F(3,59) = 3.13, P =
0.032), but there was no exercise X group interaction effect (F(3,59) =1.75, P =
0.17). Planned comparisons indicated that MIF (P = 0.044) and Sul50 (P = 0.05)
reduced RIs of sedentary mice compared to vehicle-treated non-exercising
mice, Fig. 4.6. Also, Sul25-treated running mice had a lower RI than vehicle-
treated running mice (P = 0.01) and their respective sedentary mice (P = 0.005),
Fig. 4.6. One sample t-tests comparing RIs of all groups to 50% (no
discrimination) indicated that all groups had a higher RI than 50% (P <0.05, in
all case), Fig. 4.6. Similarly, the no-wheel and non-injected groups explored the
novel object for a longer time than the familiar object (P = 0.026, P = 0.025,
respectively), and their recognition indices were higher than 50% (P = 0.022, P
= 0.023, respectively), table 4.4.
Also, the two-way ANOVA with repeated measures indicated a significant main
group effect on the total exploration times between the vehicle-treated sedentary
and no-wheel groups (F(1,14) = 20.43, P <0.001). Mice in the no-wheel group
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spent a shorter time exploring objects during the acquisition and retention trials
(planned comparisons: P<0.001 and P = 0.008, respectively) than vehicle-
treated sedentary mice, table 4.4. Nevertheless, the unpaired t-test (t(14) = 0.72, P
= 0.48) showed no significant difference between RIs of the vehicle-treated
sedentary (65.54 ± 1.99) and no-wheel (62.21 ± 4.17) groups. On the other
hand, there were no significant differences in the total exploration times
between the non-injected and vehicle-treated running mice (F(1,15) = 2.05, P =
0.17), table 4.4. Also, RIs of the non-injected (59.54 ± 3.31) and vehicle-treated
exercising mice (62.98 ±1.82) did not significantly differ (t(15) = 0.94, P = 0.36).
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Group
TET
(acquisition)
Familiar
object
Novel object
TET
(retention)
No-wheel 34.94
xxx
± 7.13 16.38 ± 3.20 26.38
a
± 4.01 42.75
xx
± 6.34
Non-injected 84.25 ± 7.30 28.94 ± 4.33 40.56
a
± 4.24 69.50 ± 7.54
Vehicle 73.25 ± 5.83 23.44 ± 1.60 45.19
c
± 3.60 68.63 ± 3.93
MIF 65.69 ± 5.26 26.94 ± 2.56 39.69
a
± 5.27 66.63 ± 6.79
Sul25 78.75 ± 8.56 25.75 ± 1.82 46.88
b
± 4.20 72.63 ± 4.89S
ed
en
ta
ry
Sul50 86.06 ± 5.31 34.69 ± 2.72 50.00
a
± 4.29 84.69 ± 5.84
Vehicle 59.89 ± 9.09 23.17 ± 3.45 39.50
c
± 5.53 62.67 ± 8.59
MIF 48.00 ± 6.27 24.50 ± 2.38 36.83
a
± 4.83 61.33 ± 6.34
Sul25 90.06** ± 8.89 36.39 ± 3.62 44.00
a
± 4.60 80.39 ± 7.70R
u
n
n
in
g
Sul50 101.75***± 5.97 38.38 ± 3.26 51.13
a
± 5.17 89.50** ± 7.08
Table 4.4 Exploration times (sec) of the familiar and novel objects during the
retention trial and total exploration times (TET) during the 10-minute acquisition
and retention trials of the novel object recognition test which was carried out 5
days after the last week of treatment. Data are expressed as mean ± SEM (n = 8-
9 mice/group). Planned comparisons: **P <0.01 and ***P <0.001 compared to
the vehicle-treated running group, xxP <0.01 and xxxP <0.001 compared to the
vehicle-treated sedentary group; paired sample t-tests: aP <0.05, bP <0.01 and cP
= 0.001 compared to the familiar object. MIF = mifepristone (30 mg/kg, i.p.),
Sul25 = sulpiride (25 mg/kg, i.p.), Sul50 = sulpiride (50 mg/kg, i.p.).
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4.4.6 The novel object location test
The three-way ANOVA with repeated measures revealed significant main
effects of exercise (F(1,59) = 20.24, P <0.001), groups (F(3,59) = 4.09, P = 0.011)
and trial X exercise interaction (F(1,59) = 5.89, P = 0.018), but there were no
significant main effects of trials (F(1,59) = 0.16, P = 0.69) or exercise X group
interaction (F(3,59) = 0.25, P = 0.86). Also, there was no significant object
displacement effect (F(1,59) = 2.92, P = 0.093). Planned comparisons showed a
significant increase in the total exploration times of Sul25 (P <0.001) or Sul50
(P = 0.003) treated running groups during the acquisition trial compared to their
corresponding sedentary mice, table 4.5. Also, Sul50 increased the total
exploration times of exercising mice (P = 0.038) during the acquisition trial
compared to vehicle-treated exercising mice, table 4.5. On the other hand,
paired sample t-tests indicated that mice in all groups exhibited no preference
for any of the two identical objects during the acquisition trial (P >0.05, in all
case). Similarly, mice did not spend more time exploring the displaced object
compared to the non-displaced object during the retention trial (P >0.05, in all
case), table 4.5. Also, the two-way ANOVA revealed no significant main
effects of exercise (F(1,59) = 3.00, P = 0.089), groups (F(3,59) = 1.78, P = 0.16)
and exercise X group interaction (F(3,59) = 0.77, P = 0.52) on the LIs of
sedentary and running groups. Likewise, LI of each group was not significantly
higher than 50% (no discrimination), as indicated by one sample t-tests (P
>0.05, in all case), Fig. 4.7. Moreover, the total exploration times did not differ
significantly between the vehicle-treated sedentary and no-wheel groups (F(1,14)
= 2.60, P = 0.13) and between the non-injected and vehicle-treated running
groups (F(1,15) = 0.06, P = 0.81), table 4.5. However, mice in the no-wheel and
non-injected groups demonstrated a significant preference for the displaced
object to the non-displaced one (P = 0.019, P = 0.024, respectively), table 4.5.
Likewise, LIs of mice in the no-wheel (65.83 ± 4.00) and non-injected (59.89 ±
3.44) groups were higher than 50% (P = 0.005 and P = 0.024, respectively).
Nevertheless, unpaired t-tests showed no differences in LIs between the vehicle-
treated sedentary and no-wheel groups (t(14) = 1.80, P = 0.094) and between the
non-injected and vehicle-treated running groups (t(15) = 0.52, P = 0.61).
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Group
TET
acquisition
Non-displaced
object
Displaced
object
TET
retention
No-wheel
39.00 ± 7.22 15.44 ± 2.70 30.13x ± 4.91 45.56 ± 6.26
Non-injected
74.75 ± 10.05 25.63 ± 2.83 38.19x ± 4.28 63.81 ± 5.80
Vehicle
51.75 ± 2.91 24.94 ± 2.81 30.63 ± 3.50 55.56 ± 3.92
MIF
45.50 ± 1.90 22.75 ± 2.39 26.69 ± 2.11 49.44 ± 2.07
Sul25
52.13 ± 4.08 26.00 ± 6.49 29.06 ± 3.56 55.06 ± 5.82S
ed
en
ta
ry
Sul50
58.50 ± 5.05 33.75 ± 4.45 32.00 ± 1.40 65.75 ± 4.42
Vehicle
66.89 ± 10.11 28.56 ± 3.06 37.89 ± 4.26 66.44 ± 5.97
MIF
59.89 ± 4.70 31.06 ± 2.51 29.39 ± 2.37 60.44 ± 2.20
Sul25
79.67
###
± 5.57 37.50 ± 4.91 29.67 ± 3.19 67.17 ± 6.40R
u
n
n
in
g
Sul50
83.63* ## ± 9.46 43.94 ± 7.33 28.69 ± 4.01 72.63 ± 5.73
Table 4.5 Exploration times (sec) of the non-displaced and displaced objects
during the retention trial and total exploration times (TET) during the 10 minute
acquisition and retention trials of the novel object location test which was carried
out 24 hours after the novel object recognition test. Data are expressed as mean ±
SEM (n = 8-9 mice/group). Planned comparisons: *P <0.05 compared to vehicle-
treated running mice, ##P <0.01 and ###P <0.001 compared to the corresponding
sedentary group; paired sample t-tests: xP <0.05 compared to the non-displaced
object. MIF = mifepristone (30 mg/kg, i.p.), Sul25 = sulpiride (25 mg/kg, i.p.),
Sul50 = sulpiride (50 mg/kg, i.p.).
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4.4.7 Body weight (gram)
The three-way ANOVA with repeated measures showed no significant main
effects of exercise (F(1,59) = 1.76, P = 0.19) and groups (F(3,59) = 1.86, P = 0.15),
but there was a significant time effect (F(7,413) = 175.51, P <0.001). Also, there
were significant main effects of time X group interaction (F(21,413) = 8.89, P
<0.001) and time X exercise X group interaction (F(21,413) = 1.95, P = 0.007), but
no significant exercise X group interaction effect (F(3,59) = 0.56, P= 0.64) or
time X exercise interaction effect (F(7,413) = 0.26, P < 0.97) were detected.
Planned comparisons indicated that there was significant weight gain in MIF-
treated running group compared to MIF-treated sedentary group during week 1
(P = 0.019) and week 2 (P = 0.047), table 4.6, but this was MIF-independent as
the treatment phase began from week 3 (Day 21). In contrast, there was
significant weight loss in MIF-treated running mice during week 8 (P = 0.036)
compared to vehicle-treated running mice, table 4.6. Also, MIF-treated
sedentary mice showed significant weight loss during week 7 (P = 0.037)
compared to vehicle-treated sedentary mice, table 4.6. On the other hand, BW
of the no-wheel group did not differ from vehicle-treated sedentary mice (F(1,14)
= 0 , P = 0.95), but there was a significant time effect (F(7,98) = 22.57, P <0.001),
reflecting the normal weight gain of mice over time. Similarly, there was no
group effect (F(1,15) = 0.83, P = 0.38), but a significant time effect (F(7,105) =
59.42, P <0.001) was detected between the non-injected and vehicle-treated
running mice.
4.4.8 Correlations
Interestingly, corticosterone levels of all exercising mice (n = 42) after the final
session positively correlated with their running distances during the 4 weeks of
treatment (week1: r = 0.42, P = 0.005; week2: r = 0.46, P = 0.002; week3: r =
0.51, P = 0.001; week4: r = 0.55, P <0.001), Fig. 4.8. However, there was no
correlation between corticosterone levels and distances run during the final
session (r = 0.25, P = 0.12). Also, there was a positive correlation between
running distances of Sul50-treated running mice and their LI during week1 (n =
8, r = 0.93, P = 0.001) and week 3 (n = 8, r = 0.76, P = 0.027)
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8
0
Body weight (gram)
Week 1
(D 4)
Week 2
(D 11)
Week 3
(D 18)
Week 4
(D 25)
Week 5
(D 32)
Week 6
(D 39)
Week 7
(D 46)
Week 8
(D 53)
No-wheel 23.56 ± 0.58 24.49 ± 0.62 24.51 ± 0.61 24.75 ± 0.46 25.06 ± 0.45 25.39 ± 0.48 25.85 ± 0.48 25.30 ± 0.32
Non-injected 22.13 ± 0.63 23.60 ± 0.49 23.75 ± 0.42 24.26 ± 0.51 24.85 ± 0.52 25.46 ± 0.54 25.74 ± 0.51 25.51 ± 0.51
Vehicle 23.50 ± 0.88 23.75 ± 0.79 24.18 ± 0.76 24.80 ± 0.72 25.16 ± 0.56 25.69 ± 0.59 25.91 ± 0.68 25.50 ± 0.64
MIF 22.65 ± 0.54 22.98 ± 0.65 23.81 ± 0.66 23.69 ± 0.65 23.66 ± 0.65 24.20 ± 0.56 24.23* ± 0.59 24.00 ± 0.45
Sul25 23.63 ± 0.47 24.09 ± 0.36 24.46 ± 0.42 25.13 ± 0.42 26.04 ± 0.41 26.58 ± 0.42 26.88 ± 0.44 26.34 ± 0.52
S
ed
en
ta
ry
Sul50 22.91 ± 0.88 23.26 ± 0.80 24.25 ± 0.85 24.66 ± 0.86 25.60 ± 0.93 26.36 ± 0.94 26.89 ± 0.96 25.96 ± 0.81
Vehicle 23.46 ± 0.56 23.67 ± 0.35 24.23 ± 0.23 24.60 ± 0.41 25.23 ± 0.34 25.76 ± 0.34 26.26 ± 0.38 26.18 ± 0.23
MIF 24.49
¥
± 0.38 24.53
¥
± 0.35 24.72 ± 0.28 24.88 ± 0.34 25.14 ± 0.32 25.30 ± 0.37 25.59 ± 0.37 24.58
#
± 0.45
Sul25 23.04 ± 0.84 23.68 ± 0.52 24.59 ± 0.55 25.58 ± 0.37 26.40 ± 0.37 26.88 ± 0.42 27.02 ± 0.41 26.56 ± 0.29
R
u
n
n
in
g
Sul50 23.83 ± 0.54 24.68 ± 0.48 24.84 ± 0.50 25.23 ± 0.48 26.06 ± 0.45 26.58 ± 0.50 26.93 ± 0.51 26.18 ± 0.59
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Table 4.6 Body weight (gram) of mice in all groups (n = 8-9) from D 4 to D53. Data are expressed as mean ± SEM. Planned comparisons:
¥P <0.05 compared to the MIF-treated sedentary group, *P <0.05 compared to the vehicle-treated sedentary group, #P <0.05 compared to
the vehicle-treated running group. Underlined weeks indicate the treatment phase
Group
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Running performance during repeated 1-hour
voluntary wheel running sessions
Figure 4.2 The distances (km) run by mice during the pre-treatment training
phase, the 4-week exercise X treatment phase and the final running session. Male
C57BL/6J mice (n = 8-9 / group) were treated with vehicle, MIF (mifepristone, a
GR antagonist, 30 mg/kg, i.p.), Sul25 (sulpiride 25 mg/kg, a D2/3 antagonist) or
Sul50 (sulpiride 50 mg/kg). Mice underwent repeated 1-hour/day (5 days/week)
voluntary wheel running sessions during the training (3 days) and treatment
phase (4 weeks) prior to memory tests. Before termination, mice had the final
running session; 10 days after week4, after being treated exactly as during the
treatment X exercise phase. Data are presented as mean ± SEM. Planned
comparisons:
a
P <0.05,
b
P <0.01 and
c
P <0.001 compared to vehicle-treated
mice. Paired sample t-tests: *P <0.05,
#
P <0.01 and
$
P <0.001 compared to
training.
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Daily effects of sulpiride on running
performance
Figure 4.3 Effects of sulpiride (a D2/3 receptor antagonist) at two dose levels:
Sul25 (25 mg/kg, i.p.) and Sul50 (50 mg/kg, i.p.), on the running distances of mice
(n = 8-9 / group) during daily 1-hour sessions. T is for training and F is for final
running session which was carried out 10 days after session 20. After training,
mice had two exercise-free days (dotted lines) every 5 days of 1-hour/day running
sessions. From session 13 on, running distances of Sul25-treated mice gradually
decreased until session 15, then increased on session 16 (the start of the following
week) and again slowly decreased until session 20, suggesting a withdrawal
effects of Sul25 on D2 receptor expression in running mice. In, contrast, Sul50
decreased running distances from the first day and there were no significant
differences between repeated sessions of the following weeks. Data are expressed
as mean ± SEM. Paired sample t-tests: *P <0.05, **P <0.01 and ***P <0.001
compared to the prior session.
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Figure 4.4 Plasma corticosterone levels (ng/ml). Immediately after the final
running session, circulating corticosterone levels of sedentary and running mice
(n = 8-9 / group) treated with vehicle, MIF (mifepristone, a GR antagonist, 30
mg/kg, i.p.), Sul25 (sulpiride 25 mg/kg, a D2/3 antagonist) or Sul50 (sulpiride 50
mg/kg) were measured in duplicate using a commercial ELISA kit. The exercise
session was carried out 10 days after 4 weeks of (1-hour running session/day
(5days/week) X treatment). Data are expressed as mean ± SEM. Planned
comparisons: ***P <0.001compared to corresponding sedentary groups, ^P
<0.05 and ^^^P <0.001 compared to the vehicle-treated running group.
Plasma corticosterone levels
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Spontaneous alternation performance
Figure 4.5 The percentage of correct alternations in a T-maze. Vehicle, MIF
(mifepristone, a GR antagonist, 30 mg/kg, i.p.), Sul25 (sulpiride 25 mg/kg, a
D2/3 receptor antagonist) and Sul50 (sulpiride 50 mg/kg) treated mice (n =
8-9 / group) were examined in a T-maze before and 3 days after the 4 week
(exercise X treatment) phase. After 1 minute habituation, each mouse
underwent a series of 9 consecutive trials testing its spontaneous alternation
between the two arms of the T-maze. Data are expressed as mean ± SEM.
Paired sample t-tests: *P <0.05 and **P <0.01 compared to before. One
sample t-tests: #P <0.05 compared to 50% (chance).
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Novel object recognition performance
Figure 4.6 The recognition index. Vehicle, MIF (mifepristone, a GR
antagonist, 30 mg/kg, i.p.), Sul25 (sulpiride 25 mg/kg, a D2/3 receptor
antagonist) and Sul50 (sulpiride 50 mg/kg) treated mice (n = 8-9 / group) were
subjected to two 10-minute trials (acquisition and retention) of the novel object
recognition test with 4 hour inter-trial interval. Recognition index was
calculated as % (novel object exploration time / total exploration time). Data
are expressed as mean ± SEM. One sample tWHVWV33DQG
3FRPSDUHG WR QRGLVFULPLQDWLRQ SODQQHGFRPSDULVRQV aP
 FRPSDUHG WR YHKLFOHWUHDWHG VHGHQWDU\ PLFH bP = 0.01 compared to
vehicle-treated running mice,
$
P <0.01 compared to Sul25-treated sedentary
mice.
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Novel object location performance
Figure 4.7 The location index. 24 hours after the novel object recognition
test, sedentary and running mice (n = 8-9/group) treated with vehicle, MIF
(mifepristone, a GR antagonist, 30 mg/kg, i.p.), Sul25 (sulpiride 25 mg/kg, a
D2/3 receptor antagonist) or Sul50 (sulpiride 50 mg/kg) underwent
acquisition and retention trials (10 minutes each) of the novel object location
test with a 1-hour inter-trial interval. Location index was calculated as %
(displaced object exploration time / total exploration time). Data are
expressed as mean ± SEM.
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Figure 4.8 Pearsons correlations between plasma corticosterone levels (ng/ml),
after the final exercise session, and mean running distances of all exercising
mice (n = 42) during week 1, week 2, week 3 and week 4 of the treatment X
exercise phase.
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4.5 Discussion
The results of the present experiment demonstrate that although MIF did not
significantly influence the running activity and/or corticosterone levels of exercising
and sedentary mice compared to corresponding vehicle-treated mice, it only impaired
recognition memory in sedentary mice, suggesting that repeated voluntary wheel
running sessions protected against MIF-induced memory deficits. In contrast, D2
receptors did appear to be involved in the rewarding and cognitive effects of
voluntary wheel running. Whereas the two sulpiride doses lowered running distances
and corticosterone levels of mice, they had exercise-dependent opposing effects on
mices memory performance.
4.5.1 Running performance and corticosterone levels
First of all, there were no differences in corticosterone levels between any of the
sedentary groups, indicating that none of the treatment conditions affected HPA axis
activity of the sedentary mice. Also, the lack of significant differences in
corticosterone levels between the vehicle-treated sedentary and no-wheel mice
suggests that exploring the static wheel did not increase corticosterone levels.
Moreover, it is important to point out that there were no differences in the running
distances and corticosterone levels between the non-injected and vehicle-treated
exercising mice, indicating negligible stressful effects of injection on the running
performance and HPA axis activity.
The vehicle-treated exercising mice sustained high running activity which was not
significantly different from their training level (0.73 km ± 0.05, per session on
average) over all weeks, and displayed high plasma corticosterone levels (106.05
ng/ml ± 7.52) after the final session (10 days after the last week of treatment X
exercise phase) compared to the vehicle-treated sedentary mice (63.80 ng/ml ± 5.66).
In agreement with this, after 5 weeks of treadmill exercise (1hour/day, 5 days a
week), male C57BL/6J mice showed a significant elevation of corticosterone levels
(Chang et al., 2008). Also, mice which ran continuously for 4 weeks exhibited higher
circadian corticosterone peaks than sedentary mice, after they had no access to
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running wheels (Droste et al., 2003). Additionally, results of the chronic pilot study,
Chapter 3-Part 1, showed that corticosterone levels of exercising mice, which were
subjected to 5 weeks of the same exercise protocol used in the present experiment,
increased after the final 1-hour wheel running session. This indicates that both
continuous and intermittent wheel running effectively elevates corticosterone levels.
Results also revealed that MIF minimally decreased running distances of mice only
during the first week of treatment compared to the training level. This suggests that
the activation of GRs is not crucial for mice to maintain high running performance.
MIF-treated mice ran almost as long distances as vehicle-treated mice during the pre-
sacrifice session and subsequently exhibited higher plasma corticosterone levels than
the corresponding sedentary mice. It is also important to emphasize that chronic
exposure to MIF did not apparently influence negative feedback imposed by
corticosterone on HPA axis, since there were no differences in corticosterone levels
between the non-exercising MIF and vehicle treated mice, suggesting that the increase
in corticosterone levels in MIF-treated exercising mice was secondary to their running
activity and was not produced by disruption of HPA axis tone. In agreement with this,
chronic voluntary exercise in the wheel was reported to induce HPA axis adaptation,
as GR expression in the hippocampus of running rats or mice was not significantly
different from sedentary groups (Droste et al., 2003; Fediuc et al., 2006). On the
contrary, MIF treatment has been reported to disrupt HPA axis activity. For example,
MIF blocked dexamethasone-, a GR agonist, induced cortisol suppression in healthy
volunteers (Bertagna et al., 1984).
It has been suggested that GRs mediate the rewarding effects of corticosterone. In
agreement with this, rats self-administered corticosterone resulting in high levels
comparable to those induced by stress (Piazza et al., 1993), and it has been found that
GRs are mainly activated by high corticosterone levels (Reul and de Kloet, 1985),
suggesting a potential role of GRs in the rewarding effects of the stress hormone. A
number of studies have also shown that GRs are important for drug-seeking
behaviour. For instance, MIF attenuated cocaine-self administration in rats and mice
(Deroche-Gamonet et al., 2003; Fiancette et al., 2010). Furthermore, MIF impaired
morphine-induced CPP in rats (Dong et al., 2006). Thus, although GRs have been
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implicated in the rewarding effects of certain abused drugs, MIF did not attenuate
running performance of mice.
In the present experiment, it is also important to distinguish between the acquisition
and maintenance of the voluntary running behaviour. MIF did not have a significant
influence on the running performance of mice which had already acquired the running
behaviour during the training phase, but it is not known whether GR blockade could
attenuate the initiation of this behaviour in running naïve mice. This may explain why
MIF slightly decreased the running activity of mice during the first week of the
treatment phase compared to the training level. In support of this, corticosterone
treatment enhanced the acquisition of cocaine self-administration (Goeders and
Guerin, 1996; Mantsch et al., 1998), but stress-induced corticosterone elevation was
not required for reinstatement of cocaine-seeking behaviour (Erb et al., 1998).
However in the results presented in Chapter 3-Part 2, metyrapone decreased the
running distances of trained mice after a single session, and metyrapone slowly
attenuated the running performance of Wistar rats over 10 days of unlimited access to
running wheels (Hajisoltani et al., 2011), suggesting that corticosterone regulates the
long-term motivation to run in C57BL/6J mice probably via a GR-independent
mechanism.
Our results also showed that both sulpiride doses attenuated the running performance
of mice during some or all weeks of treatment, compared to the training levels and
vehicle-treated running mice. Also, Sul50 reduced the running distances of mice, and,
subsequently, attenuated exercise-evoked corticosterone increase during the final
session, compared to vehicle-treated exercising mice. In contrast, Sul25 lowered
corticosterone levels of running mice during the final session without a significant
decrease in their running activity, compared to vehicle-treated running mice. It was
reported that the D2 receptor agonist , quinpirole, activated the HPA axis and
sulpiride abolished this stimulatory effect in Sprague-Dawley rats (Borowsky and
Kuhn, 1992), suggesting that Sul25 had direct effects on HPA axis activity. However,
it is unclear why Sul25-treated sedentary mice did not show a decrease in
corticosterone levels compared to vehicle-treated sedentary mice. One explanation
could be that Sul25 blocked mainly D2 autoreceptors (Hahn et al., 2006), resulting in
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enhancement of dopamine release (Jaworski et al., 2001) and, subsequently, the
running activity of mice increased (Cador et al., 1993). Overall, results indicate that
D2 receptor activation is needed for mice to sustain high running performance.
Sulpiride preferentially blocks D2-like receptors in particular D2 and D3 receptors
(Vallone et al., 2000). Sulpiride was selected because it was found to be more
selective on dopamine receptors located in the mesolimbic dopamine pathway than
those located in the nigrostriatal dopamine pathway (White and Wang, 1983), so that
the decrease in the running performance of mice would reflect the motivation to run,
not the inability to run. It has been established that nigrostriatal dopaminergic A9
neurons; which project from the substantia nigra to the dorsal striatum (caudate-
putamen), regulate the motor function (Marsden, 2006). Also, sulpiride at the two
selected doses attenuated locomotor hyperactivity induced by abused drugs or electric
shock (Manzanedo et al., 1999; Hidaka et al., 2010), but they did not influence
spontaneous motor activity (Manzanedo et al., 1999; Simon et al., 2000).
Considerable research work has shown a pivotal role of D2 receptors in the
development of drug addiction (Volkow et al., 2002; Le Merrer et al., 2007; Gavello-
Baudy et al., 2008). For example, morphine reduced mRNA expression for D2
receptors in the nucleus accumbens and caudate-putamen of rats (Georges et al.,
1999). Previous work also showed that long-term wheel running reduced the mRNA
expression for D2 receptors in the nucleus accumbens core (Greenwood et al., 2011),
indicating both wheel running and abused drugs share common plasticity changes in
the mesolimbic reward pathway. This also suggests that wheel running enhances
dopamine release, resulting in D2 receptor downregulation. In line with this,
dopamine release increased in the nucleus accumbens of rats running on treadmills
(Freed and Yamamoto, 1985; Wilson and Marsden, 1995). Altogether, results strongly
implicated D2 receptors in the rewarding effects of voluntary wheel running, which
could be attenuated by blocking D2 receptors in the mesolimbic reward system or via
direct effects on HPA axis activity.
D2 receptors are located at presynaptic and postsynaptic sites in the striatum, nucleus
accumbens and olfactory tubercle (Marsden, 2006). Presynaptic D2 receptors are
inhibitory autoreceptors so that dopamine release is eventually increased when these
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receptors are blocked (Jaworski et al., 2001; Hahn et al., 2006). Small sulpiride doses
were reported to act mainly at these receptors and enhance dopamine transmission in
the striatum (Jaworski et al., 2001) and amphetamine-induced stereotypy (Ljungberg
and Ungerstedt, 1985), and these autoreceptors have been thought to be involved in
tardive dyskinesia, involuntary movement of the orofacial region and other parts of
the body (Marsden, 2006). Also, it has been reported that (-) sulpiride acts mainly on
D2 autoreceptors (Rossi and Forgione, 1995) which regulate dopamine release
(Marsden, 2006). Additionally, small doses (20 mg/kg) of sulpiride increased
locomotor activity of rats, but high sulpiride doses (40 mg/kg) blocked morphine-
induced locomotor hyperactivity (Manzanedo et al., 1999), suggesting that small
sulpiride doses enhance dopamine release which increases locomotor activity.
It is also important to point out that running distances of Sul25-treated mice
significantly decreased only during the last two weeks of treatment but not during the
final session which was carried out 10 days after the fourth week of treatment,
compared to vehicle-treated exercising mice. As described in Fig. 4.3, repeated 2-day
withdrawals of Sul25 indicated that mice ran longer distances at the start of the third
and fourth weeks of treatment than the prior session and then their running distances
decreased over the rest of these weeks sessions. In contrast, Sul25-withdrawn
running mice moved shorter distances in the open field during the habituation session
than vehicle-treated exercising mice. This suggests that chronic Sul25 upregulated D2
receptors at presynaptic sites, resulting in reduced activation of D1 receptors via a
decrease in dopamine release. On the other hand, Sul50 markedly decreased running
distances of mice from the first day of treatment, as described in Fig. 4.3, and during
the final session compared to vehicle-treated exercising mice, suggesting that Sul50
did not only block presynaptic D2 receptors, but also postsynaptic D2 receptors, and,
therefore, upregulation of D2 receptors at both sites probably neutralised their
inhibitory effects on postsynaptic D1 activation. In support of this, sulpiride-treated
groups tended to move shorter distances during the habituation session and during the
acquisition and/or retention trials of the object memory tests, data not shown.
It was reported that chronic sulpiride treatment resulted in upregulation of D2
receptors in the striatum (Motohashi et al., 1992; Hurley et al., 1996). Also, chronic
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(-) sulpiride injection enhanced D2 autoreceptors expression in the substantia nigra of
rats (Stefanini et al., 1991). Moreover, chronic treatment with a high dose of sulpiride
(100 mg/kg) was found to upregulate D2 receptors in the caudate-putamen and
nucleus accumbens of rats (McGonigle et al., 1989). Furthermore, imaging studies
using pharmacological MRI and PET showed enhancement of D2 receptor sensitivity
in the rat striatum subjected to 6-hydroxy dopamine (Nguyen et al., 2000b), which is
toxic to dopaminergic neurons. In fact, it was found that upregulation of D2 receptors
was maintained after cessation of chronic D2 receptor blockade (Hurley et al., 1996).
Overall, it is suggested that repeated sulpiride injections upregulated D2 receptors and
in particular Sul25 might have primarily affected presynaptic D2 receptors, which did
not only influence the running activity of mice in the wheels, but it also reduced
locomotor activity in the habituation/memory sessions.
Interestingly, the increase in corticosterone levels due to exercise in all groups was
dependent on the running activity, since there was a direct relationship between
corticosterone levels of exercising mice during the final session and their running
distances over the 4 weeks of treatment, suggesting that running mice retained active
HPA axis activity in response to wheel running. This also suggests that the observed
individual variability in the motivation of mice to run may be related to their
corticosterone response to wheel running. However, it is yet to be investigated
whether corticosterone elevation was just a result of running or also promotes the
motivation to run.
4.5.2 Memory performance
After the training phase, mice in all groups displayed no significant differences from
chance in the spontaneous alternation test. The spontaneous alternation behaviour
was found to reflect spatial short-term working memory performance (Sarter et al.,
1988), and rodents were found to alternate spontaneously above 50% (Dember and
Fowler, 1958). It is important to point out that poor spatial alternation performance
prior to treatment was unlikely to be related to exercise-induced corticosterone
elevation during the short training phase, since sedentary mice which had no access to
running wheels exhibited no significant alternation above the chance level prior to
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accessing the static wheels, Chapter 3-Part 1. Nevertheless, the same mice strain
C57BL/6J prior to corticosterone self-administration, Chapter 2-Part2, had a higher
percentage of correct alternation than chance, suggesting that the performance level
could be different between mice batches although Charles River UK was the source of
mice used in all experiments. On the other hand, this suggests that the protocol used is
sensitive enough to detect any possible improvement of the alternation performance
induced by drug treatment.
In the second alternation test, there were no significant differences in the percentage
of correct alternation between the vehicle-treated sedentary and running mice,
suggesting no role of chronic intermittent exercise-evoked corticosterone elevation on
the spontaneous alternation behaviour. Among all groups, sedentary Sul50 and
running Sul25 treated mice demonstrated significant improvement in their spatial
alternation rates compared to chance and the pre-treatment performance, although
other groups excluding MIF-treated sedentary and running groups displayed slightly
better performance during the post-treatment than the pre-treatment alternation tests.
It was reported that acute sulpiride treatment did not rescue alternation impairment
induced by repeated electric shocks (Hidaka et al., 2010). However, a small sulpiride
dose (10 mg/kg) abolished scopolamine-induced alternation impairment of mice in the
Y-maze (Ukai et al., 1998). In addition, a single methylphenidate (a dopamine
reuptake inhibitor) injection dose-dependently ameliorated the spontaneous
alternation impairment in juvenile stroke-prone spontaneously hypertensive rats,
which were used as a model of attention deficit hyperactivity disorder (Ueno et al.,
2002), suggesting that dopamine neurotransmission is involved in this behaviour.
Whereas Sul50 improved the spontaneous alternation performance of sedentary mice,
running enhanced Sul25-induced improvement in the percentage of correct
alternation. As mentioned earlier, it is suggested that D2 receptor upregulation
accompanied chronic sulpiride treatment and this effect hypothetically controlled the
degree of dopamine release and activation of postsynaptic D1 and D2 receptors.
Also, results suggest that wheel running modified sulpiride effects on the alternation
behaviour. It was found that activation of D1 receptors had an inverted U-shaped
relationship with the cognitive performance (Goldman-Rakic et al., 2000; Williams
and Castner, 2006), suggesting that moderate activation of D1 receptors is required
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for unimpaired memory. Overall, results indicate that running modified dopamine
neurotransmission and this resulted in enhancement or impairment of moderate
stimulation of D1 receptors.
Mice were also tested for their spatial memory performance in the novel object
location test and all mice, except those in the no-wheel and non-injected groups,
failed to show a significant preference for the object displaced in the novel location. It
is unclear why mice in the previous two groups acquired the object location, since
they exhibited no significant differences in the corticosterone levels and/or running
performance compared to the vehicle-treated sedentary mice and to the vehicle-treated
running mice, respectively. Interestingly, there was a positive correlation between LIs
of Sul50-treated exercising mice and their running distances during some weeks of
exercise, suggesting that the increase in the running performance at low levels,
induced by Sul50, enhances spatial memory (van Praag et al., 1999; van Praag et al.,
2005). It was reported that running at low levels improved memory performance, but
extensive exercise induced memory deficits (Garcia-Capdevila et al., 2009). A
standard protocol was used to carry out the novel object location test (Murai et al.,
2007), and the inter-trial interval was made shorter (1 hour) than previously tested in
order to help mice to acquire the task (Hikichi et al., 2010). Moreover, it was reported
that the inter-trial interval between the acquisition and retention trials was necessarily
KRXUV0XUDL et al., 2007), as mice could not discriminate the displaced object if
the retention trial was substantially delayed. Nevertheless, most groups did not seem
to acquire the task, as vehicle-treated groups were not able to recognize the displaced
object. It has to be emphasized that the performance in the object location test could
be influenced by gender and breeding method. Whereas outbred male and female CD-
1 mice showed significant location memory performance (Murai et al., 2007; Hikichi
et al., 2010), only inbred male C57BL/6J mice; the same strain used in these
experiments, exhibited significant preference for the displaced object (Frick and
Gresack, 2003). Nonetheless, male C57BL/6 mice acquired the novel object location
task using different and complex protocols which involved more than 2 objects, 2
trials and simultaneously tested the novel object recognition and location memory
(Frick and Gresack, 2003; Dere et al., 2005). Interestingly, our results showed that the
two sulpiride doses increased the total exploration times of running mice during the
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acquisition trial compared to corresponding sedentary groups, and Sul50-treated
exercising mice also exhibited an increase in the total exploration times during the
acquisition trial, compared to vehicle-treated running mice. However, LIs of
sulpiride-treated running groups tended to be lower than the vehicle-treated group and
their respective sedentary groups, suggesting that the increase in the exploration times
is not an indicator for the memory improvement. Overall, the current results suggest
that C57BL/6J mice need more complex protocols to acquire the object location task,
although it could be useful to show improvement, as some corticosterone self-
administered groups demonstrated significant performance in this memory test,
Chapter 2-Part 2.
GRs were found to be important for spatial learning in the Morris water maze (Oitzl et
al., 1997) and, therefore, this might explain why MIF attenuated the slight
improvement of the alternation rate of mice, which were observed in other groups,
compared to the pre-treatment alternation test. However, a 60 minute pre-testing
microinjection of corticosterone or a GR agonist (RU 28362) into the prefrontal
cortex impaired the rewarded delayed-alternation performance in rats (Barsegyan et
al., 2010). In contrast, a post-training systemic corticosterone injection enhanced the
novel object location memory of rats in a 24-hour retention test (Roozendaal et al.,
2010), suggesting that the alternation behaviour and the location memory are
influenced differently by glucocorticoids. Previous work showed that chronic
exposure to high corticosterone levels either had no effects on spontaneous alternation
(Luine et al., 1993; Coburn-Litvak et al., 2003), or impaired this natural behaviour
(Bardgett et al., 1994; Coburn-Litvak et al., 2003), as a result of negative effects on
the hippocampus (Sapolsky et al., 1985; Pavlides et al., 1993); which was also found
to be important for spatial working memory (O'Keefe and Dostrovsky, 1971; Conrad
et al., 1996; Eichenbaum et al., 1999; Broadbent et al., 2004).
Although spatial memory has been considered as a hippocampus-dependent task, a
previous study reported that rats with poor alternation performance showed no
impairment of hippocampal LTP (Ueno et al., 2002); which was found to be
correlated with the alternation rate (Nakao et al., 2001), indicating the involvement of
other brain regions in this behaviour. For example, the medial prefrontal cortex was
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reported to be involved in the delayed alternation task and working memory
performance (Barsegyan et al., 2010). Thus, our results suggest that although chronic
corticosterone elevation induced by exercise was not accompanied by significant
improvement of the spontaneous alternation performance, chronic GR blockade
prevented the slight increase in the percentage of correct alternation compared to
other groups.
In the novel object recognition test, mice in all groups spent a longer time exploring
the novel object than the familiar one during the retention trial which was performed 4
hours after the acquisition trial. RIs of sedentary and running vehicle-treated groups
were not significantly different, and RIs of the no-wheel group also did not differ
from the vehicle-treated sedentary mice, suggesting that repeated 1-hour running
sessions or just exploring the static wheel were not sufficient to induce significant
recognition memory improvement compared to the sedentary group. Therefore, the
inability of the exercise protocol used in this experiment to improve memory of
running mice could be either due to insufficient exercise in the light phase or chronic
excessive running as a result of limited access to wheel running, both conditions were
unable to improve memory (Shaw et al., 2003; Holmes et al., 2004; Garcia-Capdevila
et al., 2009).
Previous work showed that access (12-24 hours) to running wheels even for few days
improved spatial memory (Ebrahimi et al., 2010) and enhanced hippocampal BDNF
levels (Shaw et al., 2003) in rats. Also, running in the dark phase even for short
distances abolished memory deficits in rats (Shaw et al., 2003). Moreover, C57BL/6J
had to run at least 3 hours at night to demonstrate significant improvement of
hippocampal neurogenesis compared to non-exercising mice (Holmes et al., 2004),
and it was reported that hippocampal neurogenesis improved spatial (Dupret et al.,
2007) and recognition memory (Lafenetre et al., 2010). All these findings suggest that
there is a threshold in the exercise level which must be reached to enhance memory
performance compared to sedentary animals.
Using the same exercise schedule as in the present study but on treadmills enhanced
hippocampal neurogenesis and this was accompanied by corticosterone-induced MR
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downregulation and BDNF upregulation in the hippocampus (Chang et al., 2008), and
it was found that enhanced neurogenesis and hippocampal BDNF levels were
associated with improved memory performance (Dupret et al., 2007; Lafenetre et al.,
2010). In the passive avoidance task, mice exercising for 1 hour/day on treadmills
outperformed continuously running mice in the wheels and this memory enhancement
was independent of the running distances (Liu et al., 2009), suggesting that different
modes of exercise induced different effects on cognitive performance.
As with the running performance and corticosterone levels, there were also no
differences in recognition and location memory performance between the non-
injected and vehicle-treated exercising mice, suggesting that the stressful effects of
injections on the cognitive performance were also minimal.
Our results also showed that recognition memory impairment which was observed in
MIF-treated sedentary mice was ameliorated in MIF-treated running mice compared
to corresponding vehicle-treated groups, although there were no significant
differences in RIs of the two MIF-treated groups. In agreement with this, unlimited
wheel running for 13 days rescued short-term recognition memory deficits, and
enhanced neurogenesis and BDNF levels in the mouse hippocampus (Lafenetre et al.,
2010). Also, it was reported that metyrapone or adrenalectomy attenuated exercise-
induced enhancements of spatial memory in rats, suggesting a significant role of
corticosterone in the cognitive effects of wheel running (Hajisoltani et al., 2011).
Previous research showed that GRs were implicated in recognition memory
performance (Mesripour et al., 2008; Roozendaal et al., 2010). In addition, the
activation of membrane-bound GRs by post-training injection of corticosterone-
bovine serum albumin complex into the insular cortex was found to enhance the
consolidation of recognition memory via the activation of the cAMP/protein kinase A
pathway (Roozendaal et al., 2010). However, MIF reversed corticosterone-dependent
recognition memory deficits in morphine-withdrawn mice (Mesripour et al., 2008).
Also, MIF abolished memory deficits in diabetic mice (Revsin et al., 2009). It was
found that corticosterone levels improved memory performance in an inverted U-
shaped manner (Diamond et al., 1992; Akirav et al., 2004; Okuda et al., 2004),
suggesting that memory performance is dependent on the degree of GR activation.
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Also, it was reported that MRs were downregulated in the hippocampus of mice
chronically exercising in the wheel (Droste et al., 2003) and on treadmills (Chang et
al., 2008). Additionally, previous work reporting that exercise-induced memory
improvement via corticosterone secretion (Hajisoltani et al., 2011) suggested that
GRs; which are activated by high corticosterone levels (Reul and de Kloet, 1985), at
least partially mediate exercise effects on cognition. However, both MRs and GRs
were found to be important for memory performance (Oitzl and de Kloet, 1992;
Brinks et al., 2007). MIF is a competitive GR antagonist (Cadepond et al., 1997), and,
thus, running-induced corticosterone elevation probably attenuated memory deficits
induced by the chronic GR blocking effects through displacing MIF from GR binding
sites. In support of this, dexamethasone, a GR agonist, blocked MIF-induced
elevation of basal ACTH and cortisol levels in humans (Raux-Demay et al., 1990).
Conversely, MIF blocked dexamethasone-induced cortisol suppression (Bertagna et
al., 1984). This suggests that MIF-induced effects can be reversed with exogenous
glucocorticoid administration or with exercise-evoked corticosterone increase as in
the present experiment.
As with the alternation test, Sul25 and Sul50 produced opposing effects on the
recognition memory performance in sedentary and running mice. Whereas recognition
memory performance was attenuated in Sul50-treated sedentary mice compared to
vehicle-treated sedentary mice, Sul25 impaired recognition memory of running mice
compared to vehicle-treated exercising mice and Sul25-treated sedentary mice. As
mentioned earlier, the two sulpiride doses imposed opposite effects on the alternation
performance. Thus, improvement of working memory was accompanied by
impairment of recognition memory and vice versa. In two recent studies, activation
of the cAMP-dependent protein kinase A pathway resulted in impairment of the
delayed alternation performance (Barsegyan et al., 2010) and enhancements of
recognition memory performance (Roozendaal et al., 2010). Also, it was found that a
D1 agonist (SKF 81297), injected 10 minutes before a 4 hour retention test, improved
object recognition and location memory via enhancement of the levels of
phosphorylated cAMP response element binding protein (pCREB); a downstream
mediator of D1/cAMP/protein kinase A, in the prefrontal cortex of rats (Hotte et al.,
2005; Hotte et al., 2006). Given that chronic sulpiride treatment probably induced D2
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receptor upregulation and, subsequently, reduced D1 receptor activation, this
hypothesis may explain why chronic Sul25 treatment improved the alternation
performance and impaired recognition memory of running mice.
In the novel object recognition test, there was a significant increase in the total
exploration times of Sul25 and Sul50 treated running mice compared to vehicle-
treated running group during the acquisition trial. Also, Sul50 increased the total
exploration times of mice during the retention trial, compared to vehicle-treated
running mice. The effect of sulpiride on exploration times was clearly controlled by
exercise since sulpiride-treated sedentary groups did not show the same motivation to
explore objects. On the other hand, vehicle-treated sedentary mice spent a longer time
exploring objects during the two trials than mice in the no-wheel group, but neither
group showed any differences in their RIs. All in all, the differences in the length of
exploration times appear not to be important for mices performance in the novel
object recognition memory test. On the other hand, Sul25-treated exercising mice
moved shorter distances than vehicle-treated exercising mice during the habituation
session. This suggests that the reduced locomotor activity probably interfered with the
effective exploration of the objects and underlay the memory impairment detected in
the Sul25-treated exercising mice.
It is interesting that sulpiride-treated sedentary and running groups demonstrated
opposing performance in memory tests. Changes in exploration times and motor
activity probably underscored the interference with acquisition of memory tasks. For
example, sedentary Sul25-treated mice did not show alterations in the exploration
times or motor activity compared to vehicle-treated sedentary mice, indicating low
motor activity of Sul25-treated running mice interfered with memory performance.
On the other hand, running ameliorated recognition memory impairment induced by
Sul50, but Sul50-treated running or sedentary groups showed no changes in the motor
activity during the habituation session. As mentioned earlier, it was found that chronic
wheel running for 6 weeks induced D2 receptor downregulation in the nucleus
accumbens core of rats (Greenwood et al., 2011), and, therefore, chronic sulpiride
treatment triggering D2 receptor upregulation led to insufficient activation of D1
receptors via reduced dopamine release, Fig 4.9. Altogether, results suggest that
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exercise regulates dopamine neurotransmission, and sulpiride modifies exercise-
induced cognitive effects, Fig 4.9.
Before sulpiride After sulpiride
Dopaminergic
neurons
Gs
ATP cAMP
AC
PKA
Gi
-
+
D2
D1
D2
PKA
Gi
-AC
+
cAMPATP
Gi
-
Gs
Postsynaptic
Presynaptic
Upregulation
of D2
receptors
-
Dopamine
release
-
Figure 4.9 Running enhanced chronic sulpiride induced D2 receptor
upregulation. Whereas Sul25 seems to have enhanced presynaptic D2
receptor expression, Sul50 is suggested to have promoted D2 receptor
upregulation at pre-synaptic and postsynaptic sites. The increase in
presynaptic D2 receptors reduced dopamine release and activation of D1
receptors with a subsequent decrease in locomotor activity and recognition
memory performance, and improved alternation performance. In contrast,
these effects were attenuated by upregulation of postsynaptic D2 receptors in
Sul50-treated mice. AC = adenylyl cyclase, G proteins: stimulatory Gs and
inhibitory Gi, PKA = protein kinase A.
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As stated earlier, chronic sulpiride treatment was associated with D2 receptor
upregulation (Stefanini et al., 1991; Motohashi et al., 1992; Parsons et al., 1993;
Hurley et al., 1996), suggesting that D2 receptor-mediated effects were enhanced
while the memory tests were undertaken. This conclusion is supported by the finding
that sulpiride-treated groups and particularly Sul25-treated mice travelled short
distances during the habituation session and/or the memory tests, indicating a
decrease in dopaminergic neurotransmission and enhanced sensitivity of D2
autoreceptors which negatively regulate dopamine release (Jaworski et al., 2001;
Hahn et al., 2006; Marsden, 2006). Subsequently, Sul25 impaired recognition
memory but improved the alternation performance of running mice. Although levels
of D2 receptors were not estimated, the reduced activity of sulpiride-treated groups, in
particular Sul25-treated exercising mice during the habituation session suggests that
D2 receptors had been upregulated during the memory tests which were performed
within 3 to 5 days after the treatment ended.
Dopamine has been suggested to influence learning and memory especially when a
motivated behaviour is involved (Shohamy and Adcock, 2010), since dopaminergic
neuronal terminals and receptors are abundant in the striatum as well as in the
hippocampus and frontal cortex (Shohamy and Adcock, 2010). Also, it was found that
the blockade of D1 or D2 receptors did not impair recognition memory, but activation
of D1 receptors enhanced recognition memory performance (de Lima et al., 2011).
For example, a post-training intraperitoneal injection of SKF38393, a D1 receptor
agonist, enhanced consolidation of recognition memory of rats (de Lima et al., 2011).
In contrast, post-training injection of quinpirole, a D2 receptor agonist, or pre-training
injection of raclopride, a D2 receptor antagonist, did not influence recognition
memory (de Lima et al., 2011). Nevertheless, it has been thought that blocking D2
receptors can be translated into more activation of D1 receptors, since the two
receptors have opposite effects on adenylyl cyclase (Marsden, 2006). As stated
earlier, the activation of D1 receptors had an inverted U-shaped relationship with
memory performance (Goldman-Rakic et al., 2000; Williams and Castner, 2006), and
therefore, moderate activation of D1 receptors is required for optimum memory
performance.
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4.6 Conclusion
Results of the present experiment demonstrated that GR activation was not required
for mice to sustain high running performance, but long-term intermittent exercise-
induced corticosterone elevation provided protection from MIF-induced recognition
memory deficits. More work is needed to investigate the involvement of
corticosterone in the rewarding effects of voluntary wheel running in a standard
paradigm such as the conditioned place preference, and to test whether GR blockade
could attenuate the acquisition of wheel running behaviour. In agreement with the
previous work, our findings indicated that D2 receptors were involved in the running
performance of mice and cognitive effects of voluntary wheel running, suggesting that
the activation of the reward pathway by wheel running could influence cognition.
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Chapter 5
General Discussion
5.1 Summary of findings
The main objectives of the work described in this thesis were to investigate the
potential rewarding properties of corticosterone in male C57BL/6J mice and how their
cognitive performance could be influenced by the hedonic effects of the stress
hormone. To address this hypothesis, two models were employed in separate
experiments: 1- An oral self-administration model (the two-bottle free choice test) to
establish the rewarding properties of the stress hormone, 2- Voluntary wheel running,
a rewarding stimulus which enhances corticosterone secretion and, thus, represents an
appropriate model to study the link between its rewarding and cognitive effects.
To the best of our knowledge, this is the first work carried out to study the rewarding
effects of corticosterone in mice. Results demonstrated that mice acquired and
reinstated oral corticosterone self-administration at high doses indicating its
rewarding effects. In particular, the marked preference for the corticosterone solution
was observed when the unflavoured corticosterone solution was offered versus the
IMP solution as a result of IMPs initial aversive taste which accelerated and
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facilitated corticosterone self-administration. Results also suggest that corticosterone
self-administration protected mice to some extent from memory impairment induced
by a surprisingly low concentration (1%) of ethanol and also enhanced object location
memory. Moreover, levels of BDNF and its downstream target pERK2 in the
hippocampus and frontal cortex were significantly altered in some or all
corticosterone-treated groups compared to control groups, suggesting that they may
underlie the rewarding and cognitive effects of corticosterone. Furthermore,
corticosterone self-administration was accompanied by changes in dopamine turnover
in the striatum, which suggests a role of dopamine in the corticosterone-seeking
behaviour. These findings led us to the idea of using a stressful natural reward, such
as voluntary wheel running which promotes corticosterone secretion and modulates
cognitive performance, in order to examine the influences of corticosterone-related
reward on memory.
Whereas the exercise protocol used in the present studies increased corticosterone
levels after single or repeated sessions, it was unable to enhance memory performance
compared to non-exercising mice. Acute inhibition of exercise-induced corticosterone
elevation decreased running distances, but chronic GR blockade had no effect.
Nonetheless, running prevented MIF-induced recognition memory deficits. Finally,
results showed that D2 receptors were involved in the running performance of mice
and the effects of exercise on memory, suggesting that cognitive effects of voluntary
wheel running could be controlled by its rewarding properties.
5.2 Is corticosterone rewarding?
The current results demonstrate that inbred male C57BL/6J mice are prone to self-
administer corticosterone, indicating its rewarding properties. Also, corticosterone-
withdrawn mice were motivated to drink primarily from the corticosterone tube,
suggesting that it has addictive potential. In conjunction with these findings, others
reported that corticosterone was self-administered by male Sprague-Dawley rats in the
intravenous operant-conditioning and two-bottle free choice tasks (Deroche et al.,
1993; Piazza et al., 1993), and they relapsed to self-administer corticosterone in the
two-bottle choice test (Deroche et al., 1993). However, the same rat strain did not
exhibit CPP to corticosterone (Dietz et al., 2007). This could be dose or task related,
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as corticosterone was only self-administered at high doses (Piazza et al., 1993), and,
thus, corticosterone administered at low doses did not induce conditioned place
preference because GRs, which have been found to mediate corticosterone-facilitating
effects on drug-seeking behaviour (Fiancette et al., 2010), are activated mainly during
stress or circadian corticosterone peaks (Reul and de Kloet, 1985). Also, some abused
drugs such as pentobarbital and phencyclidine were self-administered, but they did
not induce CPP in rats (Collins et al., 1984; Marquis et al., 1989; Acquas et al., 1990;
Lew and Parker, 1998), indicating that operant self-administration procedures and
CPP probably test different aspects of drug-seeking behaviour.
An important point is whether rewarding effects of corticosterone are strain-
dependent. A considerable number of studies have shown that C57BL/6J mice have a
tendency to self-administer abused drugs (Elmer et al., 2010; Fiancette et al., 2010;
Gieryk et al., 2010). On the other hand, DBA/2J mice were found to be less
vulnerable to abused drugs-related reward (van der Veen et al., 2007; Glatt et al.,
2009; Elmer et al., 2010). Being inbred strains may explain the differences in the
propensity for drug craving. For example, it was found that differences in genetic
expression of prodynorphin or proenkephalin in the nucleus accumbens regulated
morphine-induced CPP in C57BL/6J and DBA/2J mice (Gieryk et al., 2010).
Interestingly, Sprague-Dawley rats which are outbred self-administered corticosterone
(Deroche et al., 1993), suggesting that rewarding effects of corticosterone are not
restricted to inbred strains with homogeneous genetic background.
Similarly, it has been reported that inbred C57BL/6J mice are motivated to run
spontaneously in the wheel, although other inbred strains, such as CBA and C3H,
displayed better running performance (Brene et al., 2007). In addition, our results
demonstrated a wide variability in the running performance between individual mice
of the same strain. This variability was previously observed in C57BL/6 mice (Klaus
et al., 2009). In addition, the running performance of male Long-Evans (an outbred
strain) rats was considerably different (Tarr et al., 2004), suggesting that the
variability in motivation to run is not species- or strain-dependent. Also,
corticosterone levels correlated with running distances, indicating that exercise-
evoked corticosterone elevation depends on running performance, or increased
corticosterone levels motivate mice to run. In line with this, corticosterone levels were
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found to function as a determining factor for vulnerability to amphetamine self-
administration in rats (Piazza et al., 1991). Likewise, corticosterone levels could be a
determining factor for the voluntary running performance in mice.
There is a possibility that the rewarding effects of corticosterone or voluntary wheel
running are independent, and this may explain the lack of significant chronic effects
of GR blockade on the running performance of mice. First, our results suggest that D2
receptors are implicated in the running performance of mice. In accordance with this,
chronic continuous wheel running lowered D2 receptor mRNA expression in the
nucleus accumbens core of rats (Greenwood et al., 2011). Second, it has been
reported that the endogenous opioidergic system is modulated by chronic wheel
running. Mice over-expressing ' FosB in the striatal dynorphin neurons ran more than
the control running group (Werme et al., 2002b), but the running activity was
decreased in mice which extensively expressed ' FosB in the striatal enkephalin
neurons (Werme et al., 2002b). Also, ' FosB levels increased in the striatum (Werme
et al., 2002b) and nucleus accumbens (Greenwood et al., 2011) of running rats.
Moreover, naloxone (an opioid receptor antagonist) blocked CPP induced by wheel
running, suggesting the involvement of the opioidergic system (Vargas-Perez et al.,
2008). In addition, naloxone also attenuated the acquisition of the wheel running
behaviour (Vargas-Perez et al., 2008). Third, a recent study showed that exercising
men had high plasma levels of endocannabinoids and E-endorphins (Heyman et al.,
2011), suggesting other mechanisms of exercise-induced reward. Fourth, Sprague-
Dawley rats running continuously for 5 weeks exhibited initial corticosterone
elevation during the first week, but its levels declined until running was not
accompanied by an increase in corticosterone levels (Fediuc et al., 2006). This
suggests that the same rat strain which self-administered corticosterone (Piazza et al.,
1993) retained high running performance without an increase in corticosterone levels
(Fediuc et al., 2006; Sasse et al., 2008), indicating rewarding effects of wheel running
are GRs-independent. The lack of association between running activity and the
increase in corticosterone levels in Sprague-Dawley rats (Fediuc et al., 2006; Sasse et
al., 2008) can be explained as rats kept running at high rates for corticosterone-
independent rewarding effects of wheel running.
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Several studies have indicated that wheel running modifies rewarding effects of
abused drugs. Cocaine-induced reinstatement in rats was attenuated by wheel running
(Zlebnik et al., 2010). Additionally, wheel running enhanced ethanol preference in
rats (Werme et al., 2002a). On the other hand, C57BL/6J mice which had drunk 10%
ethanol increased their running performance in a wheel when no alcohol was
available, but mice ran less when ethanol access was regained, and this occurred after
mice exhibited stable intermittent running activity with continuous ethanol access,
suggesting that rewarding effects of wheel running substitutes for ethanol-related
reward (Ozburn et al., 2008). Given that rewarding effects of wheel running are
probably mediated via multiple mechanisms, it is likely that MIF-treated mice ran at
high rates; after the first weeks mild decrease in their running activity compared to
the training level, in order to substitute for the reduced corticosterone-related reward
induced via ongoing GR blockade. In contrast to these assumptions, adrenalectomized
and metyrapone-treated Lewis rats ran slightly less than control exercising rats, when
they had only 10 days of unlimited access to wheel running (Hajisoltani et al., 2011),
and, therefore, it is not conclusive as HPA axis adaptation might have been induced
by long-term wheel running.
As discussed earlier, D2 receptor blockade attenuated the running performance of
mice, and corticosterone self-administration enhanced dopamine turnover. Thus, it is
inferred that alterations of dopamine neurotransmission influenced rewarding effects
of the wheel running and the stress hormone. Taken together, although corticosterone
elevation induced by wheel running was not required for male C57BL/6J mice to
sustain high running performance, this does not preclude the possibility that
corticosterone is rewarding, since dopamine and other mechanisms are suggested to
mediate rewarding effects of wheel running.
5.3 Implications of rewarding effects of corticosterone in psychiatric disorders.
Elevated glucocorticoid levels have been found to accompany certain mood disorders
such as major depression (Souetre et al., 1988) and psychoses (Collip et al., 2011).
Indeed, the persistent increase in endogenous secretion or chronic administration of
glucocorticoids leads to the development of Cushings syndrome; a hormone disorder
characterized by hypercortisolemia which is either ACTH-dependent or -independent
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(Fink, 2010), which may precipitate depressive symptoms (Kelly et al., 1980) and
psychotic episodes (Wada et al., 2001; Myhill et al., 2008). Interestingly, a case study
of a patient who had a history of Cushings syndrome presented with various
psychotic symptoms including euphoria, but these complications were improved after
reducing salivary and urinary cortisol levels using metyrapone and ketoconazole
(Myhill et al., 2008), indicating rewarding effects of cortisol.
Reduced glucocorticoid-induced negative feedback on HPA axis activity has been
found to underscore dysregulation of HPA axis, as high cortisol levels in depressed
patients were either unaffected (Rush et al., 1996) or increased (Heuser et al., 1994)
in response to the dexamethasone (a GR agonist) suppression test; in which an oral
dose of dexamethasone decreases the secretion of ACTH and cortisol via the
activation of GRs which mediate negative feedback of HPA axis activity (Carroll et
al., 1981). This suggests that dysfunction of GRs underlies hyperactivity of the HPA
axis in mood disorders (Abraham et al., 2003; Thomson and Craighead, 2008).
Conversely, it was reported that depressed patients treated acutely with mifepristone
exhibited rapid symptomatic improvement (Belanoff et al., 2001a). This could be
related to the ability of mifepristone to enhance GR expression, resulting in
enhancement of negative feedback inhibition on HPA axis activity and reduction of
elevated glucocorticoids (Thomson and Craighead, 2008).
Several studies have addressed the involvement of stress and glucocorticoids in the
development of depression (Johnson et al., 2006; Detanico et al., 2009). It is
important to distinguish between the influences of acute or chronic exposure to stress
or glucocorticoid treatment. Whereas acute footshock had antidepressant effects,
chronic stress exposure induced depression-like behaviour in mice in the forced swim
test (Swiergiel et al., 2008), suggesting that short-term elevation of glucocorticoids
improves mood status. On the other hand, repeated corticosterone injections were
reported to induce a depression-like state in mice (Zhao et al., 2008) and rats
(Kalynchuk et al., 2004; Johnson et al., 2006). In contrast, acute corticosterone
treatment did not increase rats immobility in the forced swim test (Johnson et al.,
2006). Nevertheless, there have been a number of conflicting studies which indicate
that glucocorticoids have mood-enhancing effects. For instance, acute corticosterone
intake in the drinking water significantly enhanced mices performance in the forced
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swim test compared to the vehicle and desmethylimipramine-treated groups (Stone
and Lin, 2008). Similarly, young male C57BL/6 mice ingesting corticosterone
chronically at low doses in drinking water outperformed the control group in the tail
suspension and forced swim tests, and this was accompanied by reduced MR
expression in the hippocampus (Xu et al., 2011). This suggests that corticosterone in
drinking water even at low doses is able to improve depression-like behaviour.
Furthermore, rats treated with a low dexamethasone dose for 1 week exhibited
attenuated sepsis-induced anhedonia (Cassol-Jr et al., 2010), indicating a role of GRs
in decreasing depression-like behaviour. Previous work has provided some evidence
that exercise improves the mood of depressed patients (Schuch et al., 2011; Tordeurs
et al., 2011). Also, running has been reported to attenuate depression-like behaviour
in experimental animals (Brene et al., 2007; Marais et al., 2009). Interestingly, long-
term wheel running protected against stress-induced depression-like behaviour via the
increase in BDNF levels, but corticosterone levels were also elevated (Adlard and
Cotman, 2004; Zheng et al., 2006), suggesting that corticosterone probably
contributes to rewarding effects of exercise or, at least, did not aggravate depression-
like behaviour. In fact, chronic running was reported to induce adaptation status in
HPA axis in rodents (Droste et al., 2003; Fediuc et al., 2006), and, therefore, regular
exercise probably improves depressive symptoms via regulation of HPA axis activity.
It is widely accepted that glucocorticoid secretion increases in response to stress to
inhibit further activation of the HPA axis and to maintain homeostasis. Thus, terms
such as allostasis and allostatic overload have been introduced to describe how
glucocorticoids mediate the remission of stress-evoked HPA axis hyperactivity.
Homeostasis can be defined as a self-regulating process which is required to maintain
the internal environment of an individual close to a set point via limited operations
important for survival (Fink, 2010). On the other hand, allostasis reflects the alteration
in the levels of mediators such as glucocorticoids required to generate energy and
modulate behaviour to cope with changes in the external environment (Fink, 2010).
Consequently, an inability to maintain homeostasis may lead to allostatic overload
which comprises overexposure to stress hormones (Fink, 2010), with subsequent
harmful effects. Altogether, the elevations of glucocorticoids which accompany
certain psychiatric disorders are probably vital to restore homeostasis or to
compensate anhedonia via their rewarding effects.
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In brief, elevation of corticosterone levels accompanies both aversive and rewarding
stressors, and habituation of the HPA axis is associated with motivated behaviours,
suggesting that the initial increase in glucocorticoid levels in mood disorders is likely
to counteract the associated anhedonia (allostasis), but chronic exposure to underlying
causes (allostatic overload) probably stimulates HPA axis to induce further adverse
effects on the mood status.
5.4 Do rewarding effects of corticosterone have positive influences on memory?
It has been believed that glucocorticoids are implicated in memory processing.
Whereas MRs are abundant in the hippocampus, GRs are widely expressed in the
brain (Reul and de Kloet, 1985), suggesting that corticosterone could influence
different forms of memory such as recognition, spatial and fear memory (Roozendaal
et al., 2008; Barsegyan et al., 2010; Roozendaal et al., 2010). However, effects of
corticosterone on memory depend on their levels (Diamond et al., 1992; Akirav et al.,
2004; Okuda et al., 2004) and duration of exposure (Coburn-Litvak et al., 2003).
Also, corticosterone has a differential impact on different phases of memory
processing. Acute corticosterone elevation was reported to enhance consolidation of
spatial and recognition memory (Sandi et al., 1997; Roozendaal et al., 2010), but it
impaired the delayed alternation performance (Barsegyan et al., 2010) and retrieval of
memory (Roozendaal et al., 2001; Roozendaal et al., 2008).
It is important to distinguish between influences of stress and glucocorticoids on
cognition. For instance, spatial memory of rats was impaired by restraint stress for 21
days (Luine et al., 1994), but unaffected by exogenous corticosterone treatment for
the same period (Coburn-Litvak et al., 2003) in male Sprague-Dawley rats which self-
administered the stress hormone (Piazza et al., 1993). Whereas exposure to
corticosterone for 3 weeks induced reversible hippocampal morphological changes
such as atrophy of apical dendritic branches in the CA3 region of the rat hippocampus
(Woolley et al., 1990; Watanabe et al., 1992), hippocampal neuronal loss was
observed after a 3-month treatment (Sapolsky et al., 1985) in male Fischer rats (an
inbred strain), suggesting that long-term exposure to corticosterone could impair
hippocampus-dependent memory. In agreement with this, the current results suggest
that short-term exposure to significant corticosterone self-administration did not
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impair spontaneous alternation or recognition memory, but it improved the object
location memory of mice and protected from ethanol-induced memory impairment.
Furthermore, restraint stress for 1 month was reported to trigger loss of hippocampal
neurons in 9-month-old castrated Wistar rats (Mizoguchi et al., 1992). In contrast,
none of these effects were detected in the hippocampus of aged macaques monkeys
treated for 12 months with high oral doses of cortisol (Leverenz et al., 1999).
Moreover, chronic moderate elevation of corticosterone levels for 3 months enhanced
spatial memory of mountain chickadees (Pravosudov, 2003). This suggests that
although the duration and intensity of corticosterone exposure have distinct effects on
cognition, other factors including species, strain and stress should be considered.
It has been reported that HPA axis dysregulation underlies cognitive disorders such as
Alzheimers disease (Swanwick et al., 1998). For example, dexamethasone treatment
for 1 week increased amyloid E-peptide levels in the whole brains of male 3X-TG-AD
mice (Green et al., 2006). Also, dexamethasone accelerated accumulation of tau-laden
neurofibrillary tangles in the hippocampus and amygdala of mice (Green et al., 2006).
In addition, immobilization stress accelerated the onset and progress of memory
impairment of a transgenic mouse model of Alzheimers disease (Jeong et al., 2006).
Overall, this suggests that disturbances of HPA axis activity are implicated in
Alzheimers-related pathological features and cognitive decline. However, all of these
studies used transgenic mice which already have or are prone to develop cognitive
impairment. In effect, Alzheimers mouse models demonstrated HPA axis
hyperactivity (Green et al., 2006), which could be induced by disease-related
destruction of hippocampal neurons (Ball et al., 1985; Braak et al., 1999), thereby
contributing to negative feedback regulation of HPA axis activity (Sapolsky et al.,
1984). Interestingly, the exercise protocol involving 1-hour wheel running (5
days/week) for 16 weeks improved memory performance in a transgenic mouse
model of Alzheimers disease (Yuede et al., 2009), and this effect could be due to
habituation of the HPA axis. As discussed earlier, corticosterone was reported to
mediate cognition-enhancing effects of voluntary wheel running (Hajisoltani et al.,
2011), and this could be via GRs as shown in the present work. In contrast, unlimited
access to running wheels for 8 weeks did not enhance memory performance of mice
with Alzheimers-like deficits (Richter et al., 2008), suggesting that intermittent
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exercise, as in the former study (Yuede et al., 2009), could be better than continuous
exercise. Overall, this suggests that elevation of glucocorticoids which accompanies
Alzheimers disease is a consequence rather than an underlying cause, but this does
not rule out the possibility that chronic glucocorticoid elevations worsen the
pathology and memory deterioration in Alzheimers disease.
The use of imaging studies has indicated that drug-seeking behaviour does not only
influence the reward system, but also other brain regions including memory circuits
are involved (Volkow et al., 2011; Volkow et al., 2012), suggesting that the effects of
corticosterone on the reward pathway may modify its effects on cognition. Abused
drugs have been shown to induce modifications of learning and memory. For
example, it has been reported that the majority of addictive drugs induce CPP
(Tzschentke, 1998), which is a learning paradigm to associate the rewarding effects of
a drug with the drug-paired environment, suggesting that motivated behaviour
facilitates learning and enhances adaptive memory via enhancements of dopamine
neurotransmission (Shohamy and Adcock, 2010). It has been found that nicotine
improves memory and, thus, nicotine patches may have a therapeutic use in retarding
cognitive deterioration in Alzheimers disease and schizophrenia (Levin and Rezvani,
2000). In contrast, repeated exposure to methamphetamine impaired recognition
memory in mice (Mizoguchi and Yamada, 2011). Also, other psychostimulants
including cocaine could modulate learning and memory (Harvey, 1987). Addiction is
accepted as the negative side of reward, suggesting that rewards without significant
dependency probably have cognition-enhancing effects. For example, spatial memory
of mice was improved by post-training self-administration of sugar which is a natural
reinforcer (Dalm et al., 2009). In agreement with this, our results showed that
significant corticosterone self-administration for a limited time enhanced spatial
memory and did not impair recognition memory.
In summary, moderate exposure to rewarding effects of corticosterone could improve
memory performance and mediate cognitive effects of exercise which has recently
been demonstrated as a novel strategy to treat cognitive dementia.
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5.5 Conclusion
The present thesis demonstrates that corticosterone has rewarding effects in male
C57BL/6J mice. Whereas acute inhibition of exercise-induced corticosterone
elevation attenuated the mices motivation to run, chronic blockade of GRs did not
influence running activity of mice. Moderate continuous corticosterone self-
administration or long-term intermittent voluntary wheel running did not impair
memory, but corticosterone self-administered groups outperformed the control groups
in the object location memory and were protected from ethanol-induced memory
impairment. In addition, exercise-evoked corticosterone rise rescued recognition
memory deficits induced by MIF in sedentary mice. All in all, the data from this
thesis suggest that rewarding effects of corticosterone improve cognition. Results also
showed that corticosterone-withdrawn mice exhibited alterations in synaptic plasticity
involving BDNF/pERK2 pathway in the hippocampus and frontal cortex, indicating
long-lasting neural adaptation induced by the stress hormone. Also, dopamine
turnover in the striatum was enhanced by corticosterone self-administration,
suggesting that dopamine is involved in the rewarding effects of corticosterone.
On the other hand, results indicate that voluntary wheel running regulates dopamine
neurotransmission, suggesting that dopamine is involved in the rewarding and
cognitive effects of wheel running. Moreover, D2 receptor blockade suggests that
cognitive effects of voluntary wheel running are controlled by the running
performance of mice. Taken together, this work provided insights into the role of
reward and motivated behaviour in the enhancement of cognitive performance.
5.6 Future work.
The present work provides more evidence that corticosterone is rewarding in mice.
However, there is a need for more experiments to unravel the mystery beyond some
findings.
First of all, it would be interesting to investigate the immediate effects of acute and
chronic corticosterone self-administration on dopamine levels in the nucleus
accumbens by means of microdialysis. Conversely, corticosterone-seeking behaviour
could be challenged by different dopamine receptor antagonists.
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Although previous work and the current results suggest that GRs have an
indispensable role in the rewarding effects of corticosterone, the use of
pharmacological interventions including GR and MR antagonists will enhance our
knowledge regarding the role of each receptor in the rewarding effects of
corticosterone.
In addition, studies involving the use of protein synthesis inhibitors such as
anisomysin, or corticosterone-bovine serum albumin complex; which acts only at
membrane-bound GRs and MRs, can be undertaken to investigate whether rewarding
effects of corticosterone are transcription-independent, since flavour-guided mice
drank almost uniquely from the corticosterone tube, which suggests that rewarding
effects of corticosterone are rapid.
Memory tests used in the thesis have provided, to some extent, insights into the
effects of corticosterone self-administration on memory performance of mice, but
other tasks including contextual fear conditioning or inhibitory avoidance can
alternatively be used, since corticosterone has been found to be important for
consolidation of fear memory (Barsegyan et al., 2010). Another good approach would
be to test memory performance of mice at the time of corticosterone self-
administration or wheel running, as this will eventually provide the opportunity to
study the simultaneous relationship between reward experience and memory
performance.
It would also be instructive to investigate whether the rewarding effects of
corticosterone are accompanied by antidepressant-like effects in standard tests.
Research can be done to examine if transgenic mouse models of cognitive disorders
have tendency to self-administer corticosterone. Then, effects on memory
performance can be studied after blocking de novo corticosterone synthesis.
Finally, results of this thesis have expanded our knowledge concerning the euphoric
effects of glucocorticoids, and the proposal that these rewarding effects could improve
memory encourages the development of new therapeutic strategies for certain
disorders, which involve dysregulation of HPA axis activity. For instance, rewarding
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stressors, such as exercise and rewarded competitions or challenges, can be examined
for their possible role in the prognosis and treatment of mood disorders and cognitive
dysfunction. Although addiction to exercise is reported in certain individuals as a
serious complication, controlled exercise could have a therapeutic potential for
substance dependence, in particular during the drug-withdrawal period, to attenuate
the risk of relapse. For example, effects of exercise or other forms of rewarding
stressors can be added to the treatment protocol of drug addicts under supervision,
especially when subjects are recovering, to study whether rewarding effects of stress
could safeguard against drug reinstatement. In addition, retrospective or meta-analysis
studies could be conducted to figure out the relationships between the risk of
developing mood disorders or substance abuse and the lack of exercise, or if these
health problems started after sufferers gave up exercising. Moreover, investigation
could be extended to find out whether subjects who were simultaneously prescribed
glucocorticoid therapy for any other diseases, such as bronchial asthma and arthritis,
had their mood status or substance dependency altered.
Taken together, these findings have provided evidence about the involvement of
glucocorticoids in the development of drug or behavioural addiction, suggesting that
the use and development of drugs which could modulate mineralocorticoid or
glucocorticoid receptor activity represent a promising therapeutic tool for substance or
behavioural dependence.
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